ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,Count,ont,comparison,geneID,symbol
hsa04010,MAPK signaling pathway,10/23,295/7844,3.606937028431824e-9,4.4365325449711435e-7,2.923517380939478e-7,10,kg,NAC,2353/3164/2318/3479/3725/4616/80310/4804/2247/4915,FOS/NR4A1/FLNC/IGF1/JUN/GADD45B/PDGFD/NGFR/FGF2/NTRK2
GO:0070371,ERK1 and ERK2 cascade,8/24,341/18493,7.002254426757727e-9,9.081923991504772e-6,5.218522246467863e-6,8,bp,NAC,9314/10252/3479/3725/80310/2247/4915/5320,KLF4/SPRY1/IGF1/JUN/PDGFD/FGF2/NTRK2/PLA2G2A
hsa04151,PI3K-Akt signaling pathway,9/23,354/7844,3.270661790631135e-7,2.011457001238148e-5,1.3254787256768284e-5,9,kg,NAC,3164/3679/3479/80310/4804/2247/8516/4915/7060,NR4A1/ITGA7/IGF1/PDGFD/NGFR/FGF2/ITGA8/NTRK2/THBS4
hsa04510,Focal adhesion,7/23,199/7844,1.057247381828186e-6,4.334714265495563e-5,2.856422750904222e-5,7,kg,NAC,3679/2318/3479/3725/80310/8516/7060,ITGA7/FLNC/IGF1/JUN/PDGFD/ITGA8/THBS4
GO:0070372,regulation of ERK1 and ERK2 cascade,7/24,324/18493,1.2725751455583421e-7,8.252649818945849e-5,4.742016858185822e-5,7,bp,NAC,9314/10252/3725/80310/2247/4915/5320,KLF4/SPRY1/JUN/PDGFD/FGF2/NTRK2/PLA2G2A
GO:0061614,pri-miRNA transcription by RNA polymerase II,4/24,44/18493,2.8601792067920077e-7,1.236550810403078e-4,7.105287292662252e-5,4,bp,NAC,2353/9314/3725/4804,FOS/KLF4/JUN/NGFR
hsa05202,Transcriptional misregulation in cancer,6/23,186/7844,1.183036353184323e-5,3.6378367860417937e-4,2.3972052419787599e-4,6,kg,NAC,3479/4616/7102/862/4804/7704,IGF1/GADD45B/TSPAN7/RUNX1T1/NGFR/ZBTB16
GO:0001936,regulation of endothelial cell proliferation,5/24,175/18493,2.6327802897199954e-6,5.691193392944723e-4,3.270190254599573e-4,5,bp,NAC,3164/3725/4804/2247/7060,NR4A1/JUN/NGFR/FGF2/THBS4
GO:0048659,smooth muscle cell proliferation,5/24,170/18493,2.2834591209277147e-6,5.691193392944723e-4,3.270190254599573e-4,5,bp,NAC,9314/3479/3725/80310/2247,KLF4/IGF1/JUN/PDGFD/FGF2
GO:0048660,regulation of smooth muscle cell proliferation,5/24,168/18493,2.154429060530717e-6,5.691193392944723e-4,3.270190254599573e-4,5,bp,NAC,9314/3479/3725/80310/2247,KLF4/IGF1/JUN/PDGFD/FGF2
GO:0001935,endothelial cell proliferation,5/24,190/18493,3.9389635491625995e-6,7.298336747519845e-4,4.193663447830256e-4,5,bp,NAC,3164/3725/4804/2247/7060,NR4A1/JUN/NGFR/FGF2/THBS4
GO:0050678,regulation of epithelial cell proliferation,6/24,368/18493,5.9248071325305675e-6,7.684474850892146e-4,4.415540473506991e-4,6,bp,NAC,3164/3479/3725/4804/2247/7060,NR4A1/IGF1/JUN/NGFR/FGF2/THBS4
GO:0050679,positive regulation of epithelial cell proliferation,5/24,203/18493,5.441564537352945e-6,7.684474850892146e-4,4.415540473506991e-4,5,bp,NAC,3164/3479/3725/2247/7060,NR4A1/IGF1/JUN/FGF2/THBS4
GO:1902895,positive regulation of pri-miRNA transcription by RNA polymerase II,3/24,27/18493,5.503704430150225e-6,7.684474850892146e-4,4.415540473506991e-4,3,bp,NAC,2353/3725/4804,FOS/JUN/NGFR
GO:0018108,peptidyl-tyrosine phosphorylation,6/24,387/18493,7.902530646799395e-6,7.808920674487415e-4,4.487047711347718e-4,6,bp,NAC,3479/9021/80310/2247/4915/7060,IGF1/SOCS3/PDGFD/FGF2/NTRK2/THBS4
GO:0018212,peptidyl-tyrosine modification,6/24,390/18493,8.258834265800429e-6,7.808920674487415e-4,4.487047711347718e-4,6,bp,NAC,3479/9021/80310/2247/4915/7060,IGF1/SOCS3/PDGFD/FGF2/NTRK2/THBS4
GO:0048011,neurotrophin TRK receptor signaling pathway,3/24,31/18493,8.429058553802916e-6,7.808920674487415e-4,4.487047711347718e-4,3,bp,NAC,10252/4804/4915,SPRY1/NGFR/NTRK2
GO:0048661,positive regulation of smooth muscle cell proliferation,4/24,98/18493,7.263006353567808e-6,7.808920674487415e-4,4.487047711347718e-4,4,bp,NAC,3479/3725/80310/2247,IGF1/JUN/PDGFD/FGF2
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,4/24,106/18493,9.919255781573958e-6,8.576849832467616e-4,4.928303925160956e-4,4,bp,NAC,9314/3479/80310/4915,KLF4/IGF1/PDGFD/NTRK2
GO:0001938,positive regulation of endothelial cell proliferation,4/24,112/18493,1.233717173473395e-5,8.790253693313479e-4,5.050926928430746e-4,4,bp,NAC,3164/3725/2247/7060,NR4A1/JUN/FGF2/THBS4
GO:0033002,muscle cell proliferation,5/24,236/18493,1.1311025250674412e-5,8.790253693313479e-4,5.050926928430746e-4,5,bp,NAC,9314/3479/3725/80310/2247,KLF4/IGF1/JUN/PDGFD/FGF2
GO:0050673,epithelial cell proliferation,6/24,420/18493,1.2595796225045066e-5,8.790253693313479e-4,5.050926928430746e-4,6,bp,NAC,3164/3479/3725/4804/2247/7060,NR4A1/IGF1/JUN/NGFR/FGF2/THBS4
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,5/24,245/18493,1.3554747406805675e-5,8.790253693313479e-4,5.050926928430746e-4,5,bp,NAC,3479/9021/80310/4915/7060,IGF1/SOCS3/PDGFD/NTRK2/THBS4
GO:0070374,positive regulation of ERK1 and ERK2 cascade,5/24,245/18493,1.3554747406805675e-5,8.790253693313479e-4,5.050926928430746e-4,5,bp,NAC,3725/80310/2247/4915/5320,JUN/PDGFD/FGF2/NTRK2/PLA2G2A
GO:1902893,regulation of pri-miRNA transcription by RNA polymerase II,3/24,37/18493,1.4496086237829106e-5,8.953058976411595e-4,5.144475717485216e-4,3,bp,NAC,2353/3725/4804,FOS/JUN/NGFR
hsa04014,Ras signaling pathway,6/23,232/7844,4.1515035516164965e-5,9.723437527606177e-4,6.407399996796538e-4,6,kg,NAC,3479/80310/4804/2247/4915/5320,IGF1/PDGFD/NGFR/FGF2/NTRK2/PLA2G2A
hsa05218,Melanoma,4/23,72/7844,5.0646636796742876e-5,9.723437527606177e-4,6.407399996796538e-4,4,kg,NAC,3479/4616/80310/2247,IGF1/GADD45B/PDGFD/FGF2
hsa05224,Breast cancer,5/23,147/7844,5.533663633597011e-5,9.723437527606177e-4,6.407399996796538e-4,5,kg,NAC,2353/3479/3725/4616/2247,FOS/IGF1/JUN/GADD45B/FGF2
GO:0038179,neurotrophin signaling pathway,3/24,39/18493,1.7021137813141658e-5,0.0010034734428929423,5.766012235265212e-4,3,bp,NAC,10252/4804/4915,SPRY1/NGFR/NTRK2
GO:0001822,kidney development,5/24,271/18493,2.203444937371188e-5,0.0012425513407697524,7.139766662054008e-4,5,bp,NAC,10252/80310/2247/8516/7704,SPRY1/PDGFD/FGF2/ITGA8/ZBTB16
GO:0014065,phosphatidylinositol 3-kinase signaling,4/24,136/18493,2.6524777889463587e-5,0.0014334432051097612,8.236641555149219e-4,4,bp,NAC,9314/3479/80310/4915,KLF4/IGF1/PDGFD/NTRK2
GO:0072001,renal system development,5/24,286/18493,2.8531335699758703e-5,0.0014802056961034816,8.505341337022805e-4,5,bp,NAC,10252/80310/2247/8516/7704,SPRY1/PDGFD/FGF2/ITGA8/ZBTB16
GO:1904707,positive regulation of vascular smooth muscle cell proliferation,3/24,48/18493,3.1967346925995216e-5,0.0015946788062698384,9.163109969070693e-4,3,bp,NAC,3479/3725/2247,IGF1/JUN/FGF2
GO:0043551,regulation of phosphatidylinositol 3-kinase activity,3/24,54/18493,4.561036541630373e-5,0.0021909868127757753,0.0012589527764032373,3,bp,NAC,9314/9021/2247,KLF4/SOCS3/FGF2
GO:0048146,positive regulation of fibroblast proliferation,3/24,55/18493,4.820066924302975e-5,0.0022327238574360564,0.0012829351061678592,3,bp,NAC,3479/3725/80310,IGF1/JUN/PDGFD
GO:0001655,urogenital system development,5/24,322/18493,5.0235044184577136e-5,0.0022467190450826393,0.0012909768160682617,5,bp,NAC,10252/80310/2247/8516/7704,SPRY1/PDGFD/FGF2/ITGA8/ZBTB16
GO:0034614,cellular response to reactive oxygen species,4/24,162/18493,5.2588802956181266e-5,0.0022735892478055702,0.001306416578700924,4,bp,NAC,2353/9314/3725/80310,FOS/KLF4/JUN/PDGFD
GO:0048015,phosphatidylinositol-mediated signaling,4/24,164/18493,5.516386420793812e-5,0.0023079848992805076,0.0013261805045575617,4,bp,NAC,9314/3479/80310/4915,KLF4/IGF1/PDGFD/NTRK2
GO:0043405,regulation of MAP kinase activity,5/24,335/18493,6.061914797705487e-5,0.002382516209886066,0.0013690065954626745,5,bp,NAC,10252/3479/4616/80310/2247,SPRY1/IGF1/GADD45B/PDGFD/FGF2
GO:0048017,inositol lipid-mediated signaling,4/24,167/18493,5.919775592262248e-5,0.002382516209886066,0.0013690065954626745,4,bp,NAC,9314/3479/80310/4915,KLF4/IGF1/PDGFD/NTRK2
GO:0043550,regulation of lipid kinase activity,3/24,63/18493,7.246434710848305e-5,0.002764301711755956,0.0015883825929661297,3,bp,NAC,9314/9021/2247,KLF4/SOCS3/FGF2
GO:1901653,cellular response to peptide,5/24,356/18493,8.082354610875008e-5,0.0029950896943728243,0.0017209946058645129,5,bp,NAC,3164/9314/3479/9021/4804,NR4A1/KLF4/IGF1/SOCS3/NGFR
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,4/24,186/18493,8.993997576204287e-5,0.0032403374600936,0.0018619152877054487,4,bp,NAC,3479/9021/4915/7060,IGF1/SOCS3/NTRK2/THBS4
GO:0002040,sprouting angiogenesis,4/24,189/18493,9.568497877824029e-5,0.0033541464182534502,0.0019273105256043845,4,bp,NAC,3164/9314/4804/2247,NR4A1/KLF4/NGFR/FGF2
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,3/24,70/18493,9.929560001026405e-5,0.003389115610876644,0.001947404011281633,3,bp,NAC,3479/80310/4915,IGF1/PDGFD/NTRK2
GO:0001933,negative regulation of protein phosphorylation,5/24,408/18493,1.533402416654154e-4,0.005099545985642148,0.002930226480407938,5,bp,NAC,9314/10252/9021/3725/4616,KLF4/SPRY1/SOCS3/JUN/GADD45B
GO:0045444,fat cell differentiation,4/24,217/18493,1.6296376465061002e-4,0.0052841000687960295,0.0030362722466482075,4,bp,NAC,3164/9314/862/7704,NR4A1/KLF4/RUNX1T1/ZBTB16
GO:0000302,response to reactive oxygen species,4/24,224/18493,1.840717310220365e-4,0.005343279257375663,0.003070276925879129,4,bp,NAC,2353/9314/3725/80310,FOS/KLF4/JUN/PDGFD
GO:0051781,positive regulation of cell division,3/24,84/18493,1.7079270054404138e-4,0.005343279257375663,0.003070276925879129,3,bp,NAC,80310/2247/7060,PDGFD/FGF2/THBS4
GO:1901342,regulation of vasculature development,5/24,421/18493,1.7750839899643514e-4,0.005343279257375663,0.003070276925879129,5,bp,NAC,9314/80310/4804/2247/7060,KLF4/PDGFD/NGFR/FGF2/THBS4
GO:1903725,regulation of phospholipid metabolic process,3/24,86/18493,1.8312827925617e-4,0.005343279257375663,0.003070276925879129,3,bp,NAC,9314/9021/2247,KLF4/SOCS3/FGF2
GO:1904705,regulation of vascular smooth muscle cell proliferation,3/24,87/18493,1.895072057357598e-4,0.005343279257375663,0.003070276925879129,3,bp,NAC,3479/3725/2247,IGF1/JUN/FGF2
GO:1990874,vascular smooth muscle cell proliferation,3/24,87/18493,1.895072057357598e-4,0.005343279257375663,0.003070276925879129,3,bp,NAC,3479/3725/2247,IGF1/JUN/FGF2
GO:0007265,Ras protein signal transduction,5/24,430/18493,1.9588012662088273e-4,0.005405457962282657,0.003106005143282978,5,bp,NAC,10252/3479/3725/4804/2247,SPRY1/IGF1/JUN/NGFR/FGF2
GO:0048145,regulation of fibroblast proliferation,3/24,90/18493,2.095054673599746e-4,0.00566101231595598,0.003252848045852237,3,bp,NAC,3479/3725/80310,IGF1/JUN/PDGFD
GO:0048144,fibroblast proliferation,3/24,91/18493,2.16463387505921e-4,0.0057296533386771336,0.0032922895457398946,3,bp,NAC,3479/3725/80310,IGF1/JUN/PDGFD
GO:0008083,growth factor activity,4/23,166/17632,5.834581832670363e-5,0.005951273469323771,0.0033779157978617897,4,mf,NAC,3479/80310/2247/7060,IGF1/PDGFD/FGF2/THBS4
GO:0042326,negative regulation of phosphorylation,5/24,448/18493,2.3696788011493496e-4,0.006146946810181414,0.0035320686130815566,5,bp,NAC,9314/10252/9021/3725/4616,KLF4/SPRY1/SOCS3/JUN/GADD45B
GO:0071560,cellular response to transforming growth factor beta stimulus,4/24,242/18493,2.473721212256925e-4,0.006291012573131827,0.0036148495733290048,4,bp,NAC,2353/3725/80310/8516,FOS/JUN/PDGFD/ITGA8
GO:0001823,mesonephros development,3/24,101/18493,2.944225817293971e-4,0.006583898077638414,0.0037831431554339956,3,bp,NAC,10252/2247/7704,SPRY1/FGF2/ZBTB16
GO:0002042,cell migration involved in sprouting angiogenesis,3/24,101/18493,2.944225817293971e-4,0.006583898077638414,0.0037831431554339956,3,bp,NAC,3164/9314/2247,NR4A1/KLF4/FGF2
GO:0007611,learning or memory,4/24,247/18493,2.6743224399653945e-4,0.006583898077638414,0.0037831431554339956,4,bp,NAC,2353/3725/8516/4915,FOS/JUN/ITGA8/NTRK2
GO:0007631,feeding behavior,3/24,101/18493,2.944225817293971e-4,0.006583898077638414,0.0037831431554339956,3,bp,NAC,2353/3953/4915,FOS/LEPR/NTRK2
GO:0035994,response to muscle stretch,2/24,19/18493,2.723255100165129e-4,0.006583898077638414,0.0037831431554339956,2,bp,NAC,2353/3725,FOS/JUN
GO:0043491,protein kinase B signaling,4/24,253/18493,2.9302213417924377e-4,0.006583898077638414,0.0037831431554339956,4,bp,NAC,9314/3479/2247/4915,KLF4/IGF1/FGF2/NTRK2
GO:0071559,response to transforming growth factor beta,4/24,249/18493,2.757753900442471e-4,0.006583898077638414,0.0037831431554339956,4,bp,NAC,2353/3725/80310/8516,FOS/JUN/PDGFD/ITGA8
GO:0014812,muscle cell migration,3/24,103/18493,3.1191351165065276e-4,0.006823446703516175,0.003920789080947491,3,bp,NAC,3479/80310/7060,IGF1/PDGFD/THBS4
GO:0043406,positive regulation of MAP kinase activity,4/24,258/18493,3.156567480423828e-4,0.006823446703516175,0.003920789080947491,4,bp,NAC,3479/4616/80310/2247,IGF1/GADD45B/PDGFD/FGF2
GO:1901652,response to peptide,5/24,481/18493,3.2907881918118513e-4,0.00699697095865569,0.0040204970488400184,5,bp,NAC,3164/9314/3479/9021/4804,NR4A1/KLF4/IGF1/SOCS3/NGFR
GO:0043235,receptor complex,5/24,396/19659,1.0021348659792291e-4,0.0072153710350504495,0.005801833434616589,5,cc,NAC,3679/3977/3953/8516/4915,ITGA7/LIFR/LEPR/ITGA8/NTRK2
GO:0071900,regulation of protein serine/threonine kinase activity,5/24,496/18493,3.7898445223787466e-4,0.007928110234718119,0.00455553467206138,5,bp,NAC,10252/3479/4616/80310/2247,SPRY1/IGF1/GADD45B/PDGFD/FGF2
GO:0090287,regulation of cellular response to growth factor stimulus,4/24,282/18493,4.4213818897910126e-4,0.008960206736029598,0.005148582858506639,4,bp,NAC,10252/6424/2247/8516,SPRY1/SFRP4/FGF2/ITGA8
GO:2000679,positive regulation of transcription regulatory region DNA binding,2/24,24/18493,4.3780445797589194e-4,0.008960206736029598,0.005148582858506639,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0001704,formation of primary germ layer,3/24,118/18493,4.647918829533537e-4,0.009133864730159088,0.005248367673540261,3,bp,NAC,9314/3679/8516,KLF4/ITGA7/ITGA8
GO:0050890,cognition,4/24,285/18493,4.6015993455243064e-4,0.009133864730159088,0.005248367673540261,4,bp,NAC,2353/3725/8516/4915,FOS/JUN/ITGA8/NTRK2
GO:0034599,cellular response to oxidative stress,4/24,289/18493,4.849994136862879e-4,0.00938871999330023,0.005394808874939385,4,bp,NAC,2353/9314/3725/80310,FOS/KLF4/JUN/PDGFD
GO:0051101,regulation of DNA binding,3/24,122/18493,5.123671538154617e-4,0.009772649977921379,0.005615417103736019,3,bp,NAC,9314/3479/3725,KLF4/IGF1/JUN
GO:0060326,cell chemotaxis,4/24,295/18493,5.240371174578017e-4,0.009850378860040128,0.005660080536386325,4,bp,NAC,3164/80310/2247/7060,NR4A1/PDGFD/FGF2/THBS4
hsa04550,Signaling pathways regulating pluripotency of stem cells,4/23,139/7844,6.435311301704835e-4,0.009894291126371184,0.006519986450411477,4,kg,NAC,9314/3479/3977/2247,KLF4/IGF1/LIFR/FGF2
GO:0032103,positive regulation of response to external stimulus,4/24,297/18493,5.375342564921457e-4,0.009959741866718755,0.00572292110671337,4,bp,NAC,80310/2247/7060/5320,PDGFD/FGF2/THBS4/PLA2G2A
GO:0000791,euchromatin,2/24,33/19659,7.369391411499354e-4,0.010121396615047172,0.008138549909760153,2,cc,NAC,9314/3725,KLF4/JUN
GO:0005667,transcription factor complex,4/24,356/19659,8.434497179205977e-4,0.010121396615047172,0.008138549909760153,4,cc,NAC,2353/3164/9314/3725,FOS/NR4A1/KLF4/JUN
GO:0005719,nuclear euchromatin,2/24,25/19659,4.212194568222821e-4,0.010121396615047172,0.008138549909760153,2,cc,NAC,9314/3725,KLF4/JUN
GO:0008305,integrin complex,2/24,32/19659,6.927922133799156e-4,0.010121396615047172,0.008138549909760153,2,cc,NAC,3679/8516,ITGA7/ITGA8
GO:0098636,protein complex involved in cell adhesion,2/24,35/19659,8.292156340002992e-4,0.010121396615047172,0.008138549909760153,2,cc,NAC,3679/8516,ITGA7/ITGA8
GO:1904646,cellular response to amyloid-beta,2/24,28/18493,5.977042875125409e-4,0.01091862620991219,0.0062739011943495765,2,bp,NAC,3479/4804,IGF1/NGFR
GO:0050921,positive regulation of chemotaxis,3/24,130/18493,6.166552917944656e-4,0.011108359909130859,0.006382923195767275,3,bp,NAC,80310/2247/7060,PDGFD/FGF2/THBS4
GO:0035014,phosphatidylinositol 3-kinase regulator activity,2/23,17/17632,2.187448346620668e-4,0.011155986567765407,0.006332087319165092,2,mf,NAC,9314/9021,KLF4/SOCS3
GO:0001077,"proximal promoter DNA-binding transcription activator activity, RNA polymerase II-specific",4/23,298/17632,5.494242852358632e-4,0.011254006294675736,0.006387722871074981,4,mf,NAC,2353/3164/9314/3725,FOS/NR4A1/KLF4/JUN
GO:0001085,RNA polymerase II transcription factor binding,3/23,140/17632,7.723337653208839e-4,0.011254006294675736,0.006387722871074981,3,mf,NAC,2353/9314/3725,FOS/KLF4/JUN
GO:0005178,integrin binding,3/23,126/17632,5.683978825260399e-4,0.011254006294675736,0.006387722871074981,3,mf,NAC,3479/2247/7060,IGF1/FGF2/THBS4
GO:0019838,growth factor binding,3/23,137/17632,7.252429167981767e-4,0.011254006294675736,0.006387722871074981,3,mf,NAC,4804/3977/4915,NGFR/LIFR/NTRK2
GO:0070412,R-SMAD binding,2/23,23/17632,4.0499664366764135e-4,0.011254006294675736,0.006387722871074981,2,mf,NAC,2353/3725,FOS/JUN
R-HSA-2586552,Signaling by Leptin,2/21,11/10554,2.0517557729303693e-4,0.012720885792168289,0.006047280172847404,2,re,NAC,9021/3953,SOCS3/LEPR
R-HSA-450341,Activation of the AP-1 family of transcription factors,2/21,10/10554,1.6807255365102163e-4,0.012720885792168289,0.006047280172847404,2,re,NAC,2353/3725,FOS/JUN
R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,6/21,455/10554,1.9384406949874054e-4,0.012720885792168289,0.006047280172847404,6,re,NAC,10252/3479/80310/2247/4915/7060,SPRY1/IGF1/PDGFD/FGF2/NTRK2/THBS4
GO:0071902,positive regulation of protein serine/threonine kinase activity,4/24,323/18493,7.363844503151427e-4,0.012906630162955948,0.00741621893062761,4,bp,NAC,3479/4616/80310/2247,IGF1/GADD45B/PDGFD/FGF2
GO:1904645,response to amyloid-beta,2/24,31/18493,7.335257175364291e-4,0.012906630162955948,0.00741621893062761,2,bp,NAC,3479/4804,IGF1/NGFR
GO:0007612,learning,3/24,141/18493,7.809052112834275e-4,0.013086256153965494,0.007519432988684469,3,bp,NAC,2353/3725/4915,FOS/JUN/NTRK2
GO:0035767,endothelial cell chemotaxis,2/24,32/18493,7.818078913407825e-4,0.013086256153965494,0.007519432988684469,2,bp,NAC,3164/2247,NR4A1/FGF2
GO:0042542,response to hydrogen peroxide,3/24,141/18493,7.809052112834275e-4,0.013086256153965494,0.007519432988684469,3,bp,NAC,9314/3725/80310,KLF4/JUN/PDGFD
GO:0044344,cellular response to fibroblast growth factor stimulus,3/24,142/18493,7.9708113813668e-4,0.013086256153965494,0.007519432988684469,3,bp,NAC,3164/10252/2247,NR4A1/SPRY1/FGF2
GO:1902107,positive regulation of leukocyte differentiation,3/24,142/18493,7.9708113813668e-4,0.013086256153965494,0.007519432988684469,3,bp,NAC,2353/3725/7704,FOS/JUN/ZBTB16
GO:1903670,regulation of sprouting angiogenesis,3/24,143/18493,8.134693742659917e-4,0.01318837223028739,0.007578109433951606,3,bp,NAC,9314/4804/2247,KLF4/NGFR/FGF2
GO:0070997,neuron death,4/24,335/18493,8.438056823607048e-4,0.013511308271874495,0.007763670215872371,4,bp,NAC,2353/3725/4804/4915,FOS/JUN/NGFR/NTRK2
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,4/24,340/18493,8.916813357805614e-4,0.0137121048392044,0.00787904900065472,4,bp,NAC,2353/3725/6424/8516,FOS/JUN/SFRP4/ITGA8
GO:0048333,mesodermal cell differentiation,2/24,34/18493,8.828628829418518e-4,0.0137121048392044,0.00787904900065472,2,bp,NAC,9314/8516,KLF4/ITGA8
GO:0071774,response to fibroblast growth factor,3/24,148/18493,8.986344728854077e-4,0.0137121048392044,0.00787904900065472,3,bp,NAC,3164/10252/2247,NR4A1/SPRY1/FGF2
GO:0098727,maintenance of cell number,3/24,147/18493,8.811678803808069e-4,0.0137121048392044,0.00787904900065472,3,bp,NAC,9314/3479/2247,KLF4/IGF1/FGF2
GO:0010631,epithelial cell migration,4/24,346/18493,9.516360376761678e-4,0.014351999312395228,0.008246735797732274,4,bp,NAC,3164/9314/3725/2247,NR4A1/KLF4/JUN/FGF2
GO:0090132,epithelium migration,4/24,349/18493,9.826586343859658e-4,0.014649520101133306,0.008417692839023156,4,bp,NAC,3164/9314/3725/2247,NR4A1/KLF4/JUN/FGF2
GO:0071276,cellular response to cadmium ion,2/24,37/18493,0.001045617437411715,0.015255622949434966,0.008765962787160618,2,bp,NAC,2353/3725,FOS/JUN
GO:0090130,tissue migration,4/24,355/18493,0.001046839200076879,0.015255622949434966,0.008765962787160618,4,bp,NAC,3164/9314/3725/2247,NR4A1/KLF4/JUN/FGF2
GO:0051302,regulation of cell division,3/24,162/18493,0.001166655223721315,0.016812798057406063,0.009660723957832644,3,bp,NAC,80310/2247/7060,PDGFD/FGF2/THBS4
GO:0060759,regulation of response to cytokine stimulus,3/24,165/18493,0.0012299556663344792,0.017530247244349664,0.010072974109483067,3,bp,NAC,9314/9021/3977,KLF4/SOCS3/LIFR
GO:0044798,nuclear transcription factor complex,3/24,198/19659,0.0017425518379476494,0.017923390333175825,0.014412082870243719,3,cc,NAC,2353/9314/3725,FOS/KLF4/JUN
hsa01521,EGFR tyrosine kinase inhibitor resistance,3/23,79/7844,0.001506083278453224,0.01819648020633277,0.011990834196727628,3,kg,NAC,3479/80310/2247,IGF1/PDGFD/FGF2
hsa04512,ECM-receptor interaction,3/23,82/7844,0.0016770124467049355,0.01819648020633277,0.011990834196727628,3,kg,NAC,3679/8516/7060,ITGA7/ITGA8/THBS4
hsa05132,Salmonella infection,3/23,86/7844,0.0019232052250595611,0.01819648020633277,0.011990834196727628,3,kg,NAC,2353/2318/3725,FOS/FLNC/JUN
hsa05210,Colorectal cancer,3/23,86/7844,0.0019232052250595611,0.01819648020633277,0.011990834196727628,3,kg,NAC,2353/3725/4616,FOS/JUN/GADD45B
hsa05410,Hypertrophic cardiomyopathy (HCM),3/23,85/7844,0.0018596655424452087,0.01819648020633277,0.011990834196727628,3,kg,NAC,3679/3479/8516,ITGA7/IGF1/ITGA8
GO:0010863,positive regulation of phospholipase C activity,2/24,42/18493,0.0013464259374818255,0.018959518067796034,0.01089424079211102,2,bp,NAC,2247/4915,FGF2/NTRK2
GO:0045765,regulation of angiogenesis,4/24,381/18493,0.0013594719971511422,0.018959518067796034,0.01089424079211102,4,bp,NAC,9314/4804/2247/7060,KLF4/NGFR/FGF2/THBS4
GO:0001102,RNA polymerase II activating transcription factor binding,2/23,44/17632,0.001489325734815914,0.018988903118902903,0.010778015186167798,2,mf,NAC,2353/3725,FOS/JUN
hsa05414,Dilated cardiomyopathy (DCM),3/23,91/7844,0.002261285713858582,0.019867010200328973,0.013091654132865473,3,kg,NAC,3679/3479/8516,ITGA7/IGF1/ITGA8
GO:1900274,regulation of phospholipase C activity,2/24,44/18493,0.0014770081463345748,0.020379569848893015,0.011710210163548476,2,bp,NAC,2247/4915,FGF2/NTRK2
GO:0007369,gastrulation,3/24,181/18493,0.0016042496072705317,0.020409974227394396,0.0117276806825429,3,bp,NAC,9314/3679/8516,KLF4/ITGA7/ITGA8
GO:0007517,muscle organ development,4/24,403/18493,0.0016709854730453954,0.020409974227394396,0.0117276806825429,4,bp,NAC,2353/3679/3479/2247,FOS/ITGA7/IGF1/FGF2
GO:0014911,positive regulation of smooth muscle cell migration,2/24,45/18493,0.0015444832334090125,0.020409974227394396,0.0117276806825429,2,bp,NAC,3479/80310,IGF1/PDGFD
GO:0016525,negative regulation of angiogenesis,3/24,178/18493,0.0015292590632658284,0.020409974227394396,0.0117276806825429,3,bp,NAC,9314/4804/7060,KLF4/NGFR/THBS4
GO:0031103,axon regeneration,2/24,46/18493,0.001613409549577201,0.020409974227394396,0.0117276806825429,2,bp,NAC,9314/3725,KLF4/JUN
GO:0031952,regulation of protein autophosphorylation,2/24,46/18493,0.001613409549577201,0.020409974227394396,0.0117276806825429,2,bp,NAC,3725/80310,JUN/PDGFD
GO:0043062,extracellular structure organization,4/24,402/18493,0.0016558367496137389,0.020409974227394396,0.0117276806825429,4,bp,NAC,3679/2247/8516/5320,ITGA7/FGF2/ITGA8/PLA2G2A
GO:0043534,blood vessel endothelial cell migration,3/24,182/18493,0.0016297508366146809,0.020409974227394396,0.0117276806825429,3,bp,NAC,3164/9314/2247,NR4A1/KLF4/FGF2
GO:0055023,positive regulation of cardiac muscle tissue growth,2/24,47/18493,0.001683783533023285,0.020409974227394396,0.0117276806825429,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0060537,muscle tissue development,4/24,395/18493,0.001552476541905328,0.020409974227394396,0.0117276806825429,4,bp,NAC,2353/3479/2247/8516,FOS/IGF1/FGF2/ITGA8
GO:0061138,morphogenesis of a branching epithelium,3/24,182/18493,0.0016297508366146809,0.020409974227394396,0.0117276806825429,3,bp,NAC,10252/9021/2247,SPRY1/SOCS3/FGF2
GO:1903708,positive regulation of hemopoiesis,3/24,183/18493,0.0016555058418684188,0.020409974227394396,0.0117276806825429,3,bp,NAC,2353/3725/7704,FOS/JUN/ZBTB16
GO:2000181,negative regulation of blood vessel morphogenesis,3/24,180/18493,0.0015790012048761937,0.020409974227394396,0.0117276806825429,3,bp,NAC,9314/4804/7060,KLF4/NGFR/THBS4
hsa01522,Endocrine resistance,3/23,98/7844,0.0027934787655534924,0.020803496246330218,0.013708765177299331,3,kg,NAC,2353/3479/3725,FOS/IGF1/JUN
hsa04015,Rap1 signaling pathway,4/23,206/7844,0.0027637643308821395,0.020803496246330218,0.013708765177299331,4,kg,NAC,3479/80310/4804/2247,IGF1/PDGFD/NGFR/FGF2
hsa05231,Choline metabolism in cancer,3/23,99/7844,0.0028752799690049896,0.020803496246330218,0.013708765177299331,3,kg,NAC,2353/3725/80310,FOS/JUN/PDGFD
GO:0031099,regeneration,3/24,188/18493,0.0017881204161710696,0.021474001664572938,0.01233907655603428,3,bp,NAC,9314/3479/3725,KLF4/IGF1/JUN
GO:0051090,regulation of DNA-binding transcription factor activity,4/24,412/18493,0.0018117171825136576,0.02155777234605701,0.012387211639011778,4,bp,NAC,2353/9314/3725/6424,FOS/KLF4/JUN/SFRP4
hsa04810,Regulation of actin cytoskeleton,4/23,214/7844,0.003172459563295467,0.021678473682519024,0.014285344232383096,4,kg,NAC,3679/80310/2247/8516,ITGA7/PDGFD/FGF2/ITGA8
GO:0007179,transforming growth factor beta receptor signaling pathway,3/24,193/18493,0.001927219240730368,0.022317887100243634,0.012823977654484026,3,bp,NAC,2353/3725/8516,FOS/JUN/ITGA8
GO:0007623,circadian rhythm,3/24,193/18493,0.001927219240730368,0.022317887100243634,0.012823977654484026,3,bp,NAC,3725/4804/4915,JUN/NGFR/NTRK2
GO:1901343,negative regulation of vasculature development,3/24,192/18493,0.0018988752363772589,0.022317887100243634,0.012823977654484026,3,bp,NAC,9314/4804/7060,KLF4/NGFR/THBS4
GO:0035265,organ growth,3/24,195/18493,0.0019846999349207267,0.022383963613845065,0.012861945573673907,3,bp,NAC,3479/3953/2247,IGF1/LEPR/FGF2
GO:0060421,positive regulation of heart growth,2/24,51/18493,0.0019796851179675803,0.022383963613845065,0.012861945573673907,2,bp,NAC,3479/2247,IGF1/FGF2
GO:2000677,regulation of transcription regulatory region DNA binding,2/24,51/18493,0.0019796851179675803,0.022383963613845065,0.012861945573673907,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0001763,morphogenesis of a branching structure,3/24,196/18493,0.0020138384153045854,0.022516796764224547,0.012938272214479551,3,bp,NAC,10252/9021/2247,SPRY1/SOCS3/FGF2
GO:0002763,positive regulation of myeloid leukocyte differentiation,2/24,52/18493,0.0020572442251387056,0.022805519316281206,0.01310417374177421,2,bp,NAC,2353/3725,FOS/JUN
hsa04668,TNF signaling pathway,3/23,110/7844,0.0038741003824986613,0.025079702476175546,0.016526633210659107,3,kg,NAC,2353/9021/3725,FOS/SOCS3/JUN
GO:0006979,response to oxidative stress,4/24,441/18493,0.0023213478510662783,0.02508990135694136,0.014416791917148463,4,bp,NAC,2353/9314/3725/80310,FOS/KLF4/JUN/PDGFD
GO:0031102,neuron projection regeneration,2/24,55/18493,0.0022984660266399263,0.02508990135694136,0.014416791917148463,2,bp,NAC,9314/3725,KLF4/JUN
GO:0071229,cellular response to acid chemical,3/24,206/18493,0.002320031303706024,0.02508990135694136,0.014416791917148463,3,bp,NAC,9314/80310/4915,KLF4/PDGFD/NTRK2
GO:0000982,"transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding",4/23,447/17632,0.002461484034251043,0.025516810185292556,0.014483225595367294,4,mf,NAC,2353/3164/9314/3725,FOS/NR4A1/KLF4/JUN
GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",4/23,449/17632,0.0025016480573816233,0.025516810185292556,0.014483225595367294,4,mf,NAC,2353/3164/9314/3725,FOS/NR4A1/KLF4/JUN
GO:0050920,regulation of chemotaxis,3/24,210/18493,0.0024501679152392378,0.026263370132771004,0.015091073370938497,3,bp,NAC,80310/2247/7060,PDGFD/FGF2/THBS4
GO:0001836,release of cytochrome c from mitochondria,2/24,58/18493,0.0025524308398361434,0.026697603219899016,0.015340586032291931,2,bp,NAC,3479/3725,IGF1/JUN
GO:0010518,positive regulation of phospholipase activity,2/24,58/18493,0.0025524308398361434,0.026697603219899016,0.015340586032291931,2,bp,NAC,2247/4915,FGF2/NTRK2
GO:0043388,positive regulation of DNA binding,2/24,58/18493,0.0025524308398361434,0.026697603219899016,0.015340586032291931,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0001667,ameboidal-type cell migration,4/24,456/18493,0.002620503204966043,0.02717422144161486,0.015614453419359105,4,bp,NAC,3164/9314/3725/2247,NR4A1/KLF4/JUN/FGF2
GO:0034113,heterotypic cell-cell adhesion,2/24,59/18493,0.0026399012348831707,0.02717422144161486,0.015614453419359105,2,bp,NAC,9314/3679,KLF4/ITGA7
GO:0051346,negative regulation of hydrolase activity,4/24,458/18493,0.002662307231189813,0.02718907463663927,0.01562298814490168,4,bp,NAC,9314/10252/4804/3953,KLF4/SPRY1/NGFR/LEPR
GO:0035019,somatic stem cell population maintenance,2/24,60/18493,0.0027287735490690557,0.027650150727676293,0.015887924940303385,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0051054,positive regulation of DNA metabolic process,3/24,220/18493,0.0027951268533059357,0.028102942083238748,0.016148101282257056,3,bp,NAC,9314/3725/2247,KLF4/JUN/FGF2
GO:0055025,positive regulation of cardiac muscle tissue development,2/24,61/18493,0.002819044305724702,0.028125388188653375,0.016160998934842827,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0006469,negative regulation of protein kinase activity,3/24,222/18493,0.002867533508226537,0.028390770688319224,0.016313489142823528,3,bp,NAC,10252/9021/4616,SPRY1/SOCS3/GADD45B
GO:0046622,positive regulation of organ growth,2/24,62/18493,0.0029107100341967916,0.02859993116934272,0.01643367387728332,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0006644,phospholipid metabolic process,4/24,473/18493,0.0029906520812936245,0.02907377723120311,0.016705948366426006,4,bp,NAC,9314/9021/2247/5320,KLF4/SOCS3/FGF2/PLA2G2A
GO:0046686,response to cadmium ion,2/24,63/18493,0.003003767269839026,0.02907377723120311,0.016705948366426006,2,bp,NAC,2353/3725,FOS/JUN
GO:0048018,receptor ligand activity,4/23,478/17632,0.003136162993883395,0.029080784125100574,0.01650612102043892,4,mf,NAC,3479/80310/2247/7060,IGF1/PDGFD/FGF2/THBS4
GO:0046777,protein autophosphorylation,3/24,227/18493,0.0030536084673454026,0.029269567275361112,0.016818450376135753,3,bp,NAC,3725/80310/4915,JUN/PDGFD/NTRK2
GO:0051896,regulation of protein kinase B signaling,3/24,228/18493,0.003091696774652639,0.029269567275361112,0.016818450376135753,3,bp,NAC,9314/2247/4915,KLF4/FGF2/NTRK2
GO:1904018,positive regulation of vasculature development,3/24,228/18493,0.003091696774652639,0.029269567275361112,0.016818450376135753,3,bp,NAC,9314/80310/2247,KLF4/PDGFD/FGF2
R-HSA-422085,"Synthesis, secretion, and deacylation of Ghrelin",2/21,19/10554,6.318152512996855e-4,0.029379409185435374,0.013966442397150941,2,re,NAC,9314/3479,KLF4/IGF1
GO:0002009,morphogenesis of an epithelium,4/24,479/18493,0.003129465317075568,0.029412438523529073,0.0169005449617811,4,bp,NAC,9314/10252/9021/2247,KLF4/SPRY1/SOCS3/FGF2
GO:0051402,neuron apoptotic process,3/24,230/18493,0.003168752800895045,0.029567427214107003,0.01698960229484053,3,bp,NAC,3725/4804/4915,JUN/NGFR/NTRK2
hsa04722,Neurotrophin signaling pathway,3/23,119/7844,0.004831526118491279,0.02971388562872137,0.01958039532230676,3,kg,NAC,3725/4804/4915,JUN/NGFR/NTRK2
GO:0046488,phosphatidylinositol metabolic process,3/24,233/18493,0.003286546638805721,0.030274863417228213,0.017396098932270884,3,bp,NAC,9021/2247/5320,SOCS3/FGF2/PLA2G2A
GO:2000573,positive regulation of DNA biosynthetic process,2/24,66/18493,0.003291253463245318,0.030274863417228213,0.017396098932270884,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0071230,cellular response to amino acid stimulus,2/24,67/18493,0.003389842200939631,0.03074563171062029,0.01766660491914066,2,bp,NAC,80310/4915,PDGFD/NTRK2
GO:1903672,positive regulation of sprouting angiogenesis,2/24,67/18493,0.003389842200939631,0.03074563171062029,0.01766660491914066,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0061564,axon development,4/24,493/18493,0.003470495265883556,0.031258558054520644,0.01796133514799384,4,bp,NAC,9314/3725/4804/4915,KLF4/JUN/NGFR/NTRK2
GO:0010517,regulation of phospholipase activity,2/24,69/18493,0.0035911390687553544,0.03190210528887462,0.018331120841231372,2,bp,NAC,2247/4915,FGF2/NTRK2
GO:0060395,SMAD protein signal transduction,2/24,69/18493,0.0035911390687553544,0.03190210528887462,0.018331120841231372,2,bp,NAC,2353/3725,FOS/JUN
GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,2/24,70/18493,0.0036938403472478536,0.03215376463342595,0.018475725650663934,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:0048678,response to axon injury,2/24,70/18493,0.0036938403472478536,0.03215376463342595,0.018475725650663934,2,bp,NAC,9314/3725,KLF4/JUN
GO:0060193,positive regulation of lipase activity,2/24,70/18493,0.0036938403472478536,0.03215376463342595,0.018475725650663934,2,bp,NAC,2247/4915,FGF2/NTRK2
GO:0033673,negative regulation of kinase activity,3/24,244/18493,0.0037414464454140735,0.03235104026468035,0.01858908128668887,3,bp,NAC,10252/9021/4616,SPRY1/SOCS3/GADD45B
GO:0001707,mesoderm formation,2/24,72/18493,0.0039033315088731046,0.033414390721324495,0.019200088163533455,2,bp,NAC,9314/8516,KLF4/ITGA8
GO:0045637,regulation of myeloid cell differentiation,3/24,248/18493,0.003915950184765863,0.033414390721324495,0.019200088163533455,3,bp,NAC,2353/3725/7704,FOS/JUN/ZBTB16
GO:0016528,sarcoplasm,2/24,76/19659,0.003852513882672307,0.03467262494405076,0.0278800346772338,2,cc,NAC,2318/7060,FLNC/THBS4
hsa04380,Osteoclast differentiation,3/23,128/7844,0.0059210378712488,0.03468036467445726,0.022853128625872562,3,kg,NAC,2353/9021/3725,FOS/SOCS3/JUN
GO:0048332,mesoderm morphogenesis,2/24,74/18493,0.004118251433107908,0.034684234472343874,0.01992974719508133,2,bp,NAC,9314/8516,KLF4/ITGA8
GO:0055021,regulation of cardiac muscle tissue growth,2/24,74/18493,0.004118251433107908,0.034684234472343874,0.01992974719508133,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0070373,negative regulation of ERK1 and ERK2 cascade,2/24,75/18493,0.004227738687030219,0.035376626303730285,0.02032759925580574,2,bp,NAC,9314/10252,KLF4/SPRY1
GO:0033613,activating transcription factor binding,2/23,76/17632,0.004374614133230518,0.03718422013245941,0.02110559450242794,2,mf,NAC,2353/3725,FOS/JUN
R-HSA-2871796,FCERI mediated MAPK activation,2/21,32/10554,0.0018042919748765113,0.03728870081411457,0.017726377297032393,2,re,NAC,2353/3725,FOS/JUN
R-HSA-449147,Signaling by Interleukins,5/21,462/10554,0.0017871407342146223,0.03728870081411457,0.017726377297032393,5,re,NAC,2353/9021/3725/3977/2247,FOS/SOCS3/JUN/LIFR/FGF2
R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,2/21,31/10554,0.0016935519415415597,0.03728870081411457,0.017726377297032393,2,re,NAC,2353/3725,FOS/JUN
R-HSA-6783589,Interleukin-6 family signaling,2/21,24/10554,0.0010136752134303263,0.03728870081411457,0.017726377297032393,2,re,NAC,9021/3977,SOCS3/LIFR
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,3/21,108/10554,0.0012119576527233056,0.03728870081411457,0.017726377297032393,3,re,NAC,2353/9021/2247,FOS/SOCS3/FGF2
GO:0017053,transcriptional repressor complex,2/24,84/19659,0.004684300641780458,0.03747440513424367,0.030132928105020492,2,cc,NAC,3725/7704,JUN/ZBTB16
GO:0046332,SMAD binding,2/23,80/17632,0.004835128038629983,0.03793715845694294,0.021532958876489806,2,mf,NAC,2353/3725,FOS/JUN
GO:1900182,positive regulation of protein localization to nucleus,2/24,78/18493,0.00456426898548529,0.03794780047547706,0.021805009728229324,2,bp,NAC,3479/4804,IGF1/NGFR
GO:0061448,connective tissue development,3/24,263/18493,0.004614471878701456,0.03812082819538719,0.021904432384315328,3,bp,NAC,80310/2247/7704,PDGFD/FGF2/ZBTB16
GO:0042509,regulation of tyrosine phosphorylation of STAT protein,2/24,80/18493,0.004795312557160438,0.03815656678918459,0.021924967972034807,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:0043542,endothelial cell migration,3/24,266/18493,0.004762667780453367,0.03815656678918459,0.021924967972034807,3,bp,NAC,3164/9314/2247,NR4A1/KLF4/FGF2
GO:0060420,regulation of heart growth,2/24,80/18493,0.004795312557160438,0.03815656678918459,0.021924967972034807,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0071277,cellular response to calcium ion,2/24,80/18493,0.004795312557160438,0.03815656678918459,0.021924967972034807,2,bp,NAC,2353/3725,FOS/JUN
GO:1902105,regulation of leukocyte differentiation,3/24,265/18493,0.004712951043525471,0.03815656678918459,0.021924967972034807,3,bp,NAC,2353/3725/7704,FOS/JUN/ZBTB16
GO:1903671,negative regulation of sprouting angiogenesis,2/24,80/18493,0.004795312557160438,0.03815656678918459,0.021924967972034807,2,bp,NAC,9314/4804,KLF4/NGFR
GO:0034504,protein localization to nucleus,3/24,269/18493,0.004913734008538214,0.03816235334774888,0.02192829295962846,3,bp,NAC,3479/4804/7704,IGF1/NGFR/ZBTB16
GO:0043537,negative regulation of blood vessel endothelial cell migration,2/24,81/18493,0.00491283126323131,0.03816235334774888,0.02192829295962846,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0050772,positive regulation of axonogenesis,2/24,81/18493,0.00491283126323131,0.03816235334774888,0.02192829295962846,2,bp,NAC,4804/4915,NGFR/NTRK2
GO:1901216,positive regulation of neuron death,2/24,81/18493,0.00491283126323131,0.03816235334774888,0.02192829295962846,2,bp,NAC,2353/3725,FOS/JUN
hsa04210,Apoptosis,3/23,136/7844,0.0070043169706363664,0.03916049942673969,0.025805378312870823,3,kg,NAC,2353/3725/4616,FOS/JUN/GADD45B
GO:0007260,tyrosine phosphorylation of STAT protein,2/24,83/18493,0.00515184575502157,0.03933842965217471,0.022604072713338225,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:0014910,regulation of smooth muscle cell migration,2/24,83/18493,0.00515184575502157,0.03933842965217471,0.022604072713338225,2,bp,NAC,3479/80310,IGF1/PDGFD
GO:0034103,regulation of tissue remodeling,2/24,84/18493,0.005273334853911262,0.03933842965217471,0.022604072713338225,2,bp,NAC,3953/7060,LEPR/THBS4
GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,2/24,84/18493,0.005273334853911262,0.03933842965217471,0.022604072713338225,2,bp,NAC,9314/4804,KLF4/NGFR
GO:0045778,positive regulation of ossification,2/24,84/18493,0.005273334853911262,0.03933842965217471,0.022604072713338225,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0048511,rhythmic process,3/24,276/18493,0.00527747629874973,0.03933842965217471,0.022604072713338225,3,bp,NAC,3725/4804/4915,JUN/NGFR/NTRK2
GO:0051348,negative regulation of transferase activity,3/24,274/18493,0.0051719341923089565,0.03933842965217471,0.022604072713338225,3,bp,NAC,10252/9021/4616,SPRY1/SOCS3/GADD45B
GO:0046427,positive regulation of JAK-STAT cascade,2/24,85/18493,0.005396140739945216,0.0397658780665281,0.02284968686531826,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:0090049,regulation of cell migration involved in sprouting angiogenesis,2/24,85/18493,0.005396140739945216,0.0397658780665281,0.02284968686531826,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0045844,positive regulation of striated muscle tissue development,2/24,86/18493,0.005520260084247339,0.04022346814195954,0.0231126205774519,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0048636,positive regulation of muscle organ development,2/24,86/18493,0.005520260084247339,0.04022346814195954,0.0231126205774519,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0006112,energy reserve metabolic process,2/24,87/18493,0.005645689563741729,0.040680329800961236,0.023375135737597332,2,bp,NAC,3479/3953,IGF1/LEPR
GO:1901863,positive regulation of muscle tissue development,2/24,87/18493,0.005645689563741729,0.040680329800961236,0.023375135737597332,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0010632,regulation of epithelial cell migration,3/24,284/18493,0.005712686937332354,0.040710741525934416,0.02339261047791386,3,bp,NAC,9314/3725/2247,KLF4/JUN/FGF2
GO:0060070,canonical Wnt signaling pathway,3/24,284/18493,0.005712686937332354,0.040710741525934416,0.02339261047791386,3,bp,NAC,9314/6424/27123,KLF4/SFRP4/DKK2
GO:1904894,positive regulation of STAT cascade,2/24,88/18493,0.005772425861144223,0.04091167399947573,0.023508067355134367,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:0001656,metanephros development,2/24,89/18493,0.005900465664953914,0.04159186938828927,0.02389891127452729,2,bp,NAC,10252/8516,SPRY1/ITGA8
GO:0014909,smooth muscle cell migration,2/24,90/18493,0.006029805669444676,0.042273826774431054,0.024290767647037442,2,bp,NAC,3479/80310,IGF1/PDGFD
R-HSA-452723,Transcriptional regulation of pluripotent stem cells,2/21,36/10554,0.002280785309306598,0.04242260675310273,0.020166943787553078,2,re,NAC,9314/2247,KLF4/FGF2
GO:0045639,positive regulation of myeloid cell differentiation,2/24,91/18493,0.006160442574656788,0.042727775504437716,0.02455160902255562,2,bp,NAC,2353/3725,FOS/JUN
GO:2000117,negative regulation of cysteine-type endopeptidase activity,2/24,91/18493,0.006160442574656788,0.042727775504437716,0.02455160902255562,2,bp,NAC,9314/4804,KLF4/NGFR
GO:1903037,regulation of leukocyte cell-cell adhesion,3/24,293/18493,0.0062275139180467285,0.042963221019715996,0.024686897278707074,3,bp,NAC,9314/3479/7704,KLF4/IGF1/ZBTB16
GO:0043255,regulation of carbohydrate biosynthetic process,2/24,92/18493,0.006292373086388406,0.043180994143099276,0.02481203088367024,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0055006,cardiac cell development,2/24,93/18493,0.006425593916187194,0.043633483294737124,0.025072033577627627,2,bp,NAC,10252/3479,SPRY1/IGF1
GO:1901214,regulation of neuron death,3/24,296/18493,0.0064051209341793305,0.043633483294737124,0.025072033577627627,3,bp,NAC,2353/3725/4915,FOS/JUN/NTRK2
GO:0070301,cellular response to hydrogen peroxide,2/24,94/18493,0.006560101781341925,0.044314854220835816,0.02546355296705089,2,bp,NAC,9314/80310,KLF4/PDGFD
GO:0060191,regulation of lipase activity,2/24,95/18493,0.006695893404874028,0.04453627562113649,0.025590782891502357,2,bp,NAC,2247/4915,FGF2/NTRK2
GO:1990823,response to leukemia inhibitory factor,2/24,95/18493,0.006695893404874028,0.04453627562113649,0.025590782891502357,2,bp,NAC,9314/9021,KLF4/SOCS3
GO:1990830,cellular response to leukemia inhibitory factor,2/24,95/18493,0.006695893404874028,0.04453627562113649,0.025590782891502357,2,bp,NAC,9314/9021,KLF4/SOCS3
GO:0043010,camera-type eye development,3/24,302/18493,0.006769416339815115,0.04479557649357247,0.025739778563851238,3,bp,NAC,9314/3725/4915,KLF4/JUN/NTRK2
GO:0001657,ureteric bud development,2/24,96/18493,0.006832965515529255,0.0449840565052573,0.025848080189686456,2,bp,NAC,10252/2247,SPRY1/FGF2
GO:0055024,regulation of cardiac muscle tissue development,2/24,97/18493,0.00697131484776925,0.0449840565052573,0.025848080189686456,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0072163,mesonephric epithelium development,2/24,97/18493,0.00697131484776925,0.0449840565052573,0.025848080189686456,2,bp,NAC,10252/2247,SPRY1/FGF2
GO:0072164,mesonephric tubule development,2/24,97/18493,0.00697131484776925,0.0449840565052573,0.025848080189686456,2,bp,NAC,10252/2247,SPRY1/FGF2
GO:0090263,positive regulation of canonical Wnt signaling pathway,2/24,97/18493,0.00697131484776925,0.0449840565052573,0.025848080189686456,2,bp,NAC,6424/27123,SFRP4/DKK2
GO:0010596,negative regulation of endothelial cell migration,2/24,98/18493,0.007110938141763202,0.04543293975303878,0.02610601091194372,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0051591,response to cAMP,2/24,98/18493,0.007110938141763202,0.04543293975303878,0.02610601091194372,2,bp,NAC,2353/3725,FOS/JUN
GO:0007229,integrin-mediated signaling pathway,2/24,99/18493,0.007251832143379496,0.046106011225309836,0.02649276139067432,2,bp,NAC,3679/8516,ITGA7/ITGA8
GO:0004896,cytokine receptor activity,2/23,92/17632,0.006344539456851106,0.046224501757058056,0.026236817302767734,2,mf,NAC,3977/3953,LIFR/LEPR
GO:0055017,cardiac muscle tissue growth,2/24,100/18493,0.007393993604177375,0.04678053514447832,0.02688034645318399,2,bp,NAC,3479/2247,IGF1/FGF2
hsa04932,Non-alcoholic fatty liver disease (NAFLD),3/23,149/7844,0.0090030992238052,0.04814700889252346,0.031727168889382165,3,kg,NAC,9021/3725/3953,SOCS3/JUN/LEPR
GO:2000278,regulation of DNA biosynthetic process,2/24,104/18493,0.007975249269081932,0.050213098553394495,0.028852715802299478,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0000980,RNA polymerase II distal enhancer sequence-specific DNA binding,2/23,100/17632,0.007455229994462743,0.05069556396234665,0.028774571908452694,2,mf,NAC,3725/7704,JUN/ZBTB16
GO:0032147,activation of protein kinase activity,3/24,323/18493,0.008141190495455287,0.050765019579834175,0.029169852584930888,3,bp,NAC,3479/4616/2247,IGF1/GADD45B/FGF2
GO:0046677,response to antibiotic,3/24,323/18493,0.008141190495455287,0.050765019579834175,0.029169852584930888,3,bp,NAC,9314/3725/80310,KLF4/JUN/PDGFD
GO:0043502,regulation of muscle adaptation,2/24,106/18493,0.008273397814041544,0.05134256920962623,0.02950171570053595,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0007159,leukocyte cell-cell adhesion,3/24,327/18493,0.008419781132364718,0.05178374544426351,0.029755217931695464,3,bp,NAC,9314/3479/7704,KLF4/IGF1/ZBTB16
GO:0060419,heart growth,2/24,107/18493,0.00842434100905135,0.05178374544426351,0.029755217931695464,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0032102,negative regulation of response to external stimulus,3/24,329/18493,0.0085611760270676,0.052224197492143326,0.03000830404125916,3,bp,NAC,9314/9021/2247,KLF4/SOCS3/FGF2
GO:0046620,regulation of organ growth,2/24,108/18493,0.008576525879588688,0.052224197492143326,0.03000830404125916,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0001101,response to acid chemical,3/24,332/18493,0.00877590212822416,0.053188528319190354,0.030562413707735887,3,bp,NAC,9314/80310/4915,KLF4/PDGFD/NTRK2
GO:0010906,regulation of glucose metabolic process,2/24,111/18493,0.009040498596426921,0.05403468515928901,0.031048619967355126,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0043200,response to amino acid,2/24,111/18493,0.009040498596426921,0.05403468515928901,0.031048619967355126,2,bp,NAC,80310/4915,PDGFD/NTRK2
GO:0046854,phosphatidylinositol phosphorylation,2/24,111/18493,0.009040498596426921,0.05403468515928901,0.031048619967355126,2,bp,NAC,9021/2247,SOCS3/FGF2
hsa04310,Wnt signaling pathway,3/23,158/7844,0.010564794813431467,0.054144573418836266,0.035679350905009774,3,kg,NAC,3725/6424/27123,JUN/SFRP4/DKK2
GO:0046717,acid secretion,2/24,112/18493,0.009197618249142324,0.05472160949145685,0.031443330373697564,2,bp,NAC,4915/5320,NTRK2/PLA2G2A
GO:0003705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",2/23,108/17632,0.008647482213019775,0.05512769910800107,0.03129023169184787,2,mf,NAC,3725/7704,JUN/ZBTB16
GO:0008543,fibroblast growth factor receptor signaling pathway,2/24,113/18493,0.009355963645397383,0.055409519854248426,0.03183860735852606,2,bp,NAC,10252/2247,SPRY1/FGF2
hsa04630,JAK-STAT signaling pathway,3/23,162/7844,0.011306592211917724,0.055628433682635196,0.036657162118638516,3,kg,NAC,9021/3977/3953,SOCS3/LIFR/LEPR
GO:0002761,regulation of myeloid leukocyte differentiation,2/24,114/18493,0.009515531615552688,0.05609838411532653,0.03223443245842728,2,bp,NAC,2353/3725,FOS/JUN
GO:0010633,negative regulation of epithelial cell migration,2/24,115/18493,0.00967631899553576,0.05678817075660579,0.03263078756294031,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0006066,alcohol metabolic process,3/24,348/18493,0.009974904824362862,0.057910698863194235,0.03327579823490769,3,bp,NAC,3479/3953/2247,IGF1/LEPR/FGF2
GO:0030198,extracellular matrix organization,3/24,348/18493,0.009974904824362862,0.057910698863194235,0.03327579823490769,3,bp,NAC,3679/2247/8516,ITGA7/FGF2/ITGA8
GO:0038095,Fc-epsilon receptor signaling pathway,2/24,117/18493,0.010001539356480732,0.057910698863194235,0.03327579823490769,2,bp,NAC,2353/3725,FOS/JUN
GO:0001654,eye development,3/24,351/18493,0.010209883390352116,0.058854305587940865,0.033817999721025956,3,bp,NAC,9314/3725/4915,KLF4/JUN/NTRK2
GO:0150063,visual system development,3/24,352/18493,0.01028892774590529,0.05904751896654496,0.03392902116488563,3,bp,NAC,9314/3725/4915,KLF4/JUN/NTRK2
GO:0043500,muscle adaptation,2/24,120/18493,0.010498436688985773,0.059984459848522236,0.03446739242198899,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0002687,positive regulation of leukocyte migration,2/24,121/18493,0.010666474393132147,0.060018821809428725,0.03448713698906426,2,bp,NAC,80310/7060,PDGFD/THBS4
GO:0008637,apoptotic mitochondrial changes,2/24,121/18493,0.010666474393132147,0.060018821809428725,0.03448713698906426,2,bp,NAC,3479/3725,IGF1/JUN
GO:0048880,sensory system development,3/24,357/18493,0.01068955114724598,0.060018821809428725,0.03448713698906426,3,bp,NAC,9314/3725/4915,KLF4/JUN/NTRK2
GO:1900180,regulation of protein localization to nucleus,2/24,121/18493,0.010666474393132147,0.060018821809428725,0.03448713698906426,2,bp,NAC,3479/4804,IGF1/NGFR
GO:0001158,enhancer sequence-specific DNA binding,2/23,119/17632,0.010416952610330703,0.06250171566198422,0.03547569000422221,2,mf,NAC,3725/7704,JUN/ZBTB16
GO:0001206,"distal enhancer DNA-binding transcription repressor activity, RNA polymerase II-specific",1/23,10/17632,0.01297145070726713,0.0630041891495832,0.03576089167417003,1,mf,NAC,7704,ZBTB16
GO:0019955,cytokine binding,2/23,125/17632,0.01144426453453994,0.0630041891495832,0.03576089167417003,2,mf,NAC,3977/3953,LIFR/LEPR
GO:0035326,enhancer binding,2/23,133/17632,0.012880782006651232,0.0630041891495832,0.03576089167417003,2,mf,NAC,3725/7704,JUN/ZBTB16
GO:0070851,growth factor receptor binding,2/23,132/17632,0.012697091604674774,0.0630041891495832,0.03576089167417003,2,mf,NAC,80310/2247,PDGFD/FGF2
GO:0046834,lipid phosphorylation,2/24,125/18493,0.01135056820396221,0.06345554724370253,0.03646189786027788,2,bp,NAC,9021/2247,SOCS3/FGF2
GO:0006650,glycerophospholipid metabolic process,3/24,367/18493,0.011517937344809968,0.06411487011252587,0.03684074831771157,3,bp,NAC,9021/2247/5320,SOCS3/FGF2/PLA2G2A
GO:0051098,regulation of binding,3/24,369/18493,0.011687978350617535,0.06478336718269634,0.03722487032045531,3,bp,NAC,9314/3479/3725,KLF4/IGF1/JUN
GO:0030177,positive regulation of Wnt signaling pathway,2/24,128/18493,0.011876091658007059,0.06526818169675913,0.03750344734107492,2,bp,NAC,6424/27123,SFRP4/DKK2
GO:0045598,regulation of fat cell differentiation,2/24,128/18493,0.011876091658007059,0.06526818169675913,0.03750344734107492,2,bp,NAC,862/7704,RUNX1T1/ZBTB16
GO:0042692,muscle cell differentiation,3/24,373/18493,0.012032443402361889,0.06568717342408789,0.03774420223532379,3,bp,NAC,2318/3479/8516,FLNC/IGF1/ITGA8
GO:0046425,regulation of JAK-STAT cascade,2/24,129/18493,0.012053621646054677,0.06568717342408789,0.03774420223532379,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:0005035,death receptor activity,1/23,11/17632,0.014259707240789732,0.06611318811638876,0.0375255453704993,1,mf,NAC,4804,NGFR
GO:0045995,regulation of embryonic development,2/24,130/18493,0.012232324245339987,0.06638211107199148,0.038143517135876284,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0007498,mesoderm development,2/24,131/18493,0.012412196379756721,0.06707757793560194,0.03854313612661297,2,bp,NAC,9314/8516,KLF4/ITGA8
GO:0014706,striated muscle tissue development,3/24,379/18493,0.01256013292453588,0.06722250009031275,0.038626409174160145,3,bp,NAC,2353/3479/2247,FOS/IGF1/FGF2
GO:0035768,endothelial cell chemotaxis to fibroblast growth factor,1/24,10/18493,0.012905476116027659,0.06722250009031275,0.038626409174160145,1,bp,NAC,2247,FGF2
GO:0060281,regulation of oocyte development,1/24,10/18493,0.012905476116027659,0.06722250009031275,0.038626409174160145,1,bp,NAC,3479,IGF1
GO:0090090,negative regulation of canonical Wnt signaling pathway,2/24,133/18493,0.012775436976698166,0.06722250009031275,0.038626409174160145,2,bp,NAC,6424/27123,SFRP4/DKK2
GO:0090193,positive regulation of glomerulus development,1/24,10/18493,0.012905476116027659,0.06722250009031275,0.038626409174160145,1,bp,NAC,80310,PDGFD
GO:0098722,asymmetric stem cell division,1/24,10/18493,0.012905476116027659,0.06722250009031275,0.038626409174160145,1,bp,NAC,7704,ZBTB16
GO:1904892,regulation of STAT cascade,2/24,133/18493,0.012775436976698166,0.06722250009031275,0.038626409174160145,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:1905879,regulation of oogenesis,1/24,10/18493,0.012905476116027659,0.06722250009031275,0.038626409174160145,1,bp,NAC,3479,IGF1
GO:2000544,regulation of endothelial cell chemotaxis to fibroblast growth factor,1/24,10/18493,0.012905476116027659,0.06722250009031275,0.038626409174160145,1,bp,NAC,2247,FGF2
GO:0010675,regulation of cellular carbohydrate metabolic process,2/24,134/18493,0.012958799314125274,0.06723025084168192,0.03863086279747661,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0000185,activation of MAPKKK activity,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,4616,GADD45B
GO:0009629,response to gravity,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,2353,FOS
GO:0010764,negative regulation of fibroblast migration,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,2247,FGF2
GO:0019216,regulation of lipid metabolic process,3/24,388/18493,0.013376515434135204,0.06765003695021027,0.038872074147424315,3,bp,NAC,9314/9021/2247,KLF4/SOCS3/FGF2
GO:0022407,regulation of cell-cell adhesion,3/24,388/18493,0.013376515434135204,0.06765003695021027,0.038872074147424315,3,bp,NAC,9314/3479/7704,KLF4/IGF1/ZBTB16
GO:0034115,negative regulation of heterotypic cell-cell adhesion,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,9314,KLF4
GO:0035630,bone mineralization involved in bone maturation,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,3479,IGF1
GO:0035766,cell chemotaxis to fibroblast growth factor,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,2247,FGF2
GO:0042532,negative regulation of tyrosine phosphorylation of STAT protein,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,9021,SOCS3
GO:0044341,sodium-dependent phosphate transport,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,6424,SFRP4
GO:0046683,response to organophosphorus,2/24,137/18493,0.013515817845160611,0.06765003695021027,0.038872074147424315,2,bp,NAC,2353/3725,FOS/JUN
GO:0048266,behavioral response to pain,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,7060,THBS4
GO:0050728,negative regulation of inflammatory response,2/24,139/18493,0.013892909375074968,0.06765003695021027,0.038872074147424315,2,bp,NAC,9314/9021,KLF4/SOCS3
GO:0051386,regulation of neurotrophin TRK receptor signaling pathway,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,10252,SPRY1
GO:0060992,response to fungicide,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,9314,KLF4
GO:0061469,regulation of type B pancreatic cell proliferation,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,3164,NR4A1
GO:0070587,regulation of cell-cell adhesion involved in gastrulation,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,9314,KLF4
GO:0072006,nephron development,2/24,136/18493,0.013328992794700956,0.06765003695021027,0.038872074147424315,2,bp,NAC,80310/2247,PDGFD/FGF2
GO:0072073,kidney epithelium development,2/24,140/18493,0.014083169794106402,0.06765003695021027,0.038872074147424315,2,bp,NAC,10252/2247,SPRY1/FGF2
GO:0072567,chemokine (C-X-C motif) ligand 2 production,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,9314,KLF4
GO:1904847,regulation of cell chemotaxis to fibroblast growth factor,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,2247,FGF2
GO:1904995,negative regulation of leukocyte adhesion to vascular endothelial cell,1/24,11/18493,0.01418720898261927,0.06765003695021027,0.038872074147424315,1,bp,NAC,9314,KLF4
GO:0071236,cellular response to antibiotic,2/24,141/18493,0.014274569284506723,0.06781727605130117,0.038968170632083125,2,bp,NAC,9314/80310,KLF4/PDGFD
GO:0005159,insulin-like growth factor receptor binding,1/23,16/17632,0.02067690219124807,0.06803367817765495,0.03861560680878248,1,mf,NAC,3479,IGF1
GO:0005161,platelet-derived growth factor receptor binding,1/23,15/17632,0.01939666851785926,0.06803367817765495,0.03861560680878248,1,mf,NAC,80310,PDGFD
GO:0008201,heparin binding,2/23,163/17632,0.01892160997712974,0.06803367817765495,0.03861560680878248,2,mf,NAC,2247/7060,FGF2/THBS4
GO:0035259,glucocorticoid receptor binding,1/23,14/17632,0.01811483409762127,0.06803367817765495,0.03861560680878248,1,mf,NAC,3164,NR4A1
GO:0035497,cAMP response element binding,1/23,14/17632,0.01811483409762127,0.06803367817765495,0.03861560680878248,1,mf,NAC,3725,JUN
GO:0039706,co-receptor binding,1/23,13/17632,0.016831397020117822,0.06803367817765495,0.03861560680878248,1,mf,NAC,27123,DKK2
GO:0046935,1-phosphatidylinositol-3-kinase regulator activity,1/23,14/17632,0.01811483409762127,0.06803367817765495,0.03861560680878248,1,mf,NAC,9021,SOCS3
GO:0047498,calcium-dependent phospholipase A2 activity,1/23,16/17632,0.02067690219124807,0.06803367817765495,0.03861560680878248,1,mf,NAC,5320,PLA2G2A
GO:0071837,HMG box domain binding,1/23,16/17632,0.02067690219124807,0.06803367817765495,0.03861560680878248,1,mf,NAC,3725,JUN
hsa04115,p53 signaling pathway,2/23,72/7844,0.01856167366214858,0.06831721622385553,0.045018619163345104,2,kg,NAC,3479/4616,IGF1/GADD45B
hsa04662,B cell receptor signaling pathway,2/23,71/7844,0.018078048188623668,0.06831721622385553,0.045018619163345104,2,kg,NAC,2353/3725,FOS/JUN
hsa04917,Prolactin signaling pathway,2/23,70/7844,0.017599942663107934,0.06831721622385553,0.045018619163345104,2,kg,NAC,2353/9021,FOS/SOCS3
hsa04920,Adipocytokine signaling pathway,2/23,69/7844,0.017127390706225282,0.06831721622385553,0.045018619163345104,2,kg,NAC,9021/3953,SOCS3/LEPR
hsa05031,Amphetamine addiction,2/23,68/7844,0.016660426073471242,0.06831721622385553,0.045018619163345104,2,kg,NAC,2353/3725,FOS/JUN
hsa05133,Pertussis,2/23,76/7844,0.020550707319371177,0.06831721622385553,0.045018619163345104,2,kg,NAC,2353/3725,FOS/JUN
hsa05140,Leishmaniasis,2/23,74/7844,0.019545350642407755,0.06831721622385553,0.045018619163345104,2,kg,NAC,2353/3725,FOS/JUN
hsa05167,Kaposi sarcoma-associated herpesvirus infection,3/23,186/7844,0.016388232488709544,0.06831721622385553,0.045018619163345104,3,kg,NAC,2353/3725/2247,FOS/JUN/FGF2
hsa05205,Proteoglycans in cancer,3/23,201/7844,0.020124208759489993,0.06831721622385553,0.045018619163345104,3,kg,NAC,2318/3479/2247,FLNC/IGF1/FGF2
hsa05214,Glioma,2/23,75/7844,0.020045335578235356,0.06831721622385553,0.045018619163345104,2,kg,NAC,3479/4616,IGF1/GADD45B
hsa05221,Acute myeloid leukemia,2/23,66/7844,0.015743394479381563,0.06831721622385553,0.045018619163345104,2,kg,NAC,862/7704,RUNX1T1/ZBTB16
hsa05412,Arrhythmogenic right ventricular cardiomyopathy (ARVC),2/23,72/7844,0.01856167366214858,0.06831721622385553,0.045018619163345104,2,kg,NAC,3679/8516,ITGA7/ITGA8
GO:0007259,JAK-STAT cascade,2/24,147/18493,0.015446718157173496,0.06917637513318715,0.039749116255566694,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:0010770,positive regulation of cell morphogenesis involved in differentiation,2/24,147/18493,0.015446718157173496,0.06917637513318715,0.039749116255566694,2,bp,NAC,4804/4915,NGFR/NTRK2
GO:0019827,stem cell population maintenance,2/24,144/18493,0.014855572042412352,0.06917637513318715,0.039749116255566694,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0030099,myeloid cell differentiation,3/24,405/18493,0.01500051223902979,0.06917637513318715,0.039749116255566694,3,bp,NAC,2353/3725/7704,FOS/JUN/ZBTB16
GO:0031953,negative regulation of protein autophosphorylation,1/24,12/18493,0.015467346791537606,0.06917637513318715,0.039749116255566694,1,bp,NAC,3725,JUN
GO:0033160,"positive regulation of protein import into nucleus, translocation",1/24,12/18493,0.015467346791537606,0.06917637513318715,0.039749116255566694,1,bp,NAC,3479,IGF1
GO:0043524,negative regulation of neuron apoptotic process,2/24,147/18493,0.015446718157173496,0.06917637513318715,0.039749116255566694,2,bp,NAC,3725/4915,JUN/NTRK2
GO:0043922,negative regulation by host of viral transcription,1/24,12/18493,0.015467346791537606,0.06917637513318715,0.039749116255566694,1,bp,NAC,3725,JUN
GO:0048934,peripheral nervous system neuron differentiation,1/24,12/18493,0.015467346791537606,0.06917637513318715,0.039749116255566694,1,bp,NAC,4915,NTRK2
GO:0048935,peripheral nervous system neuron development,1/24,12/18493,0.015467346791537606,0.06917637513318715,0.039749116255566694,1,bp,NAC,4915,NTRK2
GO:0051592,response to calcium ion,2/24,146/18493,0.015248547405108287,0.06917637513318715,0.039749116255566694,2,bp,NAC,2353/3725,FOS/JUN
GO:0060670,branching involved in labyrinthine layer morphogenesis,1/24,12/18493,0.015467346791537606,0.06917637513318715,0.039749116255566694,1,bp,NAC,9021,SOCS3
GO:0060707,trophoblast giant cell differentiation,1/24,12/18493,0.015467346791537606,0.06917637513318715,0.039749116255566694,1,bp,NAC,9021,SOCS3
GO:0070586,cell-cell adhesion involved in gastrulation,1/24,12/18493,0.015467346791537606,0.06917637513318715,0.039749116255566694,1,bp,NAC,9314,KLF4
GO:0097201,negative regulation of transcription from RNA polymerase II promoter in response to stress,1/24,12/18493,0.015467346791537606,0.06917637513318715,0.039749116255566694,1,bp,NAC,3725,JUN
GO:0099550,"trans-synaptic signaling, modulating synaptic transmission",1/24,12/18493,0.015467346791537606,0.06917637513318715,0.039749116255566694,1,bp,NAC,4915,NTRK2
GO:1901722,regulation of cell proliferation involved in kidney development,1/24,12/18493,0.015467346791537606,0.06917637513318715,0.039749116255566694,1,bp,NAC,80310,PDGFD
GO:0000187,activation of MAPK activity,2/24,150/18493,0.016047926893453912,0.06939112204376595,0.03987251098241796,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0002693,positive regulation of cellular extravasation,1/24,13/18493,0.01674589144155647,0.06939112204376595,0.03987251098241796,1,bp,NAC,80310,PDGFD
GO:0014074,response to purine-containing compound,2/24,151/18493,0.016250552051217136,0.06939112204376595,0.03987251098241796,2,bp,NAC,2353/3725,FOS/JUN
GO:0014745,negative regulation of muscle adaptation,1/24,13/18493,0.01674589144155647,0.06939112204376595,0.03987251098241796,1,bp,NAC,9314,KLF4
GO:0014842,regulation of skeletal muscle satellite cell proliferation,1/24,13/18493,0.01674589144155647,0.06939112204376595,0.03987251098241796,1,bp,NAC,2247,FGF2
GO:0016202,regulation of striated muscle tissue development,2/24,149/18493,0.015846410878295025,0.06939112204376595,0.03987251098241796,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0042659,regulation of cell fate specification,1/24,13/18493,0.01674589144155647,0.06939112204376595,0.03987251098241796,1,bp,NAC,2247,FGF2
GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,1/24,13/18493,0.01674589144155647,0.06939112204376595,0.03987251098241796,1,bp,NAC,3479,IGF1
GO:0045414,regulation of interleukin-8 biosynthetic process,1/24,13/18493,0.01674589144155647,0.06939112204376595,0.03987251098241796,1,bp,NAC,9314,KLF4
GO:0048634,regulation of muscle organ development,2/24,153/18493,0.016659117944802335,0.06939112204376595,0.03987251098241796,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0048754,branching morphogenesis of an epithelial tube,2/24,150/18493,0.016047926893453912,0.06939112204376595,0.03987251098241796,2,bp,NAC,10252/2247,SPRY1/FGF2
GO:0051052,regulation of DNA metabolic process,3/24,412/18493,0.01570056843550972,0.06939112204376595,0.03987251098241796,3,bp,NAC,9314/3725/2247,KLF4/JUN/FGF2
GO:0051451,myoblast migration,1/24,13/18493,0.01674589144155647,0.06939112204376595,0.03987251098241796,1,bp,NAC,7060,THBS4
GO:0055062,phosphate ion homeostasis,1/24,13/18493,0.01674589144155647,0.06939112204376595,0.03987251098241796,1,bp,NAC,6424,SFRP4
GO:0060712,spongiotrophoblast layer development,1/24,13/18493,0.01674589144155647,0.06939112204376595,0.03987251098241796,1,bp,NAC,9021,SOCS3
GO:0061029,eyelid development in camera-type eye,1/24,13/18493,0.01674589144155647,0.06939112204376595,0.03987251098241796,1,bp,NAC,3725,JUN
GO:0072109,glomerular mesangium development,1/24,13/18493,0.01674589144155647,0.06939112204376595,0.03987251098241796,1,bp,NAC,80310,PDGFD
GO:0072505,divalent inorganic anion homeostasis,1/24,13/18493,0.01674589144155647,0.06939112204376595,0.03987251098241796,1,bp,NAC,6424,SFRP4
GO:0072506,trivalent inorganic anion homeostasis,1/24,13/18493,0.01674589144155647,0.06939112204376595,0.03987251098241796,1,bp,NAC,6424,SFRP4
GO:0090192,regulation of glomerulus development,1/24,13/18493,0.01674589144155647,0.06939112204376595,0.03987251098241796,1,bp,NAC,80310,PDGFD
GO:0097696,STAT cascade,2/24,151/18493,0.016250552051217136,0.06939112204376595,0.03987251098241796,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:1901861,regulation of muscle tissue development,2/24,151/18493,0.016250552051217136,0.06939112204376595,0.03987251098241796,2,bp,NAC,3479/2247,IGF1/FGF2
GO:1903706,regulation of hemopoiesis,3/24,418/18493,0.016315250449949595,0.06939112204376595,0.03987251098241796,3,bp,NAC,2353/3725/7704,FOS/JUN/ZBTB16
GO:0001959,regulation of cytokine-mediated signaling pathway,2/24,155/18493,0.01707208491213143,0.07029363216201417,0.04039109813797511,2,bp,NAC,9021/3977,SOCS3/LIFR
GO:0050727,regulation of inflammatory response,3/24,425/18493,0.017049505918397455,0.07029363216201417,0.04039109813797511,3,bp,NAC,9314/9021/5320,KLF4/SOCS3/PLA2G2A
GO:0004713,protein tyrosine kinase activity,2/23,177/17632,0.022077984225776774,0.07037357471966346,0.0399437214611093,2,mf,NAC,2247/4915,FGF2/NTRK2
R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),2/21,54/10554,0.0050702129366058755,0.07254304663143792,0.034485658840072354,2,re,NAC,3479/2247,IGF1/FGF2
R-HSA-2428924,IGF1R signaling cascade,2/21,53/10554,0.004888270900464125,0.07254304663143792,0.034485658840072354,2,re,NAC,3479/2247,IGF1/FGF2
R-HSA-2428928,IRS-related events triggered by IGF1R,2/21,52/10554,0.004709438161646314,0.07254304663143792,0.034485658840072354,2,re,NAC,3479/2247,IGF1/FGF2
GO:0014841,skeletal muscle satellite cell proliferation,1/24,14/18493,0.018022844829294615,0.0725503474538675,0.04168781885106375,1,bp,NAC,2247,FGF2
GO:0020027,hemoglobin metabolic process,1/24,14/18493,0.018022844829294615,0.0725503474538675,0.04168781885106375,1,bp,NAC,9314,KLF4
GO:0034374,low-density lipoprotein particle remodeling,1/24,14/18493,0.018022844829294615,0.0725503474538675,0.04168781885106375,1,bp,NAC,5320,PLA2G2A
GO:0034392,negative regulation of smooth muscle cell apoptotic process,1/24,14/18493,0.018022844829294615,0.0725503474538675,0.04168781885106375,1,bp,NAC,3479,IGF1
GO:0042228,interleukin-8 biosynthetic process,1/24,14/18493,0.018022844829294615,0.0725503474538675,0.04168781885106375,1,bp,NAC,9314,KLF4
GO:0043433,negative regulation of DNA-binding transcription factor activity,2/24,160/18493,0.018123602602199747,0.0725503474538675,0.04168781885106375,2,bp,NAC,9314/6424,KLF4/SFRP4
GO:0043535,regulation of blood vessel endothelial cell migration,2/24,158/18493,0.017699735855342135,0.0725503474538675,0.04168781885106375,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0061051,positive regulation of cell growth involved in cardiac muscle cell development,1/24,14/18493,0.018022844829294615,0.0725503474538675,0.04168781885106375,1,bp,NAC,3479,IGF1
GO:1903034,regulation of response to wounding,2/24,160/18493,0.018123602602199747,0.0725503474538675,0.04168781885106375,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0006109,regulation of carbohydrate metabolic process,2/24,162/18493,0.018551788318218146,0.07403590599608903,0.04254142875886136,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0010455,positive regulation of cell fate commitment,1/24,15/18493,0.019298208849214293,0.0742723349478663,0.042677282102900886,1,bp,NAC,2247,FGF2
GO:0010634,positive regulation of epithelial cell migration,2/24,165/18493,0.01920211407676038,0.0742723349478663,0.042677282102900886,2,bp,NAC,3725/2247,JUN/FGF2
GO:0014067,negative regulation of phosphatidylinositol 3-kinase signaling,1/24,15/18493,0.019298208849214293,0.0742723349478663,0.042677282102900886,1,bp,NAC,9314,KLF4
GO:0014857,regulation of skeletal muscle cell proliferation,1/24,15/18493,0.019298208849214293,0.0742723349478663,0.042677282102900886,1,bp,NAC,2247,FGF2
GO:0030178,negative regulation of Wnt signaling pathway,2/24,164/18493,0.01898426973239155,0.0742723349478663,0.042677282102900886,2,bp,NAC,6424/27123,SFRP4/DKK2
GO:0034616,response to laminar fluid shear stress,1/24,15/18493,0.019298208849214293,0.0742723349478663,0.042677282102900886,1,bp,NAC,9314,KLF4
GO:0035051,cardiocyte differentiation,2/24,163/18493,0.018767493514233805,0.0742723349478663,0.042677282102900886,2,bp,NAC,10252/3479,SPRY1/IGF1
GO:0045721,negative regulation of gluconeogenesis,1/24,15/18493,0.019298208849214293,0.0742723349478663,0.042677282102900886,1,bp,NAC,3953,LEPR
GO:0048569,post-embryonic animal organ development,1/24,15/18493,0.019298208849214293,0.0742723349478663,0.042677282102900886,1,bp,NAC,9314,KLF4
GO:0055002,striated muscle cell development,2/24,163/18493,0.018767493514233805,0.0742723349478663,0.042677282102900886,2,bp,NAC,2318/3479,FLNC/IGF1
GO:0090136,epithelial cell-cell adhesion,1/24,15/18493,0.019298208849214293,0.0742723349478663,0.042677282102900886,1,bp,NAC,7060,THBS4
GO:2001028,positive regulation of endothelial cell chemotaxis,1/24,15/18493,0.019298208849214293,0.0742723349478663,0.042677282102900886,1,bp,NAC,2247,FGF2
GO:0050839,cell adhesion molecule binding,3/23,486/17632,0.024472741610329,0.07564301952283509,0.042934634404085965,3,mf,NAC,3479/2247/7060,IGF1/FGF2/THBS4
GO:0042110,T cell activation,3/24,451/18493,0.019939053871249487,0.07651169488464671,0.04396403033585997,3,bp,NAC,3479/3953/7704,IGF1/LEPR/ZBTB16
GO:0030506,ankyrin binding,1/23,20/17632,0.025781867548769433,0.076653357193582225,0.043508097478297446,1,mf,NAC,2318,FLNC
GO:0102567,"phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)",1/23,21/17632,0.027054126068323137,0.076653357193582225,0.043508097478297446,1,mf,NAC,5320,PLA2G2A
GO:0102568,"phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)",1/23,21/17632,0.027054126068323137,0.076653357193582225,0.043508097478297446,1,mf,NAC,5320,PLA2G2A
GO:0043901,negative regulation of multi-organism process,2/24,169/18493,0.020084114978279777,0.07684099447442144,0.044153247646707285,2,bp,NAC,3479/3725,IGF1/JUN
R-HSA-186797,Signaling by PDGF,2/21,58/10554,0.005828837139353876,0.07744026485141578,0.036813708248550785,2,re,NAC,80310/7060,PDGFD/THBS4
GO:0048771,tissue remodeling,2/24,170/18493,0.020307256695185995,0.07746621156957717,0.044512500743627496,2,bp,NAC,3953/7060,LEPR/THBS4
GO:0001832,blastocyst growth,1/24,16/18493,0.020571985393625036,0.0775635612079409,0.04456843836807383,1,bp,NAC,3479,IGF1
GO:0014856,skeletal muscle cell proliferation,1/24,16/18493,0.020571985393625036,0.0775635612079409,0.04456843836807383,1,bp,NAC,2247,FGF2
GO:0030214,hyaluronan catabolic process,1/24,16/18493,0.020571985393625036,0.0775635612079409,0.04456843836807383,1,bp,NAC,2247,FGF2
GO:0033158,"regulation of protein import into nucleus, translocation",1/24,16/18493,0.020571985393625036,0.0775635612079409,0.04456843836807383,1,bp,NAC,3479,IGF1
GO:0005158,insulin receptor binding,1/23,22/17632,0.0283247952580582,0.07808457071140368,0.04432044777221056,1,mf,NAC,3479,IGF1
GO:0046486,glycerolipid metabolic process,3/24,459/18493,0.020879830175546548,0.07849605721067789,0.04510425557372069,3,bp,NAC,9021/2247/5320,SOCS3/FGF2/PLA2G2A
GO:0010744,positive regulation of macrophage derived foam cell differentiation,1/24,17/18493,0.021844176352685207,0.07936105526451741,0.045601288095831125,1,bp,NAC,5320,PLA2G2A
GO:0016055,Wnt signaling pathway,3/24,463/18493,0.02135936897044543,0.07936105526451741,0.045601288095831125,3,bp,NAC,9314/6424/27123,KLF4/SFRP4/DKK2
GO:0036149,phosphatidylinositol acyl-chain remodeling,1/24,17/18493,0.021844176352685207,0.07936105526451741,0.045601288095831125,1,bp,NAC,5320,PLA2G2A
GO:0043923,positive regulation by host of viral transcription,1/24,17/18493,0.021844176352685207,0.07936105526451741,0.045601288095831125,1,bp,NAC,3725,JUN
GO:0044320,cellular response to leptin stimulus,1/24,17/18493,0.021844176352685207,0.07936105526451741,0.045601288095831125,1,bp,NAC,3953,LEPR
GO:0045725,positive regulation of glycogen biosynthetic process,1/24,17/18493,0.021844176352685207,0.07936105526451741,0.045601288095831125,1,bp,NAC,3479,IGF1
GO:0055001,muscle cell development,2/24,176/18493,0.021668075111645542,0.07936105526451741,0.045601288095831125,2,bp,NAC,2318/3479,FLNC/IGF1
GO:0070102,interleukin-6-mediated signaling pathway,1/24,17/18493,0.021844176352685207,0.07936105526451741,0.045601288095831125,1,bp,NAC,9021,SOCS3
GO:0070886,positive regulation of calcineurin-NFAT signaling cascade,1/24,17/18493,0.021844176352685207,0.07936105526451741,0.045601288095831125,1,bp,NAC,3479,IGF1
GO:0106058,positive regulation of calcineurin-mediated signaling,1/24,17/18493,0.021844176352685207,0.07936105526451741,0.045601288095831125,1,bp,NAC,3479,IGF1
GO:0198738,cell-cell signaling by wnt,3/24,465/18493,0.021601428172495708,0.07936105526451741,0.045601288095831125,3,bp,NAC,9314/6424/27123,KLF4/SFRP4/DKK2
GO:2000811,negative regulation of anoikis,1/24,17/18493,0.021844176352685207,0.07936105526451741,0.045601288095831125,1,bp,NAC,4915,NTRK2
GO:0019207,kinase regulator activity,2/23,208/17632,0.029780608686687072,0.07993742331689688,0.04537211849772269,2,mf,NAC,9314/9021,KLF4/SOCS3
GO:0000979,RNA polymerase II core promoter sequence-specific DNA binding,1/23,24/17632,0.030861373227051958,0.08071436074767435,0.04581310465554272,1,mf,NAC,2353,FOS
GO:0006091,generation of precursor metabolites and energy,3/24,471/18493,0.022336771340752775,0.0809240011982021,0.04649936521391639,3,bp,NAC,3479/862/3953,IGF1/RUNX1T1/LEPR
GO:0001710,mesodermal cell fate commitment,1/24,18/18493,0.02311478361440522,0.08102668742671236,0.046558369271689604,1,bp,NAC,9314,KLF4
GO:0002685,regulation of leukocyte migration,2/24,180/18493,0.022596000888853194,0.08102668742671236,0.046558369271689604,2,bp,NAC,80310/7060,PDGFD/THBS4
GO:0022604,regulation of cell morphogenesis,3/24,474/18493,0.022709601440357986,0.08102668742671236,0.046558369271689604,3,bp,NAC,3679/4804/4915,ITGA7/NGFR/NTRK2
GO:0031293,membrane protein intracellular domain proteolysis,1/24,18/18493,0.02311478361440522,0.08102668742671236,0.046558369271689604,1,bp,NAC,4804,NGFR
GO:0032717,negative regulation of interleukin-8 production,1/24,18/18493,0.02311478361440522,0.08102668742671236,0.046558369271689604,1,bp,NAC,9314,KLF4
GO:0036148,phosphatidylglycerol acyl-chain remodeling,1/24,18/18493,0.02311478361440522,0.08102668742671236,0.046558369271689604,1,bp,NAC,5320,PLA2G2A
GO:0043409,negative regulation of MAPK cascade,2/24,182/18493,0.023066109982124362,0.08102668742671236,0.046558369271689604,2,bp,NAC,9314/10252,KLF4/SPRY1
GO:0043931,ossification involved in bone maturation,1/24,18/18493,0.02311478361440522,0.08102668742671236,0.046558369271689604,1,bp,NAC,3479,IGF1
GO:0045655,regulation of monocyte differentiation,1/24,18/18493,0.02311478361440522,0.08102668742671236,0.046558369271689604,1,bp,NAC,3725,JUN
GO:0048639,positive regulation of developmental growth,2/24,180/18493,0.022596000888853194,0.08102668742671236,0.046558369271689604,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0050770,regulation of axonogenesis,2/24,180/18493,0.022596000888853194,0.08102668742671236,0.046558369271689604,2,bp,NAC,4804/4915,NGFR/NTRK2
GO:0051099,positive regulation of binding,2/24,181/18493,0.02283054559590998,0.08102668742671236,0.046558369271689604,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0010975,regulation of neuron projection development,3/24,478/18493,0.02321206088381975,0.08114836379060436,0.046628285163127774,3,bp,NAC,9314/4804/4915,KLF4/NGFR/NTRK2
GO:0043087,regulation of GTPase activity,3/24,481/18493,0.023592921438403802,0.08203758473353816,0.04713923628725805,3,bp,NAC,10252/3725/4915,SPRY1/JUN/NTRK2
GO:0071248,cellular response to metal ion,2/24,184/18493,0.02354028658043831,0.08203758473353816,0.04713923628725805,2,bp,NAC,2353/3725,FOS/JUN
GO:0008356,asymmetric cell division,1/24,19/18493,0.024383809064648765,0.0823588550959621,0.047323839960995956,1,bp,NAC,7704,ZBTB16
GO:0010560,positive regulation of glycoprotein biosynthetic process,1/24,19/18493,0.024383809064648765,0.0823588550959621,0.047323839960995956,1,bp,NAC,3479,IGF1
GO:0038093,Fc receptor signaling pathway,2/24,187/18493,0.0242591291309746,0.0823588550959621,0.047323839960995956,2,bp,NAC,2353/3725,FOS/JUN
GO:0044342,type B pancreatic cell proliferation,1/24,19/18493,0.024383809064648765,0.0823588550959621,0.047323839960995956,1,bp,NAC,3164,NR4A1
GO:0045821,positive regulation of glycolytic process,1/24,19/18493,0.024383809064648765,0.0823588550959621,0.047323839960995956,1,bp,NAC,3479,IGF1
GO:0046426,negative regulation of JAK-STAT cascade,1/24,19/18493,0.024383809064648765,0.0823588550959621,0.047323839960995956,1,bp,NAC,9021,SOCS3
GO:0070875,positive regulation of glycogen metabolic process,1/24,19/18493,0.024383809064648765,0.0823588550959621,0.047323839960995956,1,bp,NAC,3479,IGF1
GO:0072111,cell proliferation involved in kidney development,1/24,19/18493,0.024383809064648765,0.0823588550959621,0.047323839960995956,1,bp,NAC,80310,PDGFD
GO:0090201,negative regulation of release of cytochrome c from mitochondria,1/24,19/18493,0.024383809064648765,0.0823588550959621,0.047323839960995956,1,bp,NAC,3479,IGF1
GO:1905288,vascular associated smooth muscle cell apoptotic process,1/24,19/18493,0.024383809064648765,0.0823588550959621,0.047323839960995956,1,bp,NAC,3479,IGF1
GO:1905459,regulation of vascular associated smooth muscle cell apoptotic process,1/24,19/18493,0.024383809064648765,0.0823588550959621,0.047323839960995956,1,bp,NAC,3479,IGF1
GO:0071897,DNA biosynthetic process,2/24,189/18493,0.02474337678560854,0.08335625893749163,0.04789695355901804,2,bp,NAC,9314/2247,KLF4/FGF2
R-HSA-1059683,Interleukin-6 signaling,1/21,11/10554,0.021681147721764438,0.08345449878708075,0.039672766825776924,1,re,NAC,9021,SOCS3
R-HSA-1257604,PIP3 activates AKT signaling,3/21,260/10554,0.01415675007427456,0.08345449878708075,0.039672766825776924,3,re,NAC,3164/3725/2247,NR4A1/JUN/FGF2
R-HSA-1474244,Extracellular matrix organization,3/21,301/10554,0.020880172132532585,0.08345449878708075,0.039672766825776924,3,re,NAC,3679/2247/8516,ITGA7/FGF2/ITGA8
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,2/21,95/10554,0.01506423359334886,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-166166,MyD88-independent TLR4 cascade ,2/21,100/10554,0.016601338224349265,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,2/21,98/10554,0.015978670802728013,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,2/21,85/10554,0.012189124874814708,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,2/21,99/10554,0.016288707285961154,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,2/21,85/10554,0.012189124874814708,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,2/21,98/10554,0.015978670802728013,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,2/21,94/10554,0.014764680581355615,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,2/21,95/10554,0.01506423359334886,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,2/21,98/10554,0.015978670802728013,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-1839122,Signaling by activated point mutants of FGFR1,1/21,11/10554,0.021681147721764438,0.08345449878708075,0.039672766825776924,1,re,NAC,2247,FGF2
R-HSA-1839130,Signaling by activated point mutants of FGFR3,1/21,12/10554,0.023629805209940624,0.08345449878708075,0.039672766825776924,1,re,NAC,2247,FGF2
R-HSA-190239,FGFR3 ligand binding and activation,1/21,13/10554,0.025574765757331197,0.08345449878708075,0.039672766825776924,1,re,NAC,2247,FGF2
R-HSA-190372,FGFR3c ligand binding and activation,1/21,13/10554,0.025574765757331197,0.08345449878708075,0.039672766825776924,1,re,NAC,2247,FGF2
R-HSA-190373,FGFR1c ligand binding and activation,1/21,12/10554,0.023629805209940624,0.08345449878708075,0.039672766825776924,1,re,NAC,2247,FGF2
R-HSA-190375,FGFR2c ligand binding and activation,1/21,13/10554,0.025574765757331197,0.08345449878708075,0.039672766825776924,1,re,NAC,2247,FGF2
R-HSA-190377,FGFR2b ligand binding and activation,1/21,10/10554,0.01972878661772115,0.08345449878708075,0.039672766825776924,1,re,NAC,2247,FGF2
R-HSA-193692,Regulated proteolysis of p75NTR,1/21,11/10554,0.021681147721764438,0.08345449878708075,0.039672766825776924,1,re,NAC,4804,NGFR
R-HSA-193697,p75NTR regulates axonogenesis,1/21,10/10554,0.01972878661772115,0.08345449878708075,0.039672766825776924,1,re,NAC,4804,NGFR
R-HSA-2033514,FGFR3 mutant receptor activation,1/21,12/10554,0.023629805209940624,0.08345449878708075,0.039672766825776924,1,re,NAC,2247,FGF2
R-HSA-209543,p75NTR recruits signalling complexes,1/21,13/10554,0.025574765757331197,0.08345449878708075,0.039672766825776924,1,re,NAC,4804,NGFR
R-HSA-209560,NF-kB is activated and signals survival,1/21,13/10554,0.025574765757331197,0.08345449878708075,0.039672766825776924,1,re,NAC,4804,NGFR
R-HSA-216083,Integrin cell surface interactions,2/21,85/10554,0.012189124874814708,0.08345449878708075,0.039672766825776924,2,re,NAC,3679/8516,ITGA7/ITGA8
R-HSA-2219528,PI3K/AKT Signaling in Cancer,2/21,97/10554,0.015671239311484616,0.08345449878708075,0.039672766825776924,2,re,NAC,3164/2247,NR4A1/FGF2
R-HSA-2559580,Oxidative Stress Induced Senescence,2/21,125/10554,0.02523005936190445,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),2/21,110/10554,0.019868044574301056,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-2892247,"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",1/21,13/10554,0.025574765757331197,0.08345449878708075,0.039672766825776924,1,re,NAC,2247,FGF2
R-HSA-2980736,Peptide hormone metabolism,2/21,89/10554,0.013306840846864778,0.08345449878708075,0.039672766825776924,2,re,NAC,9314/3479,KLF4/IGF1
R-HSA-3000178,ECM proteoglycans,2/21,76/10554,0.009835894153012408,0.08345449878708075,0.039672766825776924,2,re,NAC,3679/8516,ITGA7/ITGA8
R-HSA-448424,Interleukin-17 signaling,2/21,72/10554,0.00886347814682644,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-450294,MAP kinase activation,2/21,64/10554,0.0070580487832471875,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-5654227,Phospholipase C-mediated cascade; FGFR3,1/21,13/10554,0.025574765757331197,0.08345449878708075,0.039672766825776924,1,re,NAC,2247,FGF2
R-HSA-5658623,FGFRL1 modulation of FGFR1 signaling,1/21,13/10554,0.025574765757331197,0.08345449878708075,0.039672766825776924,1,re,NAC,2247,FGF2
R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,2/21,65/10554,0.007273416532524526,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-9006925,Intracellular signaling by second messengers,3/21,293/10554,0.01945115112699453,0.08345449878708075,0.039672766825776924,3,re,NAC,3164/3725/2247,NR4A1/JUN/FGF2
R-HSA-9028731,Activated NTRK2 signals through FRS2 and FRS3,1/21,11/10554,0.021681147721764438,0.08345449878708075,0.039672766825776924,1,re,NAC,4915,NTRK2
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,2/21,100/10554,0.016601338224349265,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,2/21,93/10554,0.014467774991275191,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-975155,MyD88 dependent cascade initiated on endosome,2/21,94/10554,0.014764680581355615,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
R-HSA-975871,MyD88 cascade initiated on plasma membrane,2/21,85/10554,0.012189124874814708,0.08345449878708075,0.039672766825776924,2,re,NAC,2353/3725,FOS/JUN
GO:0005104,fibroblast growth factor receptor binding,1/23,26/17632,0.0333916165921927,0.08350128554798047,0.047394950517429583,1,mf,NAC,2247,FGF2
GO:0005539,glycosaminoglycan binding,2/23,222/17632,0.03356424223007058,0.08350128554798047,0.047394950517429583,2,mf,NAC,2247/7060,FGF2/THBS4
GO:1901654,response to ketone,2/24,190/18493,0.02498699807689169,0.08395890286458166,0.048243235992471545,2,bp,NAC,2353/9314,FOS/KLF4
GO:0030813,positive regulation of nucleotide catabolic process,1/24,20/18493,0.025651254587136907,0.08487162550897083,0.04876769132033547,1,bp,NAC,3479,IGF1
GO:0032682,negative regulation of chemokine production,1/24,20/18493,0.025651254587136907,0.08487162550897083,0.04876769132033547,1,bp,NAC,9314,KLF4
GO:0051197,positive regulation of coenzyme metabolic process,1/24,20/18493,0.025651254587136907,0.08487162550897083,0.04876769132033547,1,bp,NAC,3479,IGF1
GO:0060602,branch elongation of an epithelium,1/24,20/18493,0.025651254587136907,0.08487162550897083,0.04876769132033547,1,bp,NAC,10252,SPRY1
GO:0070977,bone maturation,1/24,20/18493,0.025651254587136907,0.08487162550897083,0.04876769132033547,1,bp,NAC,3479,IGF1
GO:1904893,negative regulation of STAT cascade,1/24,20/18493,0.025651254587136907,0.08487162550897083,0.04876769132033547,1,bp,NAC,9021,SOCS3
GO:0030278,regulation of ossification,2/24,193/18493,0.025723818651745844,0.08489514705169049,0.04878120692496601,2,bp,NAC,3479/7704,IGF1/ZBTB16
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,2/21,130/10554,0.027135561980688495,0.0852997116856161,0.04054994783017403,2,re,NAC,2353/3725,FOS/JUN
R-HSA-190322,FGFR4 ligand binding and activation,1/21,14/10554,0.027516036027618096,0.0852997116856161,0.04054994783017403,1,re,NAC,2247,FGF2
R-HSA-877312,Regulation of IFNG signaling,1/21,14/10554,0.027516036027618096,0.0852997116856161,0.04054994783017403,1,re,NAC,9021,SOCS3
R-HSA-1482922,Acyl chain remodelling of PI,1/21,17/10554,0.033317771642090044,0.08553053227119355,0.04065967578257078,1,re,NAC,5320,PLA2G2A
R-HSA-1482925,Acyl chain remodelling of PG,1/21,19/10554,0.03716726565580075,0.08553053227119355,0.04065967578257078,1,re,NAC,5320,PLA2G2A
R-HSA-168898,Toll-like Receptor Cascades,2/21,155/10554,0.037494850065373314,0.08553053227119355,0.04065967578257078,2,re,NAC,2353/3725,FOS/JUN
R-HSA-190241,FGFR2 ligand binding and activation,1/21,20/10554,0.03908653356479275,0.08553053227119355,0.04065967578257078,1,re,NAC,2247,FGF2
R-HSA-190242,FGFR1 ligand binding and activation,1/21,16/10554,0.03138753233472891,0.08553053227119355,0.04065967578257078,1,re,NAC,2247,FGF2
R-HSA-193639,p75NTR signals via NF-kB,1/21,16/10554,0.03138753233472891,0.08553053227119355,0.04065967578257078,1,re,NAC,4804,NGFR
R-HSA-2033519,Activated point mutants of FGFR2,1/21,17/10554,0.033317771642090044,0.08553053227119355,0.04065967578257078,1,re,NAC,2247,FGF2
R-HSA-205043,NRIF signals cell death from the nucleus,1/21,16/10554,0.03138753233472891,0.08553053227119355,0.04065967578257078,1,re,NAC,4804,NGFR
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,2/21,134/10554,0.02870108930357829,0.08553053227119355,0.04065967578257078,2,re,NAC,2353/3725,FOS/JUN
R-HSA-3772470,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,1/21,15/10554,0.029453622673103697,0.08553053227119355,0.04065967578257078,1,re,NAC,27123,DKK2
R-HSA-416993,Trafficking of GluR2-containing AMPA receptors,1/21,17/10554,0.033317771642090044,0.08553053227119355,0.04065967578257078,1,re,NAC,7102,TSPAN7
R-HSA-446353,Cell-extracellular matrix interactions,1/21,18/10554,0.035244347213458704,0.08553053227119355,0.04065967578257078,1,re,NAC,2318,FLNC
R-HSA-5654219,Phospholipase C-mediated cascade: FGFR1,1/21,16/10554,0.03138753233472891,0.08553053227119355,0.04065967578257078,1,re,NAC,2247,FGF2
R-HSA-5654221,Phospholipase C-mediated cascade; FGFR2,1/21,18/10554,0.035244347213458704,0.08553053227119355,0.04065967578257078,1,re,NAC,2247,FGF2
R-HSA-5654228,Phospholipase C-mediated cascade; FGFR4,1/21,15/10554,0.029453622673103697,0.08553053227119355,0.04065967578257078,1,re,NAC,2247,FGF2
R-HSA-5654704,SHC-mediated cascade:FGFR3,1/21,18/10554,0.035244347213458704,0.08553053227119355,0.04065967578257078,1,re,NAC,2247,FGF2
R-HSA-5654706,FRS-mediated FGFR3 signaling,1/21,20/10554,0.03908653356479275,0.08553053227119355,0.04065967578257078,1,re,NAC,2247,FGF2
R-HSA-5654710,PI-3K cascade:FGFR3,1/21,18/10554,0.035244347213458704,0.08553053227119355,0.04065967578257078,1,re,NAC,2247,FGF2
R-HSA-5654719,SHC-mediated cascade:FGFR4,1/21,20/10554,0.03908653356479275,0.08553053227119355,0.04065967578257078,1,re,NAC,2247,FGF2
R-HSA-5654720,PI-3K cascade:FGFR4,1/21,20/10554,0.03908653356479275,0.08553053227119355,0.04065967578257078,1,re,NAC,2247,FGF2
R-HSA-5663202,Diseases of signal transduction,3/21,378/10554,0.03756945873330119,0.08553053227119355,0.04065967578257078,3,re,NAC,3164/27123/2247,NR4A1/DKK2/FGF2
R-HSA-6788467,IL-6-type cytokine receptor ligand interactions,1/21,17/10554,0.033317771642090044,0.08553053227119355,0.04065967578257078,1,re,NAC,3977,LIFR
R-HSA-8851708,Signaling by FGFR2 IIIa TM,1/21,19/10554,0.03716726565580075,0.08553053227119355,0.04065967578257078,1,re,NAC,2247,FGF2
R-HSA-8939211,ESR-mediated signaling,2/21,156/10554,0.03793679604003059,0.08553053227119355,0.04065967578257078,2,re,NAC,2353/3725,FOS/JUN
R-HSA-9018519,Estrogen-dependent gene expression,2/21,150/10554,0.03531601453398654,0.08553053227119355,0.04065967578257078,2,re,NAC,2353/3725,FOS/JUN
R-HSA-1482801,Acyl chain remodelling of PS,1/21,23/10554,0.0448224998794835,0.08684359351649928,0.04128388146794533,1,re,NAC,5320,PLA2G2A
R-HSA-5654688,SHC-mediated cascade:FGFR1,1/21,21/10554,0.04100215752484071,0.08684359351649928,0.04128388146794533,1,re,NAC,2247,FGF2
R-HSA-5654689,PI-3K cascade:FGFR1,1/21,21/10554,0.04100215752484071,0.08684359351649928,0.04128388146794533,1,re,NAC,2247,FGF2
R-HSA-5654693,FRS-mediated FGFR1 signaling,1/21,23/10554,0.0448224998794835,0.08684359351649928,0.04128388146794533,1,re,NAC,2247,FGF2
R-HSA-5654695,PI-3K cascade:FGFR2,1/21,23/10554,0.0448224998794835,0.08684359351649928,0.04128388146794533,1,re,NAC,2247,FGF2
R-HSA-5654699,SHC-mediated cascade:FGFR2,1/21,23/10554,0.0448224998794835,0.08684359351649928,0.04128388146794533,1,re,NAC,2247,FGF2
R-HSA-5654712,FRS-mediated FGFR4 signaling,1/21,22/10554,0.042914144109096886,0.08684359351649928,0.04128388146794533,1,re,NAC,2247,FGF2
R-HSA-5655332,Signaling by FGFR3 in disease,1/21,22/10554,0.042914144109096886,0.08684359351649928,0.04128388146794533,1,re,NAC,2247,FGF2
R-HSA-8853338,Signaling by FGFR3 point mutants in cancer,1/21,22/10554,0.042914144109096886,0.08684359351649928,0.04128388146794533,1,re,NAC,2247,FGF2
R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,1/21,23/10554,0.0448224998794835,0.08684359351649928,0.04128388146794533,1,re,NAC,3725,JUN
R-HSA-8863678,Neurodegenerative Diseases,1/21,23/10554,0.0448224998794835,0.08684359351649928,0.04128388146794533,1,re,NAC,3725,JUN
GO:0002573,myeloid leukocyte differentiation,2/24,197/18493,0.02672004236826469,0.08684454556291803,0.049901341767273434,2,bp,NAC,2353/3725,FOS/JUN
GO:0032332,positive regulation of chondrocyte differentiation,1/24,21/18493,0.026917122063448762,0.08684454556291803,0.049901341767273434,1,bp,NAC,7704,ZBTB16
GO:0036120,cellular response to platelet-derived growth factor stimulus,1/24,21/18493,0.026917122063448762,0.08684454556291803,0.049901341767273434,1,bp,NAC,80310,PDGFD
GO:0036150,phosphatidylserine acyl-chain remodeling,1/24,21/18493,0.026917122063448762,0.08684454556291803,0.049901341767273434,1,bp,NAC,5320,PLA2G2A
GO:0048745,smooth muscle tissue development,1/24,21/18493,0.026917122063448762,0.08684454556291803,0.049901341767273434,1,bp,NAC,8516,ITGA8
GO:0050434,positive regulation of viral transcription,1/24,21/18493,0.026917122063448762,0.08684454556291803,0.049901341767273434,1,bp,NAC,3725,JUN
GO:0060713,labyrinthine layer morphogenesis,1/24,21/18493,0.026917122063448762,0.08684454556291803,0.049901341767273434,1,bp,NAC,9021,SOCS3
GO:0071498,cellular response to fluid shear stress,1/24,21/18493,0.026917122063448762,0.08684454556291803,0.049901341767273434,1,bp,NAC,9314,KLF4
GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell,1/24,21/18493,0.026917122063448762,0.08684454556291803,0.049901341767273434,1,bp,NAC,9314,KLF4
GO:0031348,negative regulation of defense response,2/24,199/18493,0.027224017632607973,0.08739987838983301,0.05022043898876092,2,bp,NAC,9314/9021,KLF4/SOCS3
GO:0097529,myeloid leukocyte migration,2/24,199/18493,0.027224017632607973,0.08739987838983301,0.05022043898876092,2,bp,NAC,80310/7060,PDGFD/THBS4
GO:0045766,positive regulation of angiogenesis,2/24,200/18493,0.02747746157585074,0.08799572262686027,0.0505628142838267,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0001759,organ induction,1/24,22/18493,0.028181413373024267,0.08807540516822282,0.05060860029955912,1,bp,NAC,10252,SPRY1
GO:0036119,response to platelet-derived growth factor,1/24,22/18493,0.028181413373024267,0.08807540516822282,0.05060860029955912,1,bp,NAC,80310,PDGFD
GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway,1/24,22/18493,0.028181413373024267,0.08807540516822282,0.05060860029955912,1,bp,NAC,10252,SPRY1
GO:0043523,regulation of neuron apoptotic process,2/24,202/18493,0.027987248510471973,0.08807540516822282,0.05060860029955912,2,bp,NAC,3725/4915,JUN/NTRK2
GO:0044321,response to leptin,1/24,22/18493,0.028181413373024267,0.08807540516822282,0.05060860029955912,1,bp,NAC,3953,LEPR
GO:0050870,positive regulation of T cell activation,2/24,202/18493,0.027987248510471973,0.08807540516822282,0.05060860029955912,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0071677,positive regulation of mononuclear cell migration,1/24,22/18493,0.028181413373024267,0.08807540516822282,0.05060860029955912,1,bp,NAC,80310,PDGFD
GO:0072012,glomerulus vasculature development,1/24,22/18493,0.028181413373024267,0.08807540516822282,0.05060860029955912,1,bp,NAC,80310,PDGFD
GO:1901215,negative regulation of neuron death,2/24,201/18493,0.02773187277177395,0.08807540516822282,0.05060860029955912,2,bp,NAC,3725/4915,JUN/NTRK2
GO:2000050,regulation of non-canonical Wnt signaling pathway,1/24,22/18493,0.028181413373024267,0.08807540516822282,0.05060860029955912,1,bp,NAC,6424,SFRP4
GO:0006006,glucose metabolic process,2/24,204/18493,0.028500882800997194,0.08864663067840135,0.05093682954210781,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0009612,response to mechanical stimulus,2/24,204/18493,0.028500882800997194,0.08864663067840135,0.05093682954210781,2,bp,NAC,2353/3725,FOS/JUN
R-HSA-182971,EGFR downregulation,1/21,25/10554,0.0486283451702626,0.08867521766342003,0.042154602624376245,1,re,NAC,10252,SPRY1
R-HSA-5654700,FRS-mediated FGFR2 signaling,1/21,25/10554,0.0486283451702626,0.08867521766342003,0.042154602624376245,1,re,NAC,2247,FGF2
R-HSA-5654708,Downstream signaling of activated FGFR3,1/21,25/10554,0.0486283451702626,0.08867521766342003,0.042154602624376245,1,re,NAC,2247,FGF2
R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,1/21,25/10554,0.0486283451702626,0.08867521766342003,0.042154602624376245,1,re,NAC,3164,NR4A1
R-HSA-9006115,Signaling by NTRK2 (TRKB),1/21,25/10554,0.0486283451702626,0.08867521766342003,0.042154602624376245,1,re,NAC,4915,NTRK2
R-HSA-982772,Growth hormone receptor signaling,1/21,24/10554,0.046727231386703205,0.08867521766342003,0.042154602624376245,1,re,NAC,9021,SOCS3
GO:0000132,establishment of mitotic spindle orientation,1/24,23/18493,0.029444130393166512,0.08930739053556909,0.05131650570075309,1,bp,NAC,10252,SPRY1
GO:0002691,regulation of cellular extravasation,1/24,23/18493,0.029444130393166512,0.08930739053556909,0.05131650570075309,1,bp,NAC,80310,PDGFD
GO:0009266,response to temperature stimulus,2/24,208/18493,0.029539607201047913,0.08930739053556909,0.05131650570075309,2,bp,NAC,2353/3479,FOS/IGF1
GO:0045606,positive regulation of epidermal cell differentiation,1/24,23/18493,0.029444130393166512,0.08930739053556909,0.05131650570075309,1,bp,NAC,6424,SFRP4
GO:0051216,cartilage development,2/24,206/18493,0.029018342865788253,0.08930739053556909,0.05131650570075309,2,bp,NAC,2247/7704,FGF2/ZBTB16
GO:0051412,response to corticosterone,1/24,23/18493,0.029444130393166512,0.08930739053556909,0.05131650570075309,1,bp,NAC,2353,FOS
GO:0060348,bone development,2/24,208/18493,0.029539607201047913,0.08930739053556909,0.05131650570075309,2,bp,NAC,3479/6424,IGF1/SFRP4
GO:0061050,regulation of cell growth involved in cardiac muscle cell development,1/24,23/18493,0.029444130393166512,0.08930739053556909,0.05131650570075309,1,bp,NAC,3479,IGF1
GO:0071241,cellular response to inorganic substance,2/24,207/18493,0.029278500840562473,0.08930739053556909,0.05131650570075309,2,bp,NAC,2353/3725,FOS/JUN
GO:0090023,positive regulation of neutrophil chemotaxis,1/24,23/18493,0.029444130393166512,0.08930739053556909,0.05131650570075309,1,bp,NAC,7060,THBS4
GO:1903020,positive regulation of glycoprotein metabolic process,1/24,23/18493,0.029444130393166512,0.08930739053556909,0.05131650570075309,1,bp,NAC,3479,IGF1
GO:1905564,positive regulation of vascular endothelial cell proliferation,1/24,23/18493,0.029444130393166512,0.08930739053556909,0.05131650570075309,1,bp,NAC,2247,FGF2
GO:0016051,carbohydrate biosynthetic process,2/24,209/18493,0.02980165927139453,0.0896815593387441,0.05153150510232586,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,2/24,209/18493,0.02980165927139453,0.0896815593387441,0.05153150510232586,2,bp,NAC,9314/4804,KLF4/NGFR
GO:0002092,positive regulation of receptor internalization,1/24,24/18493,0.030705274999044407,0.0903055366751941,0.051890045827242964,1,bp,NAC,6424,SFRP4
GO:0032897,negative regulation of viral transcription,1/24,24/18493,0.030705274999044407,0.0903055366751941,0.051890045827242964,1,bp,NAC,3725,JUN
GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,1/24,24/18493,0.030705274999044407,0.0903055366751941,0.051890045827242964,1,bp,NAC,3479,IGF1
GO:0045672,positive regulation of osteoclast differentiation,1/24,24/18493,0.030705274999044407,0.0903055366751941,0.051890045827242964,1,bp,NAC,2353,FOS
GO:0048679,regulation of axon regeneration,1/24,24/18493,0.030705274999044407,0.0903055366751941,0.051890045827242964,1,bp,NAC,9314,KLF4
GO:0048799,animal organ maturation,1/24,24/18493,0.030705274999044407,0.0903055366751941,0.051890045827242964,1,bp,NAC,3479,IGF1
GO:0061437,renal system vasculature development,1/24,24/18493,0.030705274999044407,0.0903055366751941,0.051890045827242964,1,bp,NAC,80310,PDGFD
GO:0061440,kidney vasculature development,1/24,24/18493,0.030705274999044407,0.0903055366751941,0.051890045827242964,1,bp,NAC,80310,PDGFD
GO:2000209,regulation of anoikis,1/24,24/18493,0.030705274999044407,0.0903055366751941,0.051890045827242964,1,bp,NAC,4915,NTRK2
GO:2001026,regulation of endothelial cell chemotaxis,1/24,24/18493,0.030705274999044407,0.0903055366751941,0.051890045827242964,1,bp,NAC,2247,FGF2
R-HSA-912694,Regulation of IFNA signaling,1/21,26/10554,0.05052584775848801,0.09124085129202689,0.04337425867872246,1,re,NAC,9021,SOCS3
GO:1903039,positive regulation of leukocyte cell-cell adhesion,2/24,214/18493,0.031126011954416503,0.09133583145900045,0.052482058737144274,2,bp,NAC,3479/7704,IGF1/ZBTB16
hsa04657,IL-17 signaling pathway,2/23,93/7844,0.029934784093229534,0.09204946108668083,0.060657325662596684,2,kg,NAC,2353/3725,FOS/JUN
hsa04658,Th1 and Th2 cell differentiation,2/23,92/7844,0.029342771913689995,0.09204946108668083,0.060657325662596684,2,kg,NAC,2353/3725,FOS/JUN
hsa05323,Rheumatoid arthritis,2/23,91/7844,0.028755604024057427,0.09204946108668083,0.060657325662596684,2,kg,NAC,2353/3725,FOS/JUN
GO:0034114,regulation of heterotypic cell-cell adhesion,1/24,25/18493,0.03196484906369468,0.09274811909532885,0.05329356678934612,1,bp,NAC,9314,KLF4
GO:0055083,monovalent inorganic anion homeostasis,1/24,25/18493,0.03196484906369468,0.09274811909532885,0.05329356678934612,1,bp,NAC,6424,SFRP4
GO:0060330,regulation of response to interferon-gamma,1/24,25/18493,0.03196484906369468,0.09274811909532885,0.05329356678934612,1,bp,NAC,9021,SOCS3
GO:0060334,regulation of interferon-gamma-mediated signaling pathway,1/24,25/18493,0.03196484906369468,0.09274811909532885,0.05329356678934612,1,bp,NAC,9021,SOCS3
GO:0071624,positive regulation of granulocyte chemotaxis,1/24,25/18493,0.03196484906369468,0.09274811909532885,0.05329356678934612,1,bp,NAC,7060,THBS4
R-HSA-3000170,Syndecan interactions,1/21,27/10554,0.052419745668544016,0.09285783518427797,0.04414294372087917,1,re,NAC,2247,FGF2
R-HSA-5654716,Downstream signaling of activated FGFR4,1/21,27/10554,0.052419745668544016,0.09285783518427797,0.04414294372087917,1,re,NAC,2247,FGF2
GO:0006817,phosphate ion transport,1/24,26/18493,0.03322285445802409,0.09366868458382342,0.05382252865750678,1,bp,NAC,6424,SFRP4
GO:0007160,cell-matrix adhesion,2/24,222/18493,0.033293187041744485,0.09366868458382342,0.05382252865750678,2,bp,NAC,3679/8516,ITGA7/ITGA8
GO:0010594,regulation of endothelial cell migration,2/24,222/18493,0.033293187041744485,0.09366868458382342,0.05382252865750678,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0022011,myelination in peripheral nervous system,1/24,26/18493,0.03322285445802409,0.09366868458382342,0.05382252865750678,1,bp,NAC,4915,NTRK2
GO:0031954,positive regulation of protein autophosphorylation,1/24,26/18493,0.03322285445802409,0.09366868458382342,0.05382252865750678,1,bp,NAC,80310,PDGFD
GO:0032292,peripheral nervous system axon ensheathment,1/24,26/18493,0.03322285445802409,0.09366868458382342,0.05382252865750678,1,bp,NAC,4915,NTRK2
GO:0036152,phosphatidylethanolamine acyl-chain remodeling,1/24,26/18493,0.03322285445802409,0.09366868458382342,0.05382252865750678,1,bp,NAC,5320,PLA2G2A
GO:0046578,regulation of Ras protein signal transduction,2/24,222/18493,0.033293187041744485,0.09366868458382342,0.05382252865750678,2,bp,NAC,10252/3479,SPRY1/IGF1
GO:0051194,positive regulation of cofactor metabolic process,1/24,26/18493,0.03322285445802409,0.09366868458382342,0.05382252865750678,1,bp,NAC,3479,IGF1
GO:0060259,regulation of feeding behavior,1/24,26/18493,0.03322285445802409,0.09366868458382342,0.05382252865750678,1,bp,NAC,3953,LEPR
GO:0060669,embryonic placenta morphogenesis,1/24,26/18493,0.03322285445802409,0.09366868458382342,0.05382252865750678,1,bp,NAC,9021,SOCS3
GO:0060706,cell differentiation involved in embryonic placenta development,1/24,26/18493,0.03322285445802409,0.09366868458382342,0.05382252865750678,1,bp,NAC,9021,SOCS3
GO:1902624,positive regulation of neutrophil migration,1/24,26/18493,0.03322285445802409,0.09366868458382342,0.05382252865750678,1,bp,NAC,7060,THBS4
GO:1903588,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/24,26/18493,0.03322285445802409,0.09366868458382342,0.05382252865750678,1,bp,NAC,4804,NGFR
GO:0035902,response to immobilization stress,1/24,27/18493,0.03447929305081121,0.0949461636664589,0.054556574991561815,1,bp,NAC,2353,FOS
GO:0036151,phosphatidylcholine acyl-chain remodeling,1/24,27/18493,0.03447929305081121,0.0949461636664589,0.054556574991561815,1,bp,NAC,5320,PLA2G2A
GO:0040001,establishment of mitotic spindle localization,1/24,27/18493,0.03447929305081121,0.0949461636664589,0.054556574991561815,1,bp,NAC,10252,SPRY1
GO:0042104,positive regulation of activated T cell proliferation,1/24,27/18493,0.03447929305081121,0.0949461636664589,0.054556574991561815,1,bp,NAC,3479,IGF1
GO:0043921,modulation by host of viral transcription,1/24,27/18493,0.03447929305081121,0.0949461636664589,0.054556574991561815,1,bp,NAC,3725,JUN
GO:0048738,cardiac muscle tissue development,2/24,224/18493,0.033844120668697616,0.0949461636664589,0.054556574991561815,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0051450,myoblast proliferation,1/24,27/18493,0.03447929305081121,0.0949461636664589,0.054556574991561815,1,bp,NAC,3479,IGF1
GO:0052472,modulation by host of symbiont transcription,1/24,27/18493,0.03447929305081121,0.0949461636664589,0.054556574991561815,1,bp,NAC,3725,JUN
GO:1903792,negative regulation of anion transport,1/24,27/18493,0.03447929305081121,0.0949461636664589,0.054556574991561815,1,bp,NAC,6424,SFRP4
GO:2000144,"positive regulation of DNA-templated transcription, initiation",1/24,27/18493,0.03447929305081121,0.0949461636664589,0.054556574991561815,1,bp,NAC,3725,JUN
R-HSA-1482788,Acyl chain remodelling of PC,1/21,28/10554,0.05431004540645257,0.0952987589207564,0.04530331493686212,1,re,NAC,5320,PLA2G2A
R-HSA-1482839,Acyl chain remodelling of PE,1/21,30/10554,0.05807987633430001,0.09532010435397308,0.04531346217166801,1,re,NAC,5320,PLA2G2A
R-HSA-1839124,FGFR1 mutant receptor activation,1/21,31/10554,0.059959420480725,0.09532010435397308,0.04531346217166801,1,re,NAC,2247,FGF2
R-HSA-2559583,Cellular Senescence,2/21,195/10554,0.056675982253541646,0.09532010435397308,0.04531346217166801,2,re,NAC,2353/3725,FOS/JUN
R-HSA-3000157,Laminin interactions,1/21,30/10554,0.05807987633430001,0.09532010435397308,0.04531346217166801,1,re,NAC,3679,ITGA7
R-HSA-399719,Trafficking of AMPA receptors,1/21,31/10554,0.059959420480725,0.09532010435397308,0.04531346217166801,1,re,NAC,7102,TSPAN7
R-HSA-399721,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",1/21,31/10554,0.059959420480725,0.09532010435397308,0.04531346217166801,1,re,NAC,7102,TSPAN7
R-HSA-5654687,Downstream signaling of activated FGFR1,1/21,31/10554,0.059959420480725,0.09532010435397308,0.04531346217166801,1,re,NAC,2247,FGF2
R-HSA-5654696,Downstream signaling of activated FGFR2,1/21,30/10554,0.05807987633430001,0.09532010435397308,0.04531346217166801,1,re,NAC,2247,FGF2
R-HSA-5654732,Negative regulation of FGFR3 signaling,1/21,29/10554,0.056196753467108396,0.09532010435397308,0.04531346217166801,1,re,NAC,2247,FGF2
R-HSA-5654733,Negative regulation of FGFR4 signaling,1/21,31/10554,0.059959420480725,0.09532010435397308,0.04531346217166801,1,re,NAC,2247,FGF2
R-HSA-9006931,Signaling by Nuclear Receptors,2/21,199/10554,0.0587529411540676,0.09532010435397308,0.04531346217166801,2,re,NAC,2353/3725,FOS/JUN
GO:1901681,sulfur compound binding,2/23,242/17632,0.03927893218107857,0.09539169243976224,0.05414389147767723,2,mf,NAC,2247/7060,FGF2/THBS4
GO:0032591,dendritic spine membrane,1/24,13/19659,0.01575963736069752,0.09591199150157695,0.07712221538869492,1,cc,NAC,8516,ITGA8
GO:0043197,dendritic spine,2/24,164/19659,0.01692643317545112,0.09591199150157695,0.07712221538869492,2,cc,NAC,8516/4915,ITGA8/NTRK2
GO:0044309,neuron spine,2/24,166/19659,0.01731744291000695,0.09591199150157695,0.07712221538869492,2,cc,NAC,8516/4915,ITGA8/NTRK2
GO:0090575,RNA polymerase II transcription factor complex,2/24,161/19659,0.01634720096834585,0.09591199150157695,0.07712221538869492,2,cc,NAC,2353/3725,FOS/JUN
GO:0005979,regulation of glycogen biosynthetic process,1/24,28/18493,0.035734166708711324,0.0961356654903178,0.05524006912076045,1,bp,NAC,3479,IGF1
GO:0010962,regulation of glucan biosynthetic process,1/24,28/18493,0.035734166708711324,0.0961356654903178,0.05524006912076045,1,bp,NAC,3479,IGF1
GO:0032958,inositol phosphate biosynthetic process,1/24,28/18493,0.035734166708711324,0.0961356654903178,0.05524006912076045,1,bp,NAC,2247,FGF2
GO:0034368,protein-lipid complex remodeling,1/24,28/18493,0.035734166708711324,0.0961356654903178,0.05524006912076045,1,bp,NAC,5320,PLA2G2A
GO:0034369,plasma lipoprotein particle remodeling,1/24,28/18493,0.035734166708711324,0.0961356654903178,0.05524006912076045,1,bp,NAC,5320,PLA2G2A
GO:0035116,embryonic hindlimb morphogenesis,1/24,28/18493,0.035734166708711324,0.0961356654903178,0.05524006912076045,1,bp,NAC,7704,ZBTB16
GO:0048265,response to pain,1/24,28/18493,0.035734166708711324,0.0961356654903178,0.05524006912076045,1,bp,NAC,7060,THBS4
GO:0048730,epidermis morphogenesis,1/24,28/18493,0.035734166708711324,0.0961356654903178,0.05524006912076045,1,bp,NAC,9314,KLF4
GO:0052312,modulation of transcription in other organism involved in symbiotic interaction,1/24,28/18493,0.035734166708711324,0.0961356654903178,0.05524006912076045,1,bp,NAC,3725,JUN
GO:0070570,regulation of neuron projection regeneration,1/24,28/18493,0.035734166708711324,0.0961356654903178,0.05524006912076045,1,bp,NAC,9314,KLF4
GO:0090022,regulation of neutrophil chemotaxis,1/24,28/18493,0.035734166708711324,0.0961356654903178,0.05524006912076045,1,bp,NAC,7060,THBS4
GO:0097305,response to alcohol,2/24,231/18493,0.03580071428822166,0.0961356654903178,0.05524006912076045,2,bp,NAC,2353/9314,FOS/KLF4
GO:0014044,Schwann cell development,1/24,29/18493,0.03698747729625451,0.09652466409103039,0.05546358980355436,1,bp,NAC,4915,NTRK2
GO:0030217,T cell differentiation,2/24,234/18493,0.036652588186823015,0.09652466409103039,0.05546358980355436,2,bp,NAC,3953/7704,LEPR/ZBTB16
GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway,1/24,29/18493,0.03698747729625451,0.09652466409103039,0.05546358980355436,1,bp,NAC,8516,ITGA8
GO:0033500,carbohydrate homeostasis,2/24,234/18493,0.036652588186823015,0.09652466409103039,0.05546358980355436,2,bp,NAC,4804/3953,NGFR/LEPR
GO:0042036,negative regulation of cytokine biosynthetic process,1/24,29/18493,0.03698747729625451,0.09652466409103039,0.05546358980355436,1,bp,NAC,9314,KLF4
GO:0042593,glucose homeostasis,2/24,233/18493,0.036367749001543534,0.09652466409103039,0.05546358980355436,2,bp,NAC,4804/3953,NGFR/LEPR
GO:0046471,phosphatidylglycerol metabolic process,1/24,29/18493,0.03698747729625451,0.09652466409103039,0.05546358980355436,1,bp,NAC,5320,PLA2G2A
GO:0051294,establishment of spindle orientation,1/24,29/18493,0.03698747729625451,0.09652466409103039,0.05546358980355436,1,bp,NAC,10252,SPRY1
GO:0060441,epithelial tube branching involved in lung morphogenesis,1/24,29/18493,0.03698747729625451,0.09652466409103039,0.05546358980355436,1,bp,NAC,10252,SPRY1
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,2/24,235/18493,0.036938305186384766,0.09652466409103039,0.05546358980355436,2,bp,NAC,6424/8516,SFRP4/ITGA8
GO:0097237,cellular response to toxic substance,2/24,235/18493,0.036938305186384766,0.09652466409103039,0.05546358980355436,2,bp,NAC,9314/80310,KLF4/PDGFD
GO:1903846,positive regulation of cellular response to transforming growth factor beta stimulus,1/24,29/18493,0.03698747729625451,0.09652466409103039,0.05546358980355436,1,bp,NAC,8516,ITGA8
GO:2000116,regulation of cysteine-type endopeptidase activity,2/24,232/18493,0.03608379018297926,0.09652466409103039,0.05546358980355436,2,bp,NAC,9314/4804,KLF4/NGFR
GO:2000727,positive regulation of cardiac muscle cell differentiation,1/24,29/18493,0.03698747729625451,0.09652466409103039,0.05546358980355436,1,bp,NAC,3479,IGF1
GO:0060828,regulation of canonical Wnt signaling pathway,2/24,236/18493,0.03722489745244722,0.0969491807145061,0.05570751933276819,2,bp,NAC,6424/27123,SFRP4/DKK2
hsa05215,Prostate cancer,2/23,97/7844,0.032350662296062586,0.09705198688818775,0.06395381249799278,2,kg,NAC,3479/80310,IGF1/PDGFD
GO:0006658,phosphatidylserine metabolic process,1/24,30/18493,0.03823922667585222,0.09821044950213928,0.056432251144353046,1,bp,NAC,5320,PLA2G2A
GO:0007202,activation of phospholipase C activity,1/24,30/18493,0.03823922667585222,0.09821044950213928,0.056432251144353046,1,bp,NAC,4915,NTRK2
GO:0010743,regulation of macrophage derived foam cell differentiation,1/24,30/18493,0.03823922667585222,0.09821044950213928,0.056432251144353046,1,bp,NAC,5320,PLA2G2A
GO:0034367,protein-containing complex remodeling,1/24,30/18493,0.03823922667585222,0.09821044950213928,0.056432251144353046,1,bp,NAC,5320,PLA2G2A
GO:0050482,arachidonic acid secretion,1/24,30/18493,0.03823922667585222,0.09821044950213928,0.056432251144353046,1,bp,NAC,5320,PLA2G2A
GO:1903963,arachidonate transport,1/24,30/18493,0.03823922667585222,0.09821044950213928,0.056432251144353046,1,bp,NAC,5320,PLA2G2A
GO:2001171,positive regulation of ATP biosynthetic process,1/24,30/18493,0.03823922667585222,0.09821044950213928,0.056432251144353046,1,bp,NAC,3479,IGF1
GO:0046474,glycerophospholipid biosynthetic process,2/24,241/18493,0.03867089893264293,0.09912283777794048,0.05695651434223257,2,bp,NAC,2247/5320,FGF2/PLA2G2A
R-HSA-1839126,FGFR2 mutant receptor activation,1/21,33/10554,0.06370779844672836,0.09957689505118886,0.04733706386134615,1,re,NAC,2247,FGF2
R-HSA-5654726,Negative regulation of FGFR1 signaling,1/21,33/10554,0.06370779844672836,0.09957689505118886,0.04733706386134615,1,re,NAC,2247,FGF2
GO:0048019,receptor antagonist activity,1/23,33/17632,0.042197801091810816,0.10009710956662102,0.056814664872695105,1,mf,NAC,27123,DKK2
GO:0003401,axis elongation,1/24,31/18493,0.03948941670779593,0.10018524753701241,0.05756698068920568,1,bp,NAC,10252,SPRY1
GO:0019318,hexose metabolic process,2/24,244/18493,0.03954884097066334,0.10018524753701241,0.05756698068920568,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0030431,sleep,1/24,31/18493,0.03948941670779593,0.10018524753701241,0.05756698068920568,1,bp,NAC,2353,FOS
GO:0043552,positive regulation of phosphatidylinositol 3-kinase activity,1/24,31/18493,0.03948941670779593,0.10018524753701241,0.05756698068920568,1,bp,NAC,2247,FGF2
GO:1900745,positive regulation of p38MAPK cascade,1/24,31/18493,0.03948941670779593,0.10018524753701241,0.05756698068920568,1,bp,NAC,4616,GADD45B
GO:1902622,regulation of neutrophil migration,1/24,31/18493,0.03948941670779593,0.10018524753701241,0.05756698068920568,1,bp,NAC,7060,THBS4
R-HSA-4791275,Signaling by WNT in cancer,1/21,34/10554,0.06557664515641592,0.10080376858754844,0.047920297460973794,1,re,NAC,27123,DKK2
R-HSA-5654727,Negative regulation of FGFR2 signaling,1/21,34/10554,0.06557664515641592,0.10080376858754844,0.047920297460973794,1,re,NAC,2247,FGF2
hsa04660,T cell receptor signaling pathway,2/23,101/7844,0.03484161037937366,0.10203614468245142,0.06723819546896671,2,kg,NAC,2353/3725,FOS/JUN
GO:0006352,"DNA-templated transcription, initiation",2/24,248/18493,0.040731354358654985,0.10239777108060188,0.05883830858667056,2,bp,NAC,3164/3725,NR4A1/JUN
GO:0010762,regulation of fibroblast migration,1/24,32/18493,0.04073804925026259,0.10239777108060188,0.05883830858667056,1,bp,NAC,2247,FGF2
GO:0060317,cardiac epithelial to mesenchymal transition,1/24,32/18493,0.04073804925026259,0.10239777108060188,0.05883830858667056,1,bp,NAC,10252,SPRY1
GO:0061036,positive regulation of cartilage development,1/24,32/18493,0.04073804925026259,0.10239777108060188,0.05883830858667056,1,bp,NAC,7704,ZBTB16
GO:0001774,microglial cell activation,1/24,33/18493,0.041985126159313935,0.10274473326156637,0.059037674917168347,1,bp,NAC,3725,JUN
GO:0002269,leukocyte activation involved in inflammatory response,1/24,33/18493,0.041985126159313935,0.10274473326156637,0.059037674917168347,1,bp,NAC,3725,JUN
GO:0010092,specification of animal organ identity,1/24,33/18493,0.041985126159313935,0.10274473326156637,0.059037674917168347,1,bp,NAC,10252,SPRY1
GO:0010951,negative regulation of endopeptidase activity,2/24,250/18493,0.041327676413172976,0.10274473326156637,0.059037674917168347,2,bp,NAC,9314/4804,KLF4/NGFR
GO:0022409,positive regulation of cell-cell adhesion,2/24,251/18493,0.04162709508470347,0.10274473326156637,0.059037674917168347,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0031128,developmental induction,1/24,33/18493,0.041985126159313935,0.10274473326156637,0.059037674917168347,1,bp,NAC,10252,SPRY1
GO:0046326,positive regulation of glucose import,1/24,33/18493,0.041985126159313935,0.10274473326156637,0.059037674917168347,1,bp,NAC,3479,IGF1
GO:0060674,placenta blood vessel development,1/24,33/18493,0.041985126159313935,0.10274473326156637,0.059037674917168347,1,bp,NAC,9021,SOCS3
GO:0060795,cell fate commitment involved in formation of primary germ layer,1/24,33/18493,0.041985126159313935,0.10274473326156637,0.059037674917168347,1,bp,NAC,9314,KLF4
GO:0070873,regulation of glycogen metabolic process,1/24,33/18493,0.041985126159313935,0.10274473326156637,0.059037674917168347,1,bp,NAC,3479,IGF1
GO:0071354,cellular response to interleukin-6,1/24,33/18493,0.041985126159313935,0.10274473326156637,0.059037674917168347,1,bp,NAC,9021,SOCS3
GO:0090257,regulation of muscle system process,2/24,252/18493,0.041927348885167616,0.10274473326156637,0.059037674917168347,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0090596,sensory organ morphogenesis,2/24,251/18493,0.04162709508470347,0.10274473326156637,0.059037674917168347,2,bp,NAC,8516/4915,ITGA8/NTRK2
GO:0097009,energy homeostasis,1/24,33/18493,0.041985126159313935,0.10274473326156637,0.059037674917168347,1,bp,NAC,3953,LEPR
hsa04620,Toll-like receptor signaling pathway,2/23,104/7844,0.03675793139525072,0.10275512640035997,0.06771197888598816,2,kg,NAC,2353/3725,FOS/JUN
hsa05142,Chagas disease (American trypanosomiasis),2/23,103/7844,0.03611463519418608,0.10275512640035997,0.06771197888598816,2,kg,NAC,2353/3725,FOS/JUN
GO:0001046,core promoter sequence-specific DNA binding,1/23,38/17632,0.048440893421928255,0.10278390433473367,0.05833967738297577,1,mf,NAC,2353,FOS
GO:0001221,transcription cofactor binding,1/23,41/17632,0.05216804508702988,0.10278390433473367,0.05833967738297577,1,mf,NAC,9314,KLF4
GO:0001784,phosphotyrosine residue binding,1/23,40/17632,0.05092721550293278,0.10278390433473367,0.05833967738297577,1,mf,NAC,9021,SOCS3
GO:0004623,phospholipase A2 activity,1/23,35/17632,0.04469972513334852,0.10278390433473367,0.05833967738297577,1,mf,NAC,5320,PLA2G2A
GO:0015026,coreceptor activity,1/23,42/17632,0.053407322840596905,0.10278390433473367,0.05833967738297577,1,mf,NAC,4804,NGFR
GO:0017147,Wnt-protein binding,1/23,36/17632,0.04594834173401541,0.10278390433473367,0.05833967738297577,1,mf,NAC,6424,SFRP4
GO:0030547,receptor inhibitor activity,1/23,42/17632,0.053407322840596905,0.10278390433473367,0.05833967738297577,1,mf,NAC,27123,DKK2
GO:0031625,ubiquitin protein ligase binding,2/23,286/17632,0.05303958724695294,0.10278390433473367,0.05833967738297577,2,mf,NAC,3725/4804,JUN/NGFR
GO:0042056,chemoattractant activity,1/23,37/17632,0.04719539720913013,0.10278390433473367,0.05833967738297577,1,mf,NAC,2247,FGF2
GO:0042277,peptide binding,2/23,285/17632,0.05270981073861289,0.10278390433473367,0.05833967738297577,2,mf,NAC,4804/3953,NGFR/LEPR
GO:0003007,heart morphogenesis,2/24,253/18493,0.04222843534479926,0.10314553793258878,0.059267979431297205,2,bp,NAC,10252/3725,SPRY1/JUN
GO:0007281,germ cell development,2/24,255/18493,0.042833096385130345,0.1034504651802659,0.05944319226362721,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0014047,glutamate secretion,1/24,34/18493,0.043230649288900636,0.1034504651802659,0.05944319226362721,1,bp,NAC,4915,NTRK2
GO:0014904,myotube cell development,1/24,34/18493,0.043230649288900636,0.1034504651802659,0.05944319226362721,1,bp,NAC,3479,IGF1
GO:0030224,monocyte differentiation,1/24,34/18493,0.043230649288900636,0.1034504651802659,0.05944319226362721,1,bp,NAC,3725,JUN
GO:0032148,activation of protein kinase B activity,1/24,34/18493,0.043230649288900636,0.1034504651802659,0.05944319226362721,1,bp,NAC,3479,IGF1
GO:0042462,eye photoreceptor cell development,1/24,34/18493,0.043230649288900636,0.1034504651802659,0.05944319226362721,1,bp,NAC,4915,NTRK2
GO:0043276,anoikis,1/24,34/18493,0.043230649288900636,0.1034504651802659,0.05944319226362721,1,bp,NAC,4915,NTRK2
GO:0043403,skeletal muscle tissue regeneration,1/24,34/18493,0.043230649288900636,0.1034504651802659,0.05944319226362721,1,bp,NAC,3479,IGF1
GO:0046627,negative regulation of insulin receptor signaling pathway,1/24,34/18493,0.043230649288900636,0.1034504651802659,0.05944319226362721,1,bp,NAC,9021,SOCS3
GO:1900077,negative regulation of cellular response to insulin stimulus,1/24,34/18493,0.043230649288900636,0.1034504651802659,0.05944319226362721,1,bp,NAC,9021,SOCS3
GO:1903131,mononuclear cell differentiation,1/24,34/18493,0.043230649288900636,0.1034504651802659,0.05944319226362721,1,bp,NAC,3725,JUN
GO:0045165,cell fate commitment,2/24,257/18493,0.043441058537991586,0.10376252840474233,0.05962250546650779,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0031668,cellular response to extracellular stimulus,2/24,258/18493,0.043746271405186936,0.1042994742877343,0.05993103745137838,2,bp,NAC,2353/3725,FOS/JUN
GO:0010453,regulation of cell fate commitment,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,2247,FGF2
GO:0010466,negative regulation of peptidase activity,2/24,261/18493,0.04466680787082108,0.10494690791961239,0.06030305628948225,2,bp,NAC,9314/4804,KLF4/NGFR
GO:0010742,macrophage derived foam cell differentiation,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,5320,PLA2G2A
GO:0030212,hyaluronan metabolic process,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,2247,FGF2
GO:0032885,regulation of polysaccharide biosynthetic process,1/24,35/18493,0.044474620490864925,0.10494690791961239,0.06030305628948225,1,bp,NAC,3479,IGF1
GO:0034390,smooth muscle cell apoptotic process,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,3479,IGF1
GO:0034391,regulation of smooth muscle cell apoptotic process,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,3479,IGF1
GO:0034405,response to fluid shear stress,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,9314,KLF4
GO:0034976,response to endoplasmic reticulum stress,2/24,264/18493,0.04559464007093182,0.10494690791961239,0.06030305628948225,2,bp,NAC,3725/7060,JUN/THBS4
GO:0035137,hindlimb morphogenesis,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,7704,ZBTB16
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,10252,SPRY1
GO:0051385,response to mineralocorticoid,1/24,35/18493,0.044474620490864925,0.10494690791961239,0.06030305628948225,1,bp,NAC,2353,FOS
GO:0051973,positive regulation of telomerase activity,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,9314,KLF4
GO:0070884,regulation of calcineurin-NFAT signaling cascade,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,3479,IGF1
GO:0090077,foam cell differentiation,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,5320,PLA2G2A
GO:0090218,positive regulation of lipid kinase activity,1/24,35/18493,0.044474620490864925,0.10494690791961239,0.06030305628948225,1,bp,NAC,2247,FGF2
GO:0106056,regulation of calcineurin-mediated signaling,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,3479,IGF1
GO:1900115,extracellular regulation of signal transduction,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,27123,DKK2
GO:1900116,extracellular negative regulation of signal transduction,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,27123,DKK2
GO:1903580,positive regulation of ATP metabolic process,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,3479,IGF1
GO:1904037,positive regulation of epithelial cell apoptotic process,1/24,36/18493,0.045717041614942944,0.10494690791961239,0.06030305628948225,1,bp,NAC,6424,SFRP4
GO:0003298,physiological muscle hypertrophy,1/24,37/18493,0.04695791450876319,0.10518897256971649,0.0604421479360137,1,bp,NAC,3479,IGF1
GO:0003301,physiological cardiac muscle hypertrophy,1/24,37/18493,0.04695791450876319,0.10518897256971649,0.0604421479360137,1,bp,NAC,3479,IGF1
GO:0014037,Schwann cell differentiation,1/24,37/18493,0.04695791450876319,0.10518897256971649,0.0604421479360137,1,bp,NAC,4915,NTRK2
GO:0015980,energy derivation by oxidation of organic compounds,2/24,267/18493,0.046529702656193245,0.10518897256971649,0.0604421479360137,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0045684,positive regulation of epidermis development,1/24,37/18493,0.04695791450876319,0.10518897256971649,0.0604421479360137,1,bp,NAC,6424,SFRP4
GO:0045740,positive regulation of DNA replication,1/24,37/18493,0.04695791450876319,0.10518897256971649,0.0604421479360137,1,bp,NAC,3725,JUN
GO:0045927,positive regulation of growth,2/24,267/18493,0.046529702656193245,0.10518897256971649,0.0604421479360137,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0048009,insulin-like growth factor receptor signaling pathway,1/24,37/18493,0.04695791450876319,0.10518897256971649,0.0604421479360137,1,bp,NAC,3479,IGF1
GO:0051293,establishment of spindle localization,1/24,37/18493,0.04695791450876319,0.10518897256971649,0.0604421479360137,1,bp,NAC,10252,SPRY1
GO:0060045,positive regulation of cardiac muscle cell proliferation,1/24,37/18493,0.04695791450876319,0.10518897256971649,0.0604421479360137,1,bp,NAC,2247,FGF2
GO:0061049,cell growth involved in cardiac muscle cell development,1/24,37/18493,0.04695791450876319,0.10518897256971649,0.0604421479360137,1,bp,NAC,3479,IGF1
GO:0061756,leukocyte adhesion to vascular endothelial cell,1/24,37/18493,0.04695791450876319,0.10518897256971649,0.0604421479360137,1,bp,NAC,9314,KLF4
GO:0070741,response to interleukin-6,1/24,37/18493,0.04695791450876319,0.10518897256971649,0.0604421479360137,1,bp,NAC,9021,SOCS3
GO:2000142,"regulation of DNA-templated transcription, initiation",1/24,37/18493,0.04695791450876319,0.10518897256971649,0.0604421479360137,1,bp,NAC,3725,JUN
GO:0010976,positive regulation of neuron projection development,2/24,269/18493,0.04715706248547796,0.10545294835114641,0.06059382983614954,2,bp,NAC,4804/4915,NGFR/NTRK2
hsa04659,Th17 cell differentiation,2/23,107/7844,0.038714602576792,0.10581991370989813,0.0697315648751575,2,kg,NAC,2353/3725,FOS/JUN
GO:0016303,1-phosphatidylinositol-3-kinase activity,1/23,46/17632,0.058348952571354085,0.10627844932639494,0.06032316525233976,1,mf,NAC,2247,FGF2
GO:0044389,ubiquitin-like protein ligase binding,2/23,301/17632,0.05807570912478165,0.10627844932639494,0.06032316525233976,2,mf,NAC,3725/4804,JUN/NGFR
GO:1990841,promoter-specific chromatin binding,1/23,46/17632,0.058348952571354085,0.10627844932639494,0.06032316525233976,1,mf,NAC,9314,KLF4
GO:0001047,core promoter binding,1/23,47/17632,0.059580498920202785,0.10661773490983656,0.060515742208885566,1,mf,NAC,2353,FOS
GO:0000060,"protein import into nucleus, translocation",1/24,38/18493,0.04819724101785405,0.10685781470112259,0.06140107357740111,1,bp,NAC,3479,IGF1
GO:0003156,regulation of animal organ formation,1/24,38/18493,0.04819724101785405,0.10685781470112259,0.06140107357740111,1,bp,NAC,10252,SPRY1
GO:0010559,regulation of glycoprotein biosynthetic process,1/24,38/18493,0.04819724101785405,0.10685781470112259,0.06140107357740111,1,bp,NAC,3479,IGF1
GO:0032570,response to progesterone,1/24,38/18493,0.04819724101785405,0.10685781470112259,0.06140107357740111,1,bp,NAC,2353,FOS
GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,1/24,38/18493,0.04819724101785405,0.10685781470112259,0.06140107357740111,1,bp,NAC,2247,FGF2
GO:0003713,transcription coactivator activity,2/23,321/17632,0.0650418964023964,0.10700441021039407,0.06073521735368085,2,mf,NAC,3725/2247,JUN/FGF2
GO:0004879,nuclear receptor activity,1/23,50/17632,0.06326590084847705,0.10700441021039407,0.06073521735368085,1,mf,NAC,3164,NR4A1
GO:0017046,peptide hormone binding,1/23,51/17632,0.06449129524504682,0.10700441021039407,0.06073521735368085,1,mf,NAC,3953,LEPR
GO:0045309,protein phosphorylated amino acid binding,1/23,49/17632,0.062038971219747996,0.10700441021039407,0.06073521735368085,1,mf,NAC,9021,SOCS3
GO:0098531,"transcription factor activity, direct ligand regulated sequence-specific DNA binding",1/23,50/17632,0.06326590084847705,0.10700441021039407,0.06073521735368085,1,mf,NAC,3164,NR4A1
GO:0045017,glycerolipid biosynthetic process,2/24,273/18493,0.04842125938394918,0.10717128570133462,0.06158119569577154,2,bp,NAC,2247/5320,FGF2/PLA2G2A
GO:0098802,plasma membrane receptor complex,2/24,184/19659,0.02100795346534781,0.10804090353607447,0.0868749955333932,2,cc,NAC,3679/8516,ITGA7/ITGA8
GO:0003707,steroid hormone receptor activity,1/23,54/17632,0.06815828536927582,0.10862726730728334,0.06165634367286464,1,mf,NAC,3164,NR4A1
GO:0052742,phosphatidylinositol kinase activity,1/23,54/17632,0.06815828536927582,0.10862726730728334,0.06165634367286464,1,mf,NAC,2247,FGF2
GO:0010677,negative regulation of cellular carbohydrate metabolic process,1/24,39/18493,0.04943502298564517,0.10904289934078534,0.06265663493347079,1,bp,NAC,3953,LEPR
GO:0040019,positive regulation of embryonic development,1/24,39/18493,0.04943502298564517,0.10904289934078534,0.06265663493347079,1,bp,NAC,3479,IGF1
GO:0051146,striated muscle cell differentiation,2/24,277/18493,0.04969796564162578,0.109436776633597,0.06288295893891707,2,bp,NAC,2318/3479,FLNC/IGF1
GO:0006654,phosphatidic acid biosynthetic process,1/24,40/18493,0.05067126225346452,0.10990071428552423,0.06314954000255743,1,bp,NAC,5320,PLA2G2A
GO:0010828,positive regulation of glucose transmembrane transport,1/24,40/18493,0.05067126225346452,0.10990071428552423,0.06314954000255743,1,bp,NAC,3479,IGF1
GO:0030810,positive regulation of nucleotide biosynthetic process,1/24,40/18493,0.05067126225346452,0.10990071428552423,0.06314954000255743,1,bp,NAC,3479,IGF1
GO:0032881,regulation of polysaccharide metabolic process,1/24,40/18493,0.05067126225346452,0.10990071428552423,0.06314954000255743,1,bp,NAC,3479,IGF1
GO:0044262,cellular carbohydrate metabolic process,2/24,278/18493,0.05001907903006987,0.10990071428552423,0.06314954000255743,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0046006,regulation of activated T cell proliferation,1/24,40/18493,0.05067126225346452,0.10990071428552423,0.06314954000255743,1,bp,NAC,3479,IGF1
GO:0061900,glial cell activation,1/24,40/18493,0.05067126225346452,0.10990071428552423,0.06314954000255743,1,bp,NAC,3725,JUN
GO:0090184,positive regulation of kidney development,1/24,40/18493,0.05067126225346452,0.10990071428552423,0.06314954000255743,1,bp,NAC,80310,PDGFD
GO:1900373,positive regulation of purine nucleotide biosynthetic process,1/24,40/18493,0.05067126225346452,0.10990071428552423,0.06314954000255743,1,bp,NAC,3479,IGF1
GO:0043034,costamere,1/24,19/19659,0.02295277552010233,0.11017332249649119,0.08858965990214934,1,cc,NAC,2318,FLNC
R-HSA-2129379,Molecules associated with elastic fibres,1/21,38/10554,0.07301656671031964,0.11041529600097116,0.052489444618458274,1,re,NAC,8516,ITGA8
R-HSA-5655302,Signaling by FGFR1 in disease,1/21,38/10554,0.07301656671031964,0.11041529600097116,0.052489444618458274,1,re,NAC,2247,FGF2
GO:0001709,cell fate determination,1/24,41/18493,0.05190596066054831,0.11121207310493537,0.06390305381511524,1,bp,NAC,9314,KLF4
GO:0006110,regulation of glycolytic process,1/24,41/18493,0.05190596066054831,0.11121207310493537,0.06390305381511524,1,bp,NAC,3479,IGF1
GO:0008654,phospholipid biosynthetic process,2/24,284/18493,0.05196184757254498,0.11121207310493537,0.06390305381511524,2,bp,NAC,2247/5320,FGF2/PLA2G2A
GO:0010761,fibroblast migration,1/24,41/18493,0.05190596066054831,0.11121207310493537,0.06390305381511524,1,bp,NAC,2247,FGF2
GO:0017145,stem cell division,1/24,41/18493,0.05190596066054831,0.11121207310493537,0.06390305381511524,1,bp,NAC,7704,ZBTB16
GO:0035136,forelimb morphogenesis,1/24,41/18493,0.05190596066054831,0.11121207310493537,0.06390305381511524,1,bp,NAC,7704,ZBTB16
GO:0046473,phosphatidic acid metabolic process,1/24,41/18493,0.05190596066054831,0.11121207310493537,0.06390305381511524,1,bp,NAC,5320,PLA2G2A
GO:1905209,positive regulation of cardiocyte differentiation,1/24,41/18493,0.05190596066054831,0.11121207310493537,0.06390305381511524,1,bp,NAC,3479,IGF1
GO:0005996,monosaccharide metabolic process,2/24,287/18493,0.05294346910591256,0.1120673799953112,0.06439451774271017,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0030811,regulation of nucleotide catabolic process,1/24,42/18493,0.053139120044037313,0.1120673799953112,0.06439451774271017,1,bp,NAC,3479,IGF1
GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,1/24,42/18493,0.053139120044037313,0.1120673799953112,0.06439451774271017,1,bp,NAC,10252,SPRY1
GO:0042307,positive regulation of protein import into nucleus,1/24,42/18493,0.053139120044037313,0.1120673799953112,0.06439451774271017,1,bp,NAC,3479,IGF1
GO:0045429,positive regulation of nitric oxide biosynthetic process,1/24,42/18493,0.053139120044037313,0.1120673799953112,0.06439451774271017,1,bp,NAC,9314,KLF4
GO:0051653,spindle localization,1/24,42/18493,0.053139120044037313,0.1120673799953112,0.06439451774271017,1,bp,NAC,10252,SPRY1
GO:0071622,regulation of granulocyte chemotaxis,1/24,42/18493,0.053139120044037313,0.1120673799953112,0.06439451774271017,1,bp,NAC,7060,THBS4
GO:0071675,regulation of mononuclear cell migration,1/24,42/18493,0.053139120044037313,0.1120673799953112,0.06439451774271017,1,bp,NAC,80310,PDGFD
GO:1904407,positive regulation of nitric oxide metabolic process,1/24,42/18493,0.053139120044037313,0.1120673799953112,0.06439451774271017,1,bp,NAC,9314,KLF4
GO:0010470,regulation of gastrulation,1/24,43/18493,0.054370742238983194,0.11355692863761868,0.06525042038342249,1,bp,NAC,9314,KLF4
GO:0010613,positive regulation of cardiac muscle hypertrophy,1/24,43/18493,0.054370742238983194,0.11355692863761868,0.06525042038342249,1,bp,NAC,3479,IGF1
GO:0010907,positive regulation of glucose metabolic process,1/24,43/18493,0.054370742238983194,0.11355692863761868,0.06525042038342249,1,bp,NAC,3479,IGF1
GO:0014742,positive regulation of muscle hypertrophy,1/24,43/18493,0.054370742238983194,0.11355692863761868,0.06525042038342249,1,bp,NAC,3479,IGF1
GO:0030258,lipid modification,2/24,291/18493,0.05426277338293626,0.11355692863761868,0.06525042038342249,2,bp,NAC,9021/2247,SOCS3/FGF2
GO:0045912,negative regulation of carbohydrate metabolic process,1/24,43/18493,0.054370742238983194,0.11355692863761868,0.06525042038342249,1,bp,NAC,3953,LEPR
R-HSA-1483166,Synthesis of PA,1/21,40/10554,0.07671533789287532,0.11415242278459849,0.05426600743580234,1,re,NAC,5320,PLA2G2A
R-HSA-5654741,Signaling by FGFR3,1/21,40/10554,0.07671533789287532,0.11415242278459849,0.05426600743580234,1,re,NAC,2247,FGF2
GO:0010769,regulation of cell morphogenesis involved in differentiation,2/24,293/18493,0.05492687354783324,0.11453401124041754,0.06581185728865448,2,bp,NAC,4804/4915,NGFR/NTRK2
GO:0032309,icosanoid secretion,1/24,44/18493,0.0556008290783474,0.11464908635074178,0.06587798006437948,1,bp,NAC,5320,PLA2G2A
GO:0033173,calcineurin-NFAT signaling cascade,1/24,44/18493,0.0556008290783474,0.11464908635074178,0.06587798006437948,1,bp,NAC,3479,IGF1
GO:0046782,regulation of viral transcription,1/24,44/18493,0.0556008290783474,0.11464908635074178,0.06587798006437948,1,bp,NAC,3725,JUN
GO:0046850,regulation of bone remodeling,1/24,44/18493,0.0556008290783474,0.11464908635074178,0.06587798006437948,1,bp,NAC,3953,LEPR
GO:0050798,activated T cell proliferation,1/24,44/18493,0.0556008290783474,0.11464908635074178,0.06587798006437948,1,bp,NAC,3479,IGF1
GO:0050850,positive regulation of calcium-mediated signaling,1/24,44/18493,0.0556008290783474,0.11464908635074178,0.06587798006437948,1,bp,NAC,3479,IGF1
GO:1904591,positive regulation of protein import,1/24,44/18493,0.0556008290783474,0.11464908635074178,0.06587798006437948,1,bp,NAC,3479,IGF1
R-HSA-5654743,Signaling by FGFR4,1/21,41/10554,0.07855944840307594,0.11505557010214272,0.05469534741697786,1,re,NAC,2247,FGF2
R-HSA-8951664,Neddylation,2/21,234/10554,0.07801310758461355,0.11505557010214272,0.05469534741697786,2,re,NAC,9021/7704,SOCS3/ZBTB16
GO:0001754,eye photoreceptor cell differentiation,1/24,45/18493,0.05682938239300506,0.11589262415680433,0.06659252355883412,1,bp,NAC,4915,NTRK2
GO:0006111,regulation of gluconeogenesis,1/24,45/18493,0.05682938239300506,0.11589262415680433,0.06659252355883412,1,bp,NAC,3953,LEPR
GO:0035987,endodermal cell differentiation,1/24,45/18493,0.05682938239300506,0.11589262415680433,0.06659252355883412,1,bp,NAC,3679,ITGA7
GO:0048599,oocyte development,1/24,45/18493,0.05682938239300506,0.11589262415680433,0.06659252355883412,1,bp,NAC,3479,IGF1
GO:0071827,plasma lipoprotein particle organization,1/24,45/18493,0.05682938239300506,0.11589262415680433,0.06659252355883412,1,bp,NAC,5320,PLA2G2A
GO:0098868,bone growth,1/24,45/18493,0.05682938239300506,0.11589262415680433,0.06659252355883412,1,bp,NAC,3953,LEPR
GO:1903018,regulation of glycoprotein metabolic process,1/24,45/18493,0.05682938239300506,0.11589262415680433,0.06659252355883412,1,bp,NAC,3479,IGF1
GO:0005978,glycogen biosynthetic process,1/24,46/18493,0.0580564040117475,0.11656216099572214,0.06697724301827802,1,bp,NAC,3479,IGF1
GO:0009250,glucan biosynthetic process,1/24,46/18493,0.0580564040117475,0.11656216099572214,0.06697724301827802,1,bp,NAC,3479,IGF1
GO:0042461,photoreceptor cell development,1/24,46/18493,0.0580564040117475,0.11656216099572214,0.06697724301827802,1,bp,NAC,4915,NTRK2
GO:0045981,positive regulation of nucleotide metabolic process,1/24,46/18493,0.0580564040117475,0.11656216099572214,0.06697724301827802,1,bp,NAC,3479,IGF1
GO:0071715,icosanoid transport,1/24,46/18493,0.0580564040117475,0.11656216099572214,0.06697724301827802,1,bp,NAC,5320,PLA2G2A
GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis,1/24,46/18493,0.0580564040117475,0.11656216099572214,0.06697724301827802,1,bp,NAC,9314,KLF4
GO:1900544,positive regulation of purine nucleotide metabolic process,1/24,46/18493,0.0580564040117475,0.11656216099572214,0.06697724301827802,1,bp,NAC,3479,IGF1
GO:1900744,regulation of p38MAPK cascade,1/24,46/18493,0.0580564040117475,0.11656216099572214,0.06697724301827802,1,bp,NAC,4616,GADD45B
GO:1901571,fatty acid derivative transport,1/24,46/18493,0.0580564040117475,0.11656216099572214,0.06697724301827802,1,bp,NAC,5320,PLA2G2A
GO:1903727,positive regulation of phospholipid metabolic process,1/24,46/18493,0.0580564040117475,0.11656216099572214,0.06697724301827802,1,bp,NAC,2247,FGF2
GO:0046580,negative regulation of Ras protein signal transduction,1/24,47/18493,0.059281895761285286,0.11738720427845346,0.06745131731456808,1,bp,NAC,10252,SPRY1
GO:0046638,positive regulation of alpha-beta T cell differentiation,1/24,47/18493,0.059281895761285286,0.11738720427845346,0.06745131731456808,1,bp,NAC,7704,ZBTB16
GO:0050863,regulation of T cell activation,2/24,305/18493,0.05897259613185841,0.11738720427845346,0.06745131731456808,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0090199,regulation of release of cytochrome c from mitochondria,1/24,47/18493,0.059281895761285286,0.11738720427845346,0.06745131731456808,1,bp,NAC,3479,IGF1
GO:0097720,calcineurin-mediated signaling,1/24,47/18493,0.059281895761285286,0.11738720427845346,0.06745131731456808,1,bp,NAC,3479,IGF1
GO:0101023,vascular endothelial cell proliferation,1/24,47/18493,0.059281895761285286,0.11738720427845346,0.06745131731456808,1,bp,NAC,2247,FGF2
GO:0150076,neuroinflammatory response,1/24,47/18493,0.059281895761285286,0.11738720427845346,0.06745131731456808,1,bp,NAC,3725,JUN
GO:1901185,negative regulation of ERBB signaling pathway,1/24,47/18493,0.059281895761285286,0.11738720427845346,0.06745131731456808,1,bp,NAC,10252,SPRY1
GO:1905562,regulation of vascular endothelial cell proliferation,1/24,47/18493,0.059281895761285286,0.11738720427845346,0.06745131731456808,1,bp,NAC,2247,FGF2
GO:0033218,amide binding,2/23,348/17632,0.07487279393171513,0.1174926920159222,0.06668831848168959,2,mf,NAC,4804/3953,NGFR/LEPR
R-HSA-8878171,Transcriptional regulation by RUNX1,2/21,239/10554,0.08091263150620191,0.11757616765744966,0.05589359413257369,2,re,NAC,9021/3977,SOCS3/LIFR
R-HSA-177929,Signaling by EGFR,1/21,43/10554,0.08223715102077933,0.1176623853066535,0.05593458045138027,1,re,NAC,10252,SPRY1
R-HSA-5655253,Signaling by FGFR2 in disease,1/21,43/10554,0.08223715102077933,0.1176623853066535,0.05593458045138027,1,re,NAC,2247,FGF2
GO:0071375,cellular response to peptide hormone stimulus,2/24,307/18493,0.05965690125651909,0.11794969653918484,0.067774528385134,2,bp,NAC,3164/9021,NR4A1/SOCS3
GO:0009409,response to cold,1/24,48/18493,0.0605058594662472,0.11818689718030516,0.06791082514600986,1,bp,NAC,2353,FOS
GO:0019083,viral transcription,1/24,48/18493,0.0605058594662472,0.11818689718030516,0.06791082514600986,1,bp,NAC,3725,JUN
GO:0043470,regulation of carbohydrate catabolic process,1/24,48/18493,0.0605058594662472,0.11818689718030516,0.06791082514600986,1,bp,NAC,3479,IGF1
GO:0043525,positive regulation of neuron apoptotic process,1/24,48/18493,0.0605058594662472,0.11818689718030516,0.06791082514600986,1,bp,NAC,3725,JUN
GO:0051972,regulation of telomerase activity,1/24,48/18493,0.0605058594662472,0.11818689718030516,0.06791082514600986,1,bp,NAC,9314,KLF4
GO:0060711,labyrinthine layer development,1/24,48/18493,0.0605058594662472,0.11818689718030516,0.06791082514600986,1,bp,NAC,9021,SOCS3
GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/24,48/18493,0.0605058594662472,0.11818689718030516,0.06791082514600986,1,bp,NAC,4804,NGFR
GO:2000725,regulation of cardiac muscle cell differentiation,1/24,48/18493,0.0605058594662472,0.11818689718030516,0.06791082514600986,1,bp,NAC,3479,IGF1
GO:0001540,amyloid-beta binding,1/23,61/17632,0.07666120384502773,0.11847640594231558,0.06724667003949801,1,mf,NAC,4804,NGFR
GO:0004860,protein kinase inhibitor activity,1/23,62/17632,0.07786983126017588,0.11854810132146179,0.06728736401114963,1,mf,NAC,9021,SOCS3
GO:0001701,in utero embryonic development,2/24,311/18493,0.06103393702614843,0.11868218339267542,0.06819541926065348,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:0007568,aging,2/24,311/18493,0.06103393702614843,0.11868218339267542,0.06819541926065348,2,bp,NAC,2353/3725,FOS/JUN
GO:0030111,regulation of Wnt signaling pathway,2/24,311/18493,0.06103393702614843,0.11868218339267542,0.06819541926065348,2,bp,NAC,6424/27123,SFRP4/DKK2
GO:0032330,regulation of chondrocyte differentiation,1/24,49/18493,0.06172829694918602,0.11878575837254343,0.06825493399972467,1,bp,NAC,7704,ZBTB16
GO:0034260,negative regulation of GTPase activity,1/24,49/18493,0.06172829694918602,0.11878575837254343,0.06825493399972467,1,bp,NAC,10252,SPRY1
GO:0045599,negative regulation of fat cell differentiation,1/24,49/18493,0.06172829694918602,0.11878575837254343,0.06825493399972467,1,bp,NAC,862,RUNX1T1
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,1/24,49/18493,0.06172829694918602,0.11878575837254343,0.06825493399972467,1,bp,NAC,9021,SOCS3
GO:0060562,epithelial tube morphogenesis,2/24,313/18493,0.06172663214716134,0.11878575837254343,0.06825493399972467,2,bp,NAC,10252/2247,SPRY1/FGF2
GO:0071825,protein-lipid complex subunit organization,1/24,49/18493,0.06172829694918602,0.11878575837254343,0.06825493399972467,1,bp,NAC,5320,PLA2G2A
GO:1990090,cellular response to nerve growth factor stimulus,1/24,49/18493,0.06172829694918602,0.11878575837254343,0.06825493399972467,1,bp,NAC,4915,NTRK2
R-HSA-109704,PI3K Cascade,1/21,44/10554,0.08407075579944578,0.11936763800531996,0.05674522689556807,1,re,NAC,2247,FGF2
GO:0001706,endoderm formation,1/24,50/18493,0.06294921003057963,0.12024318911584946,0.06909238152337085,1,bp,NAC,3679,ITGA7
GO:0009994,oocyte differentiation,1/24,50/18493,0.06294921003057963,0.12024318911584946,0.06909238152337085,1,bp,NAC,3479,IGF1
GO:0015849,organic acid transport,2/24,316/18493,0.0627708466747978,0.12024318911584946,0.06909238152337085,2,bp,NAC,4915/5320,NTRK2/PLA2G2A
GO:0046942,carboxylic acid transport,2/24,316/18493,0.0627708466747978,0.12024318911584946,0.06909238152337085,2,bp,NAC,4915/5320,NTRK2/PLA2G2A
GO:0060425,lung morphogenesis,1/24,50/18493,0.06294921003057963,0.12024318911584946,0.06909238152337085,1,bp,NAC,10252,SPRY1
GO:0004714,transmembrane receptor protein tyrosine kinase activity,1/23,64/17632,0.08028254780777644,0.12042382171166466,0.06835201438742576,1,mf,NAC,4915,NTRK2
GO:0019210,kinase inhibitor activity,1/23,66/17632,0.0826892253608531,0.12049001409724308,0.0683895848849161,1,mf,NAC,9021,SOCS3
GO:0030374,nuclear receptor transcription coactivator activity,1/23,66/17632,0.0826892253608531,0.12049001409724308,0.0683895848849161,1,mf,NAC,2247,FGF2
R-HSA-1566948,Elastic fibre formation,1/21,45/10554,0.08590087132068436,0.12104213686096432,0.05754125351624789,1,re,NAC,8516,ITGA8
GO:1903829,positive regulation of cellular protein localization,2/24,318/18493,0.06347041195315378,0.12106047691653009,0.06956199947806946,2,bp,NAC,3479/4804,IGF1/NGFR
GO:0045840,positive regulation of mitotic nuclear division,1/24,51/18493,0.06416860052883211,0.1220332476332775,0.07012095875044472,1,bp,NAC,3479,IGF1
GO:0048260,positive regulation of receptor-mediated endocytosis,1/24,51/18493,0.06416860052883211,0.1220332476332775,0.07012095875044472,1,bp,NAC,6424,SFRP4
GO:0046934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",1/23,68/17632,0.08508987834949255,0.12224179706546819,0.0693838889432482,1,mf,NAC,2247,FGF2
GO:0051056,regulation of small GTPase mediated signal transduction,2/24,321/18493,0.06452484951614136,0.12253108319536654,0.07040701773511301,2,bp,NAC,10252/3479,SPRY1/IGF1
GO:0000186,activation of MAPKK activity,1/24,52/18493,0.065386470260277,0.12326490105752799,0.07082867341535513,1,bp,NAC,4616,GADD45B
GO:0002090,regulation of receptor internalization,1/24,52/18493,0.065386470260277,0.12326490105752799,0.07082867341535513,1,bp,NAC,6424,SFRP4
GO:0038066,p38MAPK cascade,1/24,52/18493,0.065386470260277,0.12326490105752799,0.07082867341535513,1,bp,NAC,4616,GADD45B
GO:1990089,response to nerve growth factor,1/24,52/18493,0.065386470260277,0.12326490105752799,0.07082867341535513,1,bp,NAC,4915,NTRK2
GO:2001169,regulation of ATP biosynthetic process,1/24,52/18493,0.065386470260277,0.12326490105752799,0.07082867341535513,1,bp,NAC,3479,IGF1
GO:0030336,negative regulation of cell migration,2/24,324/18493,0.06558534243055646,0.12328143352526337,0.07083817306000606,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0032496,response to lipopolysaccharide,2/24,324/18493,0.06558534243055646,0.12328143352526337,0.07083817306000606,2,bp,NAC,2353/3725,FOS/JUN
GO:0010721,negative regulation of cell development,2/24,326/18493,0.06629567291404985,0.12411473978134532,0.07131699530511097,2,bp,NAC,3479/4804,IGF1/NGFR
GO:0010823,negative regulation of mitochondrion organization,1/24,53/18493,0.06660282103917992,0.12411473978134532,0.07131699530511097,1,bp,NAC,3479,IGF1
GO:0036092,phosphatidylinositol-3-phosphate biosynthetic process,1/24,53/18493,0.06660282103917992,0.12411473978134532,0.07131699530511097,1,bp,NAC,2247,FGF2
GO:0043392,negative regulation of DNA binding,1/24,53/18493,0.06660282103917992,0.12411473978134532,0.07131699530511097,1,bp,NAC,3725,JUN
GO:0046579,positive regulation of Ras protein signal transduction,1/24,53/18493,0.06660282103917992,0.12411473978134532,0.07131699530511097,1,bp,NAC,3479,IGF1
GO:0051058,negative regulation of small GTPase mediated signal transduction,1/24,53/18493,0.06660282103917992,0.12411473978134532,0.07131699530511097,1,bp,NAC,10252,SPRY1
GO:0071496,cellular response to external stimulus,2/24,328/18493,0.06700865144428496,0.12469185211368378,0.07164860714725327,2,bp,NAC,2353/3725,FOS/JUN
GO:0052813,phosphatidylinositol bisphosphate kinase activity,1/23,71/17632,0.0886795932591482,0.1256294237837933,0.07130669048615718,1,mf,NAC,2247,FGF2
GO:0045123,cellular extravasation,1/24,54/18493,0.06781765467774048,0.12565642588147058,0.07220285640878234,1,bp,NAC,80310,PDGFD
GO:0061098,positive regulation of protein tyrosine kinase activity,1/24,54/18493,0.06781765467774048,0.12565642588147058,0.07220285640878234,1,bp,NAC,4915,NTRK2
GO:0090183,regulation of kidney development,1/24,54/18493,0.06781765467774048,0.12565642588147058,0.07220285640878234,1,bp,NAC,80310,PDGFD
GO:0002043,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/24,55/18493,0.06903097298609429,0.12628091955284104,0.07256169382251465,1,bp,NAC,4804,NGFR
GO:0032922,circadian regulation of gene expression,1/24,55/18493,0.06903097298609429,0.12628091955284104,0.07256169382251465,1,bp,NAC,4804,NGFR
GO:0046324,regulation of glucose import,1/24,55/18493,0.06903097298609429,0.12628091955284104,0.07256169382251465,1,bp,NAC,3479,IGF1
GO:0051196,regulation of coenzyme metabolic process,1/24,55/18493,0.06903097298609429,0.12628091955284104,0.07256169382251465,1,bp,NAC,3479,IGF1
GO:0051251,positive regulation of lymphocyte activation,2/24,333/18493,0.06880257044182987,0.12628091955284104,0.07256169382251465,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0051898,negative regulation of protein kinase B signaling,1/24,55/18493,0.06903097298609429,0.12628091955284104,0.07256169382251465,1,bp,NAC,9314,KLF4
GO:0060043,regulation of cardiac muscle cell proliferation,1/24,55/18493,0.06903097298609429,0.12628091955284104,0.07256169382251465,1,bp,NAC,2247,FGF2
GO:1903428,positive regulation of reactive oxygen species biosynthetic process,1/24,55/18493,0.06903097298609429,0.12628091955284104,0.07256169382251465,1,bp,NAC,9314,KLF4
GO:2000242,negative regulation of reproductive process,1/24,55/18493,0.06903097298609429,0.12628091955284104,0.07256169382251465,1,bp,NAC,3479,IGF1
GO:0048638,regulation of developmental growth,2/24,334/18493,0.0691633039178579,0.12634479603022775,0.07259839758909324,2,bp,NAC,3479/2247,IGF1/FGF2
GO:0002237,response to molecule of bacterial origin,2/24,337/18493,0.07024936549629959,0.12725338973282205,0.07312048040485167,2,bp,NAC,2353/3725,FOS/JUN
GO:0010656,negative regulation of muscle cell apoptotic process,1/24,56/18493,0.07024277777231525,0.12725338973282205,0.07312048040485167,1,bp,NAC,3479,IGF1
GO:0015800,acidic amino acid transport,1/24,56/18493,0.07024277777231525,0.12725338973282205,0.07312048040485167,1,bp,NAC,4915,NTRK2
GO:0048008,platelet-derived growth factor receptor signaling pathway,1/24,56/18493,0.07024277777231525,0.12725338973282205,0.07312048040485167,1,bp,NAC,80310,PDGFD
GO:0048016,inositol phosphate-mediated signaling,1/24,56/18493,0.07024277777231525,0.12725338973282205,0.07312048040485167,1,bp,NAC,3479,IGF1
GO:0055081,anion homeostasis,1/24,56/18493,0.07024277777231525,0.12725338973282205,0.07312048040485167,1,bp,NAC,6424,SFRP4
hsa04152,AMPK signaling pathway,2/23,120/7844,0.047640759610617256,0.1273872485240418,0.08394367254044688,2,kg,NAC,3479/3953,IGF1/LEPR
GO:0031589,cell-substrate adhesion,2/24,338/18493,0.07061266603131114,0.12773309322539825,0.07339612060510649,2,bp,NAC,3679/8516,ITGA7/ITGA8
R-HSA-112399,IRS-mediated signalling,1/21,48/10554,0.09137034537068445,0.1277810845033632,0.06074482794726943,1,re,NAC,2247,FGF2
GO:2000146,negative regulation of cell motility,2/24,339/18493,0.07097660306008834,0.12821261026314007,0.0736716536674132,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0046626,regulation of insulin receptor signaling pathway,1/24,57/18493,0.07145307084241659,0.1288937870411882,0.07406306149832508,1,bp,NAC,9021,SOCS3
GO:0003002,regionalization,2/24,341/18493,0.07170637820116356,0.12917107295404048,0.07422239147137982,2,bp,NAC,10252/7704,SPRY1/ZBTB16
GO:0045604,regulation of epidermal cell differentiation,1/24,58/18493,0.07266185400035652,0.13071071378427518,0.07510707735200002,1,bp,NAC,6424,SFRP4
GO:0030098,lymphocyte differentiation,2/24,344/18493,0.07280576223393295,0.13078819060583247,0.0751515959492995,2,bp,NAC,3953/7704,LEPR/ZBTB16
R-HSA-383280,Nuclear Receptor transcription pathway,1/21,50/10554,0.09499933048464215,0.13088796644550696,0.062221783709239316,1,re,NAC,3164,NR4A1
R-HSA-5654736,Signaling by FGFR1,1/21,50/10554,0.09499933048464215,0.13088796644550696,0.062221783709239316,1,re,NAC,2247,FGF2
GO:0033619,membrane protein proteolysis,1/24,59/18493,0.07386912904803711,0.1321493246555919,0.07593371087623996,1,bp,NAC,4804,NGFR
GO:0042490,mechanoreceptor differentiation,1/24,59/18493,0.07386912904803711,0.1321493246555919,0.07593371087623996,1,bp,NAC,4915,NTRK2
GO:0046173,polyol biosynthetic process,1/24,59/18493,0.07386912904803711,0.1321493246555919,0.07593371087623996,1,bp,NAC,2247,FGF2
GO:0001658,branching involved in ureteric bud morphogenesis,1/24,60/18493,0.07507489778530818,0.1332040252086795,0.07653974747209762,1,bp,NAC,2247,FGF2
GO:0022412,cellular process involved in reproduction in multicellular organism,2/24,350/18493,0.07502132106938464,0.1332040252086795,0.07653974747209762,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0030166,proteoglycan biosynthetic process,1/24,60/18493,0.07507489778530818,0.1332040252086795,0.07653974747209762,1,bp,NAC,3479,IGF1
GO:0032835,glomerulus development,1/24,60/18493,0.07507489778530818,0.1332040252086795,0.07653974747209762,1,bp,NAC,80310,PDGFD
GO:0051057,positive regulation of small GTPase mediated signal transduction,1/24,60/18493,0.07507489778530818,0.1332040252086795,0.07653974747209762,1,bp,NAC,3479,IGF1
GO:0060761,negative regulation of response to cytokine stimulus,1/24,60/18493,0.07507489778530818,0.1332040252086795,0.07653974747209762,1,bp,NAC,9314,KLF4
GO:0009913,epidermal cell differentiation,2/24,351/18493,0.07539273331969427,0.13358521190661676,0.07675877939364904,2,bp,NAC,9314/6424,KLF4/SFRP4
GO:0009880,embryonic pattern specification,1/24,61/18493,0.07627916200996743,0.13405700965708367,0.07702987691207665,1,bp,NAC,7704,ZBTB16
GO:0042733,embryonic digit morphogenesis,1/24,61/18493,0.07627916200996743,0.13405700965708367,0.07702987691207665,1,bp,NAC,7704,ZBTB16
GO:0045669,positive regulation of osteoblast differentiation,1/24,61/18493,0.07627916200996743,0.13405700965708367,0.07702987691207665,1,bp,NAC,3479,IGF1
GO:0046635,positive regulation of alpha-beta T cell activation,1/24,61/18493,0.07627916200996743,0.13405700965708367,0.07702987691207665,1,bp,NAC,7704,ZBTB16
GO:0048747,muscle fiber development,1/24,61/18493,0.07627916200996743,0.13405700965708367,0.07702987691207665,1,bp,NAC,2318,FLNC
GO:1900076,regulation of cellular response to insulin stimulus,1/24,61/18493,0.07627916200996743,0.13405700965708367,0.07702987691207665,1,bp,NAC,9021,SOCS3
GO:0001824,blastocyst development,1/24,62/18493,0.07748192351776695,0.13453019384544007,0.07730177108515324,1,bp,NAC,3479,IGF1
GO:0006027,glycosaminoglycan catabolic process,1/24,62/18493,0.07748192351776695,0.13453019384544007,0.07730177108515324,1,bp,NAC,2247,FGF2
GO:0019080,viral gene expression,1/24,62/18493,0.07748192351776695,0.13453019384544007,0.07730177108515324,1,bp,NAC,3725,JUN
GO:0035690,cellular response to drug,2/24,355/18493,0.07688445680533014,0.13453019384544007,0.07730177108515324,2,bp,NAC,9314/80310,KLF4/PDGFD
GO:0045428,regulation of nitric oxide biosynthetic process,1/24,62/18493,0.07748192351776695,0.13453019384544007,0.07730177108515324,1,bp,NAC,9314,KLF4
GO:0045666,positive regulation of neuron differentiation,2/24,356/18493,0.07725889608032768,0.13453019384544007,0.07730177108515324,2,bp,NAC,4804/4915,NGFR/NTRK2
GO:0046530,photoreceptor cell differentiation,1/24,62/18493,0.07748192351776695,0.13453019384544007,0.07730177108515324,1,bp,NAC,4915,NTRK2
GO:0048645,animal organ formation,1/24,62/18493,0.07748192351776695,0.13453019384544007,0.07730177108515324,1,bp,NAC,10252,SPRY1
GO:0062012,regulation of small molecule metabolic process,2/24,355/18493,0.07688445680533014,0.13453019384544007,0.07730177108515324,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0010038,response to metal ion,2/24,358/18493,0.07800957046439579,0.13526525787743493,0.07772414282126683,2,bp,NAC,2353/3725,FOS/JUN
GO:0010676,positive regulation of cellular carbohydrate metabolic process,1/24,63/18493,0.07868318410241082,0.13570756619790802,0.0779782955550208,1,bp,NAC,3479,IGF1
GO:0045861,negative regulation of proteolysis,2/24,359/18493,0.07838580151743747,0.13570756619790802,0.0779782955550208,2,bp,NAC,9314/4804,KLF4/NGFR
GO:0046323,glucose import,1/24,63/18493,0.07868318410241082,0.13570756619790802,0.0779782955550208,1,bp,NAC,3479,IGF1
GO:0046637,regulation of alpha-beta T cell differentiation,1/24,63/18493,0.07868318410241082,0.13570756619790802,0.0779782955550208,1,bp,NAC,7704,ZBTB16
GO:0043687,post-translational protein modification,2/24,361/18493,0.07914004123437424,0.1363142542908146,0.07832690178784785,2,bp,NAC,9021/7704,SOCS3/ZBTB16
GO:0042306,regulation of protein import into nucleus,1/24,64/18493,0.0798829455555603,0.136326553138897,0.07833396877193448,1,bp,NAC,3479,IGF1
GO:0045600,positive regulation of fat cell differentiation,1/24,64/18493,0.0798829455555603,0.136326553138897,0.07833396877193448,1,bp,NAC,7704,ZBTB16
GO:0045670,regulation of osteoclast differentiation,1/24,64/18493,0.0798829455555603,0.136326553138897,0.07833396877193448,1,bp,NAC,2353,FOS
GO:0050795,regulation of behavior,1/24,64/18493,0.0798829455555603,0.136326553138897,0.07833396877193448,1,bp,NAC,3953,LEPR
GO:0051785,positive regulation of nuclear division,1/24,64/18493,0.0798829455555603,0.136326553138897,0.07833396877193448,1,bp,NAC,3479,IGF1
GO:0060038,cardiac muscle cell proliferation,1/24,64/18493,0.0798829455555603,0.136326553138897,0.07833396877193448,1,bp,NAC,2247,FGF2
GO:1905207,regulation of cardiocyte differentiation,1/24,64/18493,0.0798829455555603,0.136326553138897,0.07833396877193448,1,bp,NAC,3479,IGF1
GO:0008013,beta-catenin binding,1/23,82/17632,0.10172696671420522,0.1365282974322228,0.07749284167979623,1,mf,NAC,9314,KLF4
GO:0019199,transmembrane receptor protein kinase activity,1/23,81/17632,0.10054826522141747,0.1365282974322228,0.07749284167979623,1,mf,NAC,4915,NTRK2
GO:0035004,phosphatidylinositol 3-kinase activity,1/23,79/17632,0.09818642242963727,0.1365282974322228,0.07749284167979623,1,mf,NAC,2247,FGF2
GO:0051219,phosphoprotein binding,1/23,82/17632,0.10172696671420522,0.1365282974322228,0.07749284167979623,1,mf,NAC,9021,SOCS3
R-HSA-74751,Insulin receptor signalling cascade,1/21,54/10554,0.10221593176990074,0.13776929934204013,0.0654930455276252,1,re,NAC,2247,FGF2
R-HSA-8848021,Signaling by PTK6,1/21,54/10554,0.10221593176990074,0.13776929934204013,0.0654930455276252,1,re,NAC,9021,SOCS3
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,1/21,54/10554,0.10221593176990074,0.13776929934204013,0.0654930455276252,1,re,NAC,9021,SOCS3
GO:0042246,tissue regeneration,1/24,65/18493,0.0810812096668343,0.13800830569276126,0.07930031281132571,1,bp,NAC,3479,IGF1
GO:0060675,ureteric bud morphogenesis,1/24,65/18493,0.0810812096668343,0.13800830569276126,0.07930031281132571,1,bp,NAC,2247,FGF2
GO:0006026,aminoglycan catabolic process,1/24,66/18493,0.08227797822381255,0.13877053024224303,0.07973829112649276,1,bp,NAC,2247,FGF2
GO:0015909,long-chain fatty acid transport,1/24,66/18493,0.08227797822381255,0.13877053024224303,0.07973829112649276,1,bp,NAC,5320,PLA2G2A
GO:0030858,positive regulation of epithelial cell differentiation,1/24,66/18493,0.08227797822381255,0.13877053024224303,0.07973829112649276,1,bp,NAC,6424,SFRP4
GO:0032677,regulation of interleukin-8 production,1/24,66/18493,0.08227797822381255,0.13877053024224303,0.07973829112649276,1,bp,NAC,9314,KLF4
GO:0050918,positive chemotaxis,1/24,66/18493,0.08227797822381255,0.13877053024224303,0.07973829112649276,1,bp,NAC,2247,FGF2
GO:0051965,positive regulation of synapse assembly,1/24,66/18493,0.08227797822381255,0.13877053024224303,0.07973829112649276,1,bp,NAC,4915,NTRK2
GO:0072171,mesonephric tubule morphogenesis,1/24,66/18493,0.08227797822381255,0.13877053024224303,0.07973829112649276,1,bp,NAC,2247,FGF2
hsa04060,Cytokine-cytokine receptor interaction,3/23,294/7844,0.053042827010349694,0.1388142068568726,0.09147363224629174,3,kg,NAC,4804/3977/3953,NGFR/LIFR/LEPR
GO:0031346,positive regulation of cell projection organization,2/24,371/18493,0.0829462699956553,0.13953477585520743,0.08017743075557913,2,bp,NAC,4804/4915,NGFR/NTRK2
GO:0043900,regulation of multi-organism process,2/24,371/18493,0.0829462699956553,0.13953477585520743,0.08017743075557913,2,bp,NAC,3479/3725,IGF1/JUN
GO:0002696,positive regulation of leukocyte activation,2/24,372/18493,0.08333005643599885,0.1396965279440168,0.08027037437354534,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1/24,67/18493,0.08347325301203778,0.1396965279440168,0.08027037437354534,1,bp,NAC,3164,NR4A1
GO:0046824,positive regulation of nucleocytoplasmic transport,1/24,67/18493,0.08347325301203778,0.1396965279440168,0.08027037437354534,1,bp,NAC,3479,IGF1
GO:1904589,regulation of protein import,1/24,67/18493,0.08347325301203778,0.1396965279440168,0.08027037437354534,1,bp,NAC,3479,IGF1
GO:0051271,negative regulation of cellular component movement,2/24,374/18493,0.08409932915398496,0.1405629251452558,0.08076821085325739,2,bp,NAC,9314/2247,KLF4/FGF2
hsa04926,Relaxin signaling pathway,2/23,130/7844,0.054973653371659346,0.14086998676487708,0.09282831819337214,2,kg,NAC,2353/3725,FOS/JUN
GO:0033692,cellular polysaccharide biosynthetic process,1/24,68/18493,0.08466703581501778,0.14114800186642423,0.0811043990759472,1,bp,NAC,3479,IGF1
GO:0061035,regulation of cartilage development,1/24,68/18493,0.08466703581501778,0.14114800186642423,0.0811043990759472,1,bp,NAC,7704,ZBTB16
hsa04068,FoxO signaling pathway,2/23,132/7844,0.05648620023676387,0.141791890390244,0.09343581994051166,2,kg,NAC,3479/4616,IGF1/GADD45B
GO:0040014,regulation of multicellular organism growth,1/24,69/18493,0.08585932841422783,0.14240351528549042,0.08182582382187817,1,bp,NAC,3479,IGF1
GO:0043647,inositol phosphate metabolic process,1/24,69/18493,0.08585932841422783,0.14240351528549042,0.08182582382187817,1,bp,NAC,2247,FGF2
GO:0050771,negative regulation of axonogenesis,1/24,69/18493,0.08585932841422783,0.14240351528549042,0.08182582382187817,1,bp,NAC,4804,NGFR
GO:0071300,cellular response to retinoic acid,1/24,69/18493,0.08585932841422783,0.14240351528549042,0.08182582382187817,1,bp,NAC,9314,KLF4
GO:0001503,ossification,2/24,380/18493,0.0864206047193627,0.1431513720574884,0.0822555463350256,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0048662,negative regulation of smooth muscle cell proliferation,1/24,70/18493,0.08705013258911165,0.14401023210214006,0.08274905192412868,1,bp,NAC,9314,KLF4
GO:0006305,DNA alkylation,1/24,71/18493,0.08823945011708556,0.14505268289209122,0.08334804974037299,1,bp,NAC,2353,FOS
GO:0006306,DNA methylation,1/24,71/18493,0.08823945011708556,0.14505268289209122,0.08334804974037299,1,bp,NAC,2353,FOS
GO:0035914,skeletal muscle cell differentiation,1/24,71/18493,0.08823945011708556,0.14505268289209122,0.08334804974037299,1,bp,NAC,2353,FOS
GO:0050867,positive regulation of cell activation,2/24,384/18493,0.08797918026120173,0.14505268289209122,0.08334804974037299,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0051155,positive regulation of striated muscle cell differentiation,1/24,71/18493,0.08823945011708556,0.14505268289209122,0.08334804974037299,1,bp,NAC,3479,IGF1
GO:0040013,negative regulation of locomotion,2/24,386/18493,0.0887617390915297,0.14572655139457472,0.08373525819693942,2,bp,NAC,9314/2247,KLF4/FGF2
GO:0005942,phosphatidylinositol 3-kinase complex,1/24,27/19659,0.032465293145609864,0.1460938191552444,0.11747310019793042,1,cc,NAC,9021,SOCS3
GO:0019226,transmission of nerve impulse,1/24,72/18493,0.08942728277353895,0.14626379036226989,0.08404395858985275,1,bp,NAC,4915,NTRK2
GO:0033555,multicellular organismal response to stress,1/24,72/18493,0.08942728277353895,0.14626379036226989,0.08404395858985275,1,bp,NAC,7060,THBS4
GO:0061045,negative regulation of wound healing,1/24,72/18493,0.08942728277353895,0.14626379036226989,0.08404395858985275,1,bp,NAC,2247,FGF2
hsa04915,Estrogen signaling pathway,2/23,138/7844,0.06111198153045661,0.14640672883877903,0.09647683457925532,2,kg,NAC,2353/3725,FOS/JUN
hsa05162,Measles,2/23,138/7844,0.06111198153045661,0.14640672883877903,0.09647683457925532,2,kg,NAC,2353/3725,FOS/JUN
hsa05418,Fluid shear stress and atherosclerosis,2/23,139/7844,0.061895527639158614,0.14640672883877903,0.09647683457925532,2,kg,NAC,2353/3725,FOS/JUN
GO:0000271,polysaccharide biosynthetic process,1/24,74/18493,0.09179850056332828,0.1471726269847179,0.08456618098866231,1,bp,NAC,3479,IGF1
GO:0005977,glycogen metabolic process,1/24,73/18493,0.0906136323318385,0.1471726269847179,0.08456618098866231,1,bp,NAC,3479,IGF1
GO:0006073,cellular glucan metabolic process,1/24,74/18493,0.09179850056332828,0.1471726269847179,0.08456618098866231,1,bp,NAC,3479,IGF1
GO:0006096,glycolytic process,1/24,74/18493,0.09179850056332828,0.1471726269847179,0.08456618098866231,1,bp,NAC,3479,IGF1
GO:0006809,nitric oxide biosynthetic process,1/24,73/18493,0.0906136323318385,0.1471726269847179,0.08456618098866231,1,bp,NAC,9314,KLF4
GO:0007492,endoderm development,1/24,74/18493,0.09179850056332828,0.1471726269847179,0.08456618098866231,1,bp,NAC,3679,ITGA7
GO:0010611,regulation of cardiac muscle hypertrophy,1/24,74/18493,0.09179850056332828,0.1471726269847179,0.08456618098866231,1,bp,NAC,3479,IGF1
GO:0010827,regulation of glucose transmembrane transport,1/24,74/18493,0.09179850056332828,0.1471726269847179,0.08456618098866231,1,bp,NAC,3479,IGF1
GO:0021954,central nervous system neuron development,1/24,74/18493,0.09179850056332828,0.1471726269847179,0.08456618098866231,1,bp,NAC,4915,NTRK2
GO:0030808,regulation of nucleotide biosynthetic process,1/24,74/18493,0.09179850056332828,0.1471726269847179,0.08456618098866231,1,bp,NAC,3479,IGF1
GO:0032637,interleukin-8 production,1/24,73/18493,0.0906136323318385,0.1471726269847179,0.08456618098866231,1,bp,NAC,9314,KLF4
GO:0044042,glucan metabolic process,1/24,74/18493,0.09179850056332828,0.1471726269847179,0.08456618098866231,1,bp,NAC,3479,IGF1
GO:0048545,response to steroid hormone,2/24,390/18493,0.09033332198103514,0.1471726269847179,0.08456618098866231,2,bp,NAC,2353/3164,FOS/NR4A1
GO:0072078,nephron tubule morphogenesis,1/24,74/18493,0.09179850056332828,0.1471726269847179,0.08456618098866231,1,bp,NAC,2247,FGF2
GO:1900371,regulation of purine nucleotide biosynthetic process,1/24,73/18493,0.0906136323318385,0.1471726269847179,0.08456618098866231,1,bp,NAC,3479,IGF1
GO:1903578,regulation of ATP metabolic process,1/24,74/18493,0.09179850056332828,0.1471726269847179,0.08456618098866231,1,bp,NAC,3479,IGF1
GO:0035258,steroid hormone receptor binding,1/23,90/17632,0.11110353424375508,0.14717611029692232,0.0835364919125978,1,mf,NAC,3164,NR4A1
R-HSA-193648,NRAGE signals death through JNK,1/21,59/10554,0.11115962974947657,0.14768350809573316,0.07020608194703784,1,re,NAC,4804,NGFR
R-HSA-3000171,Non-integrin membrane-ECM interactions,1/21,59/10554,0.11115962974947657,0.14768350809573316,0.07020608194703784,1,re,NAC,2247,FGF2
GO:0001937,negative regulation of endothelial cell proliferation,1/24,75/18493,0.09298188923733197,0.14797240532615896,0.08502573791415052,1,bp,NAC,4804,NGFR
GO:0006757,ATP generation from ADP,1/24,75/18493,0.09298188923733197,0.14797240532615896,0.08502573791415052,1,bp,NAC,3479,IGF1
GO:0007422,peripheral nervous system development,1/24,75/18493,0.09298188923733197,0.14797240532615896,0.08502573791415052,1,bp,NAC,4915,NTRK2
GO:0032642,regulation of chemokine production,1/24,75/18493,0.09298188923733197,0.14797240532615896,0.08502573791415052,1,bp,NAC,9314,KLF4
GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress,1/24,75/18493,0.09298188923733197,0.14797240532615896,0.08502573791415052,1,bp,NAC,3725,JUN
GO:0051193,regulation of cofactor metabolic process,1/24,75/18493,0.09298188923733197,0.14797240532615896,0.08502573791415052,1,bp,NAC,3479,IGF1
GO:0045785,positive regulation of cell adhesion,2/24,397/18493,0.0931040165630564,0.14798518318907372,0.08503308014272953,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0010507,negative regulation of autophagy,1/24,76/18493,0.0941638001211581,0.1483966570560657,0.08526951523409854,1,bp,NAC,3953,LEPR
GO:0014743,regulation of muscle hypertrophy,1/24,76/18493,0.0941638001211581,0.1483966570560657,0.08526951523409854,1,bp,NAC,3479,IGF1
GO:0034308,primary alcohol metabolic process,1/24,76/18493,0.0941638001211581,0.1483966570560657,0.08526951523409854,1,bp,NAC,3479,IGF1
GO:0043407,negative regulation of MAP kinase activity,1/24,76/18493,0.0941638001211581,0.1483966570560657,0.08526951523409854,1,bp,NAC,10252,SPRY1
GO:0051145,smooth muscle cell differentiation,1/24,76/18493,0.0941638001211581,0.1483966570560657,0.08526951523409854,1,bp,NAC,8516,ITGA8
GO:0051851,modification by host of symbiont morphology or physiology,1/24,76/18493,0.0941638001211581,0.1483966570560657,0.08526951523409854,1,bp,NAC,3725,JUN
GO:0072088,nephron epithelium morphogenesis,1/24,76/18493,0.0941638001211581,0.1483966570560657,0.08526951523409854,1,bp,NAC,2247,FGF2
GO:0001570,vasculogenesis,1/24,77/18493,0.09534423498009748,0.14953019681884694,0.08592085326278752,1,bp,NAC,4915,NTRK2
GO:0008306,associative learning,1/24,77/18493,0.09534423498009748,0.14953019681884694,0.08592085326278752,1,bp,NAC,2353,FOS
GO:0046209,nitric oxide metabolic process,1/24,77/18493,0.09534423498009748,0.14953019681884694,0.08592085326278752,1,bp,NAC,9314,KLF4
GO:0060291,long-term synaptic potentiation,1/24,77/18493,0.09534423498009748,0.14953019681884694,0.08592085326278752,1,bp,NAC,4915,NTRK2
R-HSA-5683057,MAPK family signaling cascades,2/21,293/10554,0.11423189291797907,0.15025826024740177,0.07143007278314516,2,re,NAC,3725/2247,JUN/FGF2
R-HSA-8943724,Regulation of PTEN gene transcription,1/21,61/10554,0.11471329545769382,0.15025826024740177,0.07143007278314516,1,re,NAC,3725,JUN
GO:0003151,outflow tract morphogenesis,1/24,78/18493,0.09652319557743017,0.1506505230612839,0.08656459873180132,1,bp,NAC,3725,JUN
GO:0042866,pyruvate biosynthetic process,1/24,78/18493,0.09652319557743017,0.1506505230612839,0.08656459873180132,1,bp,NAC,3479,IGF1
GO:0061333,renal tubule morphogenesis,1/24,78/18493,0.09652319557743017,0.1506505230612839,0.08656459873180132,1,bp,NAC,2247,FGF2
GO:0072028,nephron morphogenesis,1/24,78/18493,0.09652319557743017,0.1506505230612839,0.08656459873180132,1,bp,NAC,2247,FGF2
GO:0014855,striated muscle cell proliferation,1/24,79/18493,0.0977006836744243,0.15193979223708434,0.08730541971663815,1,bp,NAC,2247,FGF2
GO:0043536,positive regulation of blood vessel endothelial cell migration,1/24,79/18493,0.0977006836744243,0.15193979223708434,0.08730541971663815,1,bp,NAC,2247,FGF2
GO:0046470,phosphatidylcholine metabolic process,1/24,79/18493,0.0977006836744243,0.15193979223708434,0.08730541971663815,1,bp,NAC,5320,PLA2G2A
GO:0042116,macrophage activation,1/24,80/18493,0.09887670103033896,0.15303470314600195,0.08793456139866848,1,bp,NAC,3725,JUN
GO:0045913,positive regulation of carbohydrate metabolic process,1/24,80/18493,0.09887670103033896,0.15303470314600195,0.08793456139866848,1,bp,NAC,3479,IGF1
GO:0051702,interaction with symbiont,1/24,80/18493,0.09887670103033896,0.15303470314600195,0.08793456139866848,1,bp,NAC,3725,JUN
GO:2001057,reactive nitrogen species metabolic process,1/24,80/18493,0.09887670103033896,0.15303470314600195,0.08793456139866848,1,bp,NAC,9314,KLF4
R-HSA-1226099,Signaling by FGFR in disease,1/21,63/10554,0.11825342727146104,0.15381215015728497,0.0731195280883528,1,re,NAC,2247,FGF2
GO:0032088,negative regulation of NF-kappaB transcription factor activity,1/24,81/18493,0.10005124940242804,0.1543002027050525,0.08866172423420621,1,bp,NAC,9314,KLF4
GO:0043620,regulation of DNA-templated transcription in response to stress,1/24,81/18493,0.10005124940242804,0.1543002027050525,0.08866172423420621,1,bp,NAC,3725,JUN
GO:0045682,regulation of epidermis development,1/24,81/18493,0.10005124940242804,0.1543002027050525,0.08866172423420621,1,bp,NAC,6424,SFRP4
GO:0032602,chemokine production,1/24,82/18493,0.10122433054593949,0.1553703629799805,0.08927664406916866,1,bp,NAC,9314,KLF4
GO:0043434,response to peptide hormone,2/24,417/18493,0.10115828813582507,0.1553703629799805,0.08927664406916866,2,bp,NAC,3164/9021,NR4A1/SOCS3
GO:0052548,regulation of endopeptidase activity,2/24,417/18493,0.10115828813582507,0.1553703629799805,0.08927664406916866,2,bp,NAC,9314/4804,KLF4/NGFR
GO:0110110,positive regulation of animal organ morphogenesis,1/24,82/18493,0.10122433054593949,0.1553703629799805,0.08927664406916866,1,bp,NAC,10252,SPRY1
GO:0034637,cellular carbohydrate biosynthetic process,1/24,83/18493,0.10239594621412151,0.15642820051792178,0.08988448319335197,1,bp,NAC,3479,IGF1
GO:0042058,regulation of epidermal growth factor receptor signaling pathway,1/24,83/18493,0.10239594621412151,0.15642820051792178,0.08988448319335197,1,bp,NAC,10252,SPRY1
GO:0045582,positive regulation of T cell differentiation,1/24,83/18493,0.10239594621412151,0.15642820051792178,0.08988448319335197,1,bp,NAC,7704,ZBTB16
GO:0046849,bone remodeling,1/24,83/18493,0.10239594621412151,0.15642820051792178,0.08988448319335197,1,bp,NAC,3953,LEPR
GO:0001708,cell fate specification,1/24,84/18493,0.10356609815822049,0.15710553135814265,0.09027368112775637,1,bp,NAC,2247,FGF2
GO:0002690,positive regulation of leukocyte chemotaxis,1/24,84/18493,0.10356609815822049,0.15710553135814265,0.09027368112775637,1,bp,NAC,7060,THBS4
GO:0046031,ADP metabolic process,1/24,84/18493,0.10356609815822049,0.15710553135814265,0.09027368112775637,1,bp,NAC,3479,IGF1
GO:0048568,embryonic organ development,2/24,422/18493,0.10320257133752837,0.15710553135814265,0.09027368112775637,2,bp,NAC,9021/8516,SOCS3/ITGA8
GO:0097306,cellular response to alcohol,1/24,84/18493,0.10356609815822049,0.15710553135814265,0.09027368112775637,1,bp,NAC,9314,KLF4
GO:1903035,negative regulation of response to wounding,1/24,84/18493,0.10356609815822049,0.15710553135814265,0.09027368112775637,1,bp,NAC,2247,FGF2
GO:0042391,regulation of membrane potential,2/24,424/18493,0.10402361045465024,0.15761521350430063,0.09056654722318294,2,bp,NAC,3725/4915,JUN/NTRK2
GO:0045445,myoblast differentiation,1/24,85/18493,0.10473478812748549,0.15795467465273103,0.09076160342014652,1,bp,NAC,3479,IGF1
GO:0048477,oogenesis,1/24,85/18493,0.10473478812748549,0.15795467465273103,0.09076160342014652,1,bp,NAC,3479,IGF1
GO:0071674,mononuclear cell migration,1/24,85/18493,0.10473478812748549,0.15795467465273103,0.09076160342014652,1,bp,NAC,80310,PDGFD
GO:1904035,regulation of epithelial cell apoptotic process,1/24,85/18493,0.10473478812748549,0.15795467465273103,0.09076160342014652,1,bp,NAC,6424,SFRP4
hsa00592,alpha-Linolenic acid metabolism,1/23,25/7844,0.07088692084635284,0.1585289320745709,0.10446493598409891,1,kg,NAC,5320,PLA2G2A
hsa05165,Human papillomavirus infection,3/23,330/7844,0.07015571796755123,0.1585289320745709,0.10446493598409891,3,kg,NAC,3679/8516/7060,ITGA7/ITGA8/THBS4
hsa05226,Gastric cancer,2/23,149/7844,0.06992082106926094,0.1585289320745709,0.10446493598409891,2,kg,NAC,4616/2247,GADD45B/FGF2
GO:0004620,phospholipase activity,1/23,99/17632,0.12154025984315531,0.15893726287181847,0.0902120687094945,1,mf,NAC,5320,PLA2G2A
GO:0006029,proteoglycan metabolic process,1/24,86/18493,0.10590201786917064,0.15915981132829007,0.0914540814190069,1,bp,NAC,3479,IGF1
GO:0006835,dicarboxylic acid transport,1/24,86/18493,0.10590201786917064,0.15915981132829007,0.0914540814190069,1,bp,NAC,4915,NTRK2
GO:0048524,positive regulation of viral process,1/24,86/18493,0.10590201786917064,0.15915981132829007,0.0914540814190069,1,bp,NAC,3725,JUN
GO:0006094,gluconeogenesis,1/24,87/18493,0.10706778912853654,0.15998493375542844,0.09192820119209784,1,bp,NAC,3953,LEPR
GO:0034446,substrate adhesion-dependent cell spreading,1/24,87/18493,0.10706778912853654,0.15998493375542844,0.09192820119209784,1,bp,NAC,8516,ITGA8
GO:0048709,oligodendrocyte differentiation,1/24,87/18493,0.10706778912853654,0.15998493375542844,0.09192820119209784,1,bp,NAC,4915,NTRK2
GO:0055013,cardiac muscle cell development,1/24,87/18493,0.10706778912853654,0.15998493375542844,0.09192820119209784,1,bp,NAC,3479,IGF1
GO:0061097,regulation of protein tyrosine kinase activity,1/24,87/18493,0.10706778912853654,0.15998493375542844,0.09192820119209784,1,bp,NAC,4915,NTRK2
hsa04921,Oxytocin signaling pathway,2/23,153/7844,0.07322411230649996,0.16083153238749098,0.10598226781203941,2,kg,NAC,2353/3725,FOS/JUN
GO:0001892,embryonic placenta development,1/24,88/18493,0.10823210364885139,0.16098284223917458,0.09250160476024478,1,bp,NAC,9021,SOCS3
GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,1/24,88/18493,0.10823210364885139,0.16098284223917458,0.09250160476024478,1,bp,NAC,4804,NGFR
GO:0007389,pattern specification process,2/24,434/18493,0.10815670750410335,0.16098284223917458,0.09250160476024478,2,bp,NAC,10252/7704,SPRY1/ZBTB16
GO:0030510,regulation of BMP signaling pathway,1/24,88/18493,0.10823210364885139,0.16098284223917458,0.09250160476024478,1,bp,NAC,6424,SFRP4
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,2/21,309/10554,0.12471712065294266,0.16109294751005093,0.07658068812022795,2,re,NAC,9021/7704,SOCS3/ZBTB16
GO:0009791,post-embryonic development,1/24,89/18493,0.10939496317139519,0.1625260793050396,0.09338835705715053,1,bp,NAC,9314,KLF4
GO:0019319,hexose biosynthetic process,1/24,90/18493,0.11055636943546232,0.16331618582892327,0.09384235650438476,1,bp,NAC,3953,LEPR
GO:0045638,negative regulation of myeloid cell differentiation,1/24,90/18493,0.11055636943546232,0.16331618582892327,0.09384235650438476,1,bp,NAC,7704,ZBTB16
GO:0051899,membrane depolarization,1/24,90/18493,0.11055636943546232,0.16331618582892327,0.09384235650438476,1,bp,NAC,3725,JUN
GO:0060333,interferon-gamma-mediated signaling pathway,1/24,90/18493,0.11055636943546232,0.16331618582892327,0.09384235650438476,1,bp,NAC,9021,SOCS3
GO:1901184,regulation of ERBB signaling pathway,1/24,90/18493,0.11055636943546232,0.16331618582892327,0.09384235650438476,1,bp,NAC,10252,SPRY1
GO:0044070,regulation of anion transport,1/24,91/18493,0.11171632417836053,0.16428126129176146,0.09439689404258174,1,bp,NAC,6424,SFRP4
GO:0046634,regulation of alpha-beta T cell activation,1/24,91/18493,0.11171632417836053,0.16428126129176146,0.09439689404258174,1,bp,NAC,7704,ZBTB16
GO:0048525,negative regulation of viral process,1/24,91/18493,0.11171632417836053,0.16428126129176146,0.09439689404258174,1,bp,NAC,3725,JUN
GO:0052547,regulation of peptidase activity,2/24,442/18493,0.11149582216470036,0.16428126129176146,0.09439689404258174,2,bp,NAC,9314/4804,KLF4/NGFR
GO:0042562,hormone binding,1/23,104/17632,0.12728768680384883,0.16434612726572886,0.0932821155791031,1,mf,NAC,3953,LEPR
GO:0009314,response to radiation,2/24,443/18493,0.11191520166835574,0.1643873347269053,0.09445784440745766,2,bp,NAC,2353/3725,FOS/JUN
R-HSA-909733,Interferon alpha/beta signaling,1/21,69/10554,0.12879310825795087,0.1652104699033025,0.07853808416455807,1,re,NAC,9021,SOCS3
GO:0002768,immune response-regulating cell surface receptor signaling pathway,2/24,445/18493,0.11275526849278728,0.1652355004386382,0.09494520497549472,2,bp,NAC,2353/3725,FOS/JUN
GO:0006165,nucleoside diphosphate phosphorylation,1/24,92/18493,0.11287482913541513,0.1652355004386382,0.09494520497549472,1,bp,NAC,3479,IGF1
GO:0010660,regulation of muscle cell apoptotic process,1/24,92/18493,0.11287482913541513,0.1652355004386382,0.09494520497549472,1,bp,NAC,3479,IGF1
GO:0015908,fatty acid transport,1/24,93/18493,0.1140318860399715,0.1661790519031944,0.09548737470881115,1,bp,NAC,5320,PLA2G2A
GO:0044728,DNA methylation or demethylation,1/24,93/18493,0.1140318860399715,0.1661790519031944,0.09548737470881115,1,bp,NAC,2353,FOS
GO:0072080,nephron tubule development,1/24,93/18493,0.1140318860399715,0.1661790519031944,0.09548737470881115,1,bp,NAC,2247,FGF2
GO:1901655,cellular response to ketone,1/24,93/18493,0.1140318860399715,0.1661790519031944,0.09548737470881115,1,bp,NAC,9314,KLF4
GO:0007409,axonogenesis,2/24,449/18493,0.11444058549410328,0.1663676872166447,0.0955957655718739,2,bp,NAC,4804/4915,NGFR/NTRK2
GO:0042035,regulation of cytokine biosynthetic process,1/24,94/18493,0.11518749662339778,0.1663676872166447,0.0955957655718739,1,bp,NAC,9314,KLF4
GO:0045621,positive regulation of lymphocyte differentiation,1/24,94/18493,0.11518749662339778,0.1663676872166447,0.0955957655718739,1,bp,NAC,7704,ZBTB16
GO:0046939,nucleotide phosphorylation,1/24,94/18493,0.11518749662339778,0.1663676872166447,0.0955957655718739,1,bp,NAC,3479,IGF1
GO:0050830,defense response to Gram-positive bacterium,1/24,94/18493,0.11518749662339778,0.1663676872166447,0.0955957655718739,1,bp,NAC,5320,PLA2G2A
GO:0060993,kidney morphogenesis,1/24,94/18493,0.11518749662339778,0.1663676872166447,0.0955957655718739,1,bp,NAC,2247,FGF2
GO:1900542,regulation of purine nucleotide metabolic process,1/24,94/18493,0.11518749662339778,0.1663676872166447,0.0955957655718739,1,bp,NAC,3479,IGF1
GO:1903426,regulation of reactive oxygen species biosynthetic process,1/24,94/18493,0.11518749662339778,0.1663676872166447,0.0955957655718739,1,bp,NAC,9314,KLF4
GO:0003012,muscle system process,2/24,456/18493,0.11740623662958703,0.16746177836039014,0.09622443621243859,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0009135,purine nucleoside diphosphate metabolic process,1/24,96/18493,0.11749438574244797,0.16746177836039014,0.09622443621243859,1,bp,NAC,3479,IGF1
GO:0009179,purine ribonucleoside diphosphate metabolic process,1/24,96/18493,0.11749438574244797,0.16746177836039014,0.09622443621243859,1,bp,NAC,3479,IGF1
GO:0010657,muscle cell apoptotic process,1/24,96/18493,0.11749438574244797,0.16746177836039014,0.09622443621243859,1,bp,NAC,3479,IGF1
GO:0010771,negative regulation of cell morphogenesis involved in differentiation,1/24,96/18493,0.11749438574244797,0.16746177836039014,0.09622443621243859,1,bp,NAC,4804,NGFR
GO:0030316,osteoclast differentiation,1/24,95/18493,0.11634166261508394,0.16746177836039014,0.09622443621243859,1,bp,NAC,2353,FOS
GO:0042472,inner ear morphogenesis,1/24,96/18493,0.11749438574244797,0.16746177836039014,0.09622443621243859,1,bp,NAC,8516,ITGA8
GO:0046364,monosaccharide biosynthetic process,1/24,96/18493,0.11749438574244797,0.16746177836039014,0.09622443621243859,1,bp,NAC,3953,LEPR
GO:0048259,regulation of receptor-mediated endocytosis,1/24,96/18493,0.11749438574244797,0.16746177836039014,0.09622443621243859,1,bp,NAC,6424,SFRP4
GO:0050769,positive regulation of neurogenesis,2/24,453/18493,0.11613272285626557,0.16746177836039014,0.09622443621243859,2,bp,NAC,4804/4915,NGFR/NTRK2
GO:0061326,renal tubule development,1/24,95/18493,0.11634166261508394,0.16746177836039014,0.09622443621243859,1,bp,NAC,2247,FGF2
GO:0120162,positive regulation of cold-induced thermogenesis,1/24,96/18493,0.11749438574244797,0.16746177836039014,0.09622443621243859,1,bp,NAC,3953,LEPR
GO:0008544,epidermis development,2/24,458/18493,0.11825732096452474,0.16836261602518782,0.09674206236727101,2,bp,NAC,9314/6424,KLF4/SFRP4
GO:0021782,glial cell development,1/24,97/18493,0.11864566773093421,0.16836261602518782,0.09674206236727101,1,bp,NAC,4915,NTRK2
GO:0042102,positive regulation of T cell proliferation,1/24,97/18493,0.11864566773093421,0.16836261602518782,0.09674206236727101,1,bp,NAC,3479,IGF1
GO:0062014,negative regulation of small molecule metabolic process,1/24,97/18493,0.11864566773093421,0.16836261602518782,0.09674206236727101,1,bp,NAC,3953,LEPR
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,1/21,71/10554,0.13227959256832977,0.1685205768336256,0.08011164942854868,1,re,NAC,2247,FGF2
GO:0015711,organic anion transport,2/24,460/18493,0.11911004982346145,0.1688368684382836,0.09701457034801346,2,bp,NAC,4915/5320,NTRK2/PLA2G2A
GO:0006140,regulation of nucleotide metabolic process,1/24,98/18493,0.11979551030401825,0.16925356956896695,0.09725400905314174,1,bp,NAC,3479,IGF1
GO:0009185,ribonucleoside diphosphate metabolic process,1/24,98/18493,0.11979551030401825,0.16925356956896695,0.09725400905314174,1,bp,NAC,3479,IGF1
GO:2000379,positive regulation of reactive oxygen species metabolic process,1/24,98/18493,0.11979551030401825,0.16925356956896695,0.09725400905314174,1,bp,NAC,9314,KLF4
GO:0044264,cellular polysaccharide metabolic process,1/24,99/18493,0.12094391518320857,0.1706901610365849,0.09807948221718306,1,bp,NAC,3479,IGF1
R-HSA-5654738,Signaling by FGFR2,1/21,73/10554,0.1357527861858845,0.17176883150050692,0.08165581123962977,1,re,NAC,2247,FGF2
GO:0050848,regulation of calcium-mediated signaling,1/24,100/18493,0.12209088408804714,0.17212160506760557,0.0989019976365416,1,bp,NAC,3479,IGF1
GO:0030593,neutrophil chemotaxis,1/24,101/18493,0.12323641873611346,0.17317186901488532,0.09950548493490144,1,bp,NAC,7060,THBS4
GO:0046632,alpha-beta T cell differentiation,1/24,101/18493,0.12323641873611346,0.17317186901488532,0.09950548493490144,1,bp,NAC,7704,ZBTB16
GO:1904659,glucose transmembrane transport,1/24,101/18493,0.12323641873611346,0.17317186901488532,0.09950548493490144,1,bp,NAC,3479,IGF1
hsa00591,Linoleic acid metabolism,1/23,29/7844,0.08177299864335752,0.1734151522953961,0.11427442641630722,1,kg,NAC,5320,PLA2G2A
hsa05161,Hepatitis B,2/23,163/7844,0.08170176522567753,0.1734151522953961,0.11427442641630722,2,kg,NAC,2353/3725,FOS/JUN
GO:0042826,histone deacetylase binding,1/23,112/17632,0.136408824089557,0.17392125071418518,0.09871691217007415,1,mf,NAC,9314,KLF4
GO:0035567,non-canonical Wnt signaling pathway,1/24,102/18493,0.12438052084302609,0.1742133213103724,0.10010390901087014,1,bp,NAC,6424,SFRP4
GO:0042136,neurotransmitter biosynthetic process,1/24,102/18493,0.12438052084302609,0.1742133213103724,0.10010390901087014,1,bp,NAC,9314,KLF4
GO:0051249,regulation of lymphocyte activation,2/24,472/18493,0.12426021627118859,0.1742133213103724,0.10010390901087014,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0033138,positive regulation of peptidyl-serine phosphorylation,1/24,103/18493,0.12552319212244345,0.17543489243837193,0.1008058303342672,1,bp,NAC,4915,NTRK2
GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1/24,103/18493,0.12552319212244345,0.17543489243837193,0.1008058303342672,1,bp,NAC,8516,ITGA8
GO:0030282,bone mineralization,1/24,104/18493,0.12666443428606844,0.17645947504729403,0.10139456099783646,1,bp,NAC,3479,IGF1
GO:0051963,regulation of synapse assembly,1/24,104/18493,0.12666443428606844,0.17645947504729403,0.10139456099783646,1,bp,NAC,4915,NTRK2
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,1/24,104/18493,0.12666443428606844,0.17645947504729403,0.10139456099783646,1,bp,NAC,3479,IGF1
GO:0050900,leukocyte migration,2/24,478/18493,0.1268564342035953,0.17653733386487458,0.10143929909210014,2,bp,NAC,80310/7060,PDGFD/THBS4
GO:0032526,response to retinoic acid,1/24,105/18493,0.12780424904364818,0.17709627244616633,0.10176046819939598,1,bp,NAC,9314,KLF4
GO:0042089,cytokine biosynthetic process,1/24,105/18493,0.12780424904364818,0.17709627244616633,0.10176046819939598,1,bp,NAC,9314,KLF4
GO:0043467,regulation of generation of precursor metabolites and energy,1/24,105/18493,0.12780424904364818,0.17709627244616633,0.10176046819939598,1,bp,NAC,3479,IGF1
GO:0097006,regulation of plasma lipoprotein particle levels,1/24,105/18493,0.12780424904364818,0.17709627244616633,0.10176046819939598,1,bp,NAC,5320,PLA2G2A
R-HSA-204998,"Cell death signalling via NRAGE, NRIF and NADE",1/21,76/10554,0.14093776182613227,0.17712448445716625,0.08420179227165797,1,re,NAC,4804,NGFR
GO:0019359,nicotinamide nucleotide biosynthetic process,1/24,106/18493,0.1289426381029778,0.1781028771241344,0.10233886864739451,1,bp,NAC,3479,IGF1
GO:0019363,pyridine nucleotide biosynthetic process,1/24,106/18493,0.1289426381029778,0.1781028771241344,0.10233886864739451,1,bp,NAC,3479,IGF1
GO:0042107,cytokine metabolic process,1/24,106/18493,0.1289426381029778,0.1781028771241344,0.10233886864739451,1,bp,NAC,9314,KLF4
R-HSA-187037,Signaling by NTRK1 (TRKA),1/21,78/10554,0.14437793896664763,0.17902864431864307,0.08510699560139229,1,re,NAC,4915,NTRK2
R-HSA-74752,Signaling by Insulin receptor,1/21,78/10554,0.14437793896664763,0.17902864431864307,0.08510699560139229,1,re,NAC,2247,FGF2
GO:0003300,cardiac muscle hypertrophy,1/24,107/18493,0.13007960316990164,0.17910110967235926,0.10291245842472942,1,bp,NAC,3479,IGF1
GO:0006275,regulation of DNA replication,1/24,107/18493,0.13007960316990164,0.17910110967235926,0.10291245842472942,1,bp,NAC,3725,JUN
GO:0031623,receptor internalization,1/24,107/18493,0.13007960316990164,0.17910110967235926,0.10291245842472942,1,bp,NAC,6424,SFRP4
GO:0008645,hexose transmembrane transport,1/24,108/18493,0.13121514594831574,0.18009105216398466,0.10348128469106938,1,bp,NAC,3479,IGF1
GO:0014902,myotube differentiation,1/24,108/18493,0.13121514594831574,0.18009105216398466,0.10348128469106938,1,bp,NAC,3479,IGF1
GO:1904019,epithelial cell apoptotic process,1/24,108/18493,0.13121514594831574,0.18009105216398466,0.10348128469106938,1,bp,NAC,6424,SFRP4
GO:0002688,regulation of leukocyte chemotaxis,1/24,109/18493,0.13234926814017,0.18069157976610578,0.1038263510728425,1,bp,NAC,7060,THBS4
GO:0005976,polysaccharide metabolic process,1/24,109/18493,0.13234926814017,0.18069157976610578,0.1038263510728425,1,bp,NAC,3479,IGF1
GO:0014897,striated muscle hypertrophy,1/24,109/18493,0.13234926814017,0.18069157976610578,0.1038263510728425,1,bp,NAC,3479,IGF1
GO:0072009,nephron epithelium development,1/24,109/18493,0.13234926814017,0.18069157976610578,0.1038263510728425,1,bp,NAC,2247,FGF2
GO:0072525,pyridine-containing compound biosynthetic process,1/24,109/18493,0.13234926814017,0.18069157976610578,0.1038263510728425,1,bp,NAC,3479,IGF1
GO:0015749,monosaccharide transmembrane transport,1/24,110/18493,0.13348197144547036,0.18185516487896541,0.104494953320868,1,bp,NAC,3479,IGF1
GO:1903510,mucopolysaccharide metabolic process,1/24,110/18493,0.13348197144547036,0.18185516487896541,0.104494953320868,1,bp,NAC,2247,FGF2
GO:0014896,muscle hypertrophy,1/24,111/18493,0.13461325756227938,0.18282030896154594,0.10504953028833705,1,bp,NAC,3479,IGF1
GO:0021987,cerebral cortex development,1/24,111/18493,0.13461325756227938,0.18282030896154594,0.10504953028833705,1,bp,NAC,4915,NTRK2
GO:0060349,bone morphogenesis,1/24,111/18493,0.13461325756227938,0.18282030896154594,0.10504953028833705,1,bp,NAC,6424,SFRP4
GO:0006304,DNA modification,1/24,112/18493,0.13574312818672252,0.18301334434322153,0.10516044945420673,1,bp,NAC,2353,FOS
GO:0007613,memory,1/24,112/18493,0.13574312818672252,0.18301334434322153,0.10516044945420673,1,bp,NAC,8516,ITGA8
GO:0034219,carbohydrate transmembrane transport,1/24,112/18493,0.13574312818672252,0.18301334434322153,0.10516044945420673,1,bp,NAC,3479,IGF1
GO:0046822,regulation of nucleocytoplasmic transport,1/24,112/18493,0.13574312818672252,0.18301334434322153,0.10516044945420673,1,bp,NAC,3479,IGF1
GO:0051149,positive regulation of muscle cell differentiation,1/24,112/18493,0.13574312818672252,0.18301334434322153,0.10516044945420673,1,bp,NAC,3479,IGF1
GO:0051817,modification of morphology or physiology of other organism involved in symbiotic interaction,1/24,112/18493,0.13574312818672252,0.18301334434322153,0.10516044945420673,1,bp,NAC,3725,JUN
GO:1990266,neutrophil migration,1/24,112/18493,0.13574312818672252,0.18301334434322153,0.10516044945420673,1,bp,NAC,7060,THBS4
GO:0006090,pyruvate metabolic process,1/24,113/18493,0.13687158501298413,0.18415191469070585,0.10581467808385321,1,bp,NAC,3479,IGF1
GO:0051153,regulation of striated muscle cell differentiation,1/24,113/18493,0.13687158501298413,0.18415191469070585,0.10581467808385321,1,bp,NAC,3479,IGF1
GO:0005179,hormone activity,1/23,121/17632,0.1465611032742724,0.18455842634538008,0.10475452475743967,1,mf,NAC,3479,IGF1
GO:0042552,myelination,1/24,114/18493,0.13799862973331523,0.18509226759473615,0.1063550099071324,1,bp,NAC,4915,NTRK2
GO:0072089,stem cell proliferation,1/24,114/18493,0.13799862973331523,0.18509226759473615,0.1063550099071324,1,bp,NAC,2247,FGF2
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,1/24,114/18493,0.13799862973331523,0.18509226759473615,0.1063550099071324,1,bp,NAC,9314,KLF4
GO:1903409,reactive oxygen species biosynthetic process,1/24,115/18493,0.13912426403803269,0.1864092670013723,0.10711176483136922,1,bp,NAC,9314,KLF4
GO:0006754,ATP biosynthetic process,1/24,116/18493,0.1402484896155214,0.18675799900547357,0.1073121481117358,1,bp,NAC,3479,IGF1
GO:0007272,ensheathment of neurons,1/24,116/18493,0.1402484896155214,0.18675799900547357,0.1073121481117358,1,bp,NAC,4915,NTRK2
GO:0008366,axon ensheathment,1/24,116/18493,0.1402484896155214,0.18675799900547357,0.1073121481117358,1,bp,NAC,4915,NTRK2
GO:0009132,nucleoside diphosphate metabolic process,1/24,116/18493,0.1402484896155214,0.18675799900547357,0.1073121481117358,1,bp,NAC,3479,IGF1
GO:0042471,ear morphogenesis,1/24,116/18493,0.1402484896155214,0.18675799900547357,0.1073121481117358,1,bp,NAC,8516,ITGA8
GO:0051209,release of sequestered calcium ion into cytosol,1/24,116/18493,0.1402484896155214,0.18675799900547357,0.1073121481117358,1,bp,NAC,2247,FGF2
GO:0002062,chondrocyte differentiation,1/24,117/18493,0.1413713081522372,0.18786740437853652,0.10794961839062116,1,bp,NAC,7704,ZBTB16
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,1/24,117/18493,0.1413713081522372,0.18786740437853652,0.10794961839062116,1,bp,NAC,8516,ITGA8
GO:0019730,antimicrobial humoral response,1/24,118/18493,0.14249272133270874,0.18897040855677222,0.10858341050861887,1,bp,NAC,5320,PLA2G2A
GO:0051283,negative regulation of sequestering of calcium ion,1/24,118/18493,0.14249272133270874,0.18897040855677222,0.10858341050861887,1,bp,NAC,2247,FGF2
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,1/24,119/18493,0.14361273083953963,0.1902611970366526,0.1093251044937305,1,bp,NAC,8516,ITGA8
R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,1/21,84/10554,0.15461992295564042,0.1904589779453584,0.09054077050034015,1,re,NAC,9314,KLF4
GO:0016298,lipase activity,1/23,127/17632,0.1532657587244518,0.19064765109626933,0.10821074107631387,1,mf,NAC,5320,PLA2G2A
GO:0007173,epidermal growth factor receptor signaling pathway,1/24,120/18493,0.1447313383534098,0.19096291540627924,0.10972831563336095,1,bp,NAC,10252,SPRY1
GO:0019751,polyol metabolic process,1/24,120/18493,0.1447313383534098,0.19096291540627924,0.10972831563336095,1,bp,NAC,2247,FGF2
GO:0051282,regulation of sequestering of calcium ion,1/24,120/18493,0.1447313383534098,0.19096291540627924,0.10972831563336095,1,bp,NAC,2247,FGF2
GO:0071621,granulocyte chemotaxis,1/24,120/18493,0.1447313383534098,0.19096291540627924,0.10972831563336095,1,bp,NAC,7060,THBS4
GO:0045667,regulation of osteoblast differentiation,1/24,121/18493,0.14584854555307858,0.19204625744400297,0.11035080977994081,1,bp,NAC,3479,IGF1
GO:1902807,negative regulation of cell cycle G1/S phase transition,1/24,121/18493,0.14584854555307858,0.19204625744400297,0.11035080977994081,1,bp,NAC,9314,KLF4
hsa04215,Apoptosis - multiple species,1/23,33/7844,0.0925370115840769,0.19291614279392305,0.12712488656510118,1,kg,NAC,4804,NGFR
GO:0010595,positive regulation of endothelial cell migration,1/24,122/18493,0.14696435411538677,0.1931233711121141,0.11096972507192858,1,bp,NAC,2247,FGF2
GO:1903038,negative regulation of leukocyte cell-cell adhesion,1/24,122/18493,0.14696435411538677,0.1931233711121141,0.11096972507192858,1,bp,NAC,9314,KLF4
GO:0051208,sequestering of calcium ion,1/24,123/18493,0.1480787657152578,0.1943908493245844,0.11169802485233593,1,bp,NAC,2247,FGF2
R-HSA-190236,Signaling by FGFR,1/21,87/10554,0.15969702519153373,0.1954187281949031,0.09289854651031047,1,re,NAC,2247,FGF2
GO:0030326,embryonic limb morphogenesis,1/24,125/18493,0.15030340471781134,0.1969126423424256,0.11314706064881491,1,bp,NAC,7704,ZBTB16
GO:0035113,embryonic appendage morphogenesis,1/24,125/18493,0.15030340471781134,0.1969126423424256,0.11314706064881491,1,bp,NAC,7704,ZBTB16
R-HSA-3700989,Transcriptional Regulation by TP53,2/21,365/10554,0.16311754211622545,0.19701209632219438,0.09365600504280885,2,re,NAC,2353/3725,FOS/JUN
R-HSA-5687128,MAPK6/MAPK4 signaling,1/21,89/10554,0.16306561252602725,0.19701209632219438,0.09365600504280885,1,re,NAC,3725,JUN
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,1/24,126/18493,0.1514136354607759,0.1981669880853949,0.11386781444179651,1,bp,NAC,4804,NGFR
R-HSA-446728,Cell junction organization,1/21,91/10554,0.16642133653213853,0.1991436714931516,0.0946693175179668,1,re,NAC,2318,FLNC
R-HSA-877300,Interferon gamma signaling,1/21,92/10554,0.16809438937862797,0.1991436714931516,0.0946693175179668,1,re,NAC,9021,SOCS3
R-HSA-983169,Class I MHC mediated antigen processing & presentation,2/21,371/10554,0.1673628658018314,0.1991436714931516,0.0946693175179668,2,re,NAC,9021/7704,SOCS3/ZBTB16
GO:0009206,purine ribonucleoside triphosphate biosynthetic process,1/24,127/18493,0.15252247592187163,0.19941698716801157,0.11458607062042138,1,bp,NAC,3479,IGF1
R-HSA-1912408,Pre-NOTCH Transcription and Translation,1/21,93/10554,0.16976424388283828,0.19984904659625266,0.09500464014762436,1,re,NAC,3725,JUN
GO:0002576,platelet degranulation,1/24,128/18493,0.15362992776646867,0.20025931287749735,0.11507007549183794,1,bp,NAC,3479,IGF1
GO:0009145,purine nucleoside triphosphate biosynthetic process,1/24,128/18493,0.15362992776646867,0.20025931287749735,0.11507007549183794,1,bp,NAC,3479,IGF1
GO:0030010,establishment of cell polarity,1/24,128/18493,0.15362992776646867,0.20025931287749735,0.11507007549183794,1,bp,NAC,10252,SPRY1
GO:0055007,cardiac muscle cell differentiation,1/24,129/18493,0.15473599265803484,0.20129647189315064,0.1156660326261824,1,bp,NAC,3479,IGF1
GO:1902850,microtubule cytoskeleton organization involved in mitosis,1/24,129/18493,0.15473599265803484,0.20129647189315064,0.1156660326261824,1,bp,NAC,10252,SPRY1
GO:0032590,dendrite membrane,1/24,40/19659,0.047734112665997475,0.20216800658540107,0.1625619935993722,1,cc,NAC,8516,ITGA8
GO:0052689,carboxylic ester hydrolase activity,1/23,139/17632,0.1665242337244599,0.20464423903487844,0.11615514083507034,1,mf,NAC,5320,PLA2G2A
GO:0006865,amino acid transport,1/24,132/18493,0.15804588222068605,0.20478072851171808,0.11766810517087725,1,bp,NAC,4915,NTRK2
GO:0008286,insulin receptor signaling pathway,1/24,132/18493,0.15804588222068605,0.20478072851171808,0.11766810517087725,1,bp,NAC,9021,SOCS3
GO:0050671,positive regulation of lymphocyte proliferation,1/24,132/18493,0.15804588222068605,0.20478072851171808,0.11766810517087725,1,bp,NAC,3479,IGF1
GO:0097553,calcium ion transmembrane import into cytosol,1/24,132/18493,0.15804588222068605,0.20478072851171808,0.11766810517087725,1,bp,NAC,2247,FGF2
R-HSA-193704,p75 NTR receptor-mediated signalling,1/21,97/10554,0.17641179450809397,0.20507871111565926,0.09749072854394668,1,re,NAC,4804,NGFR
R-HSA-6803157,Antimicrobial peptides,1/21,97/10554,0.17641179450809397,0.20507871111565926,0.09749072854394668,1,re,NAC,5320,PLA2G2A
GO:0001508,action potential,1/24,133/18493,0.15914641589677714,0.20538597156031835,0.11801588107349381,1,bp,NAC,4915,NTRK2
GO:0009201,ribonucleoside triphosphate biosynthetic process,1/24,133/18493,0.15914641589677714,0.20538597156031835,0.11801588107349381,1,bp,NAC,3479,IGF1
GO:0032946,positive regulation of mononuclear cell proliferation,1/24,133/18493,0.15914641589677714,0.20538597156031835,0.11801588107349381,1,bp,NAC,3479,IGF1
GO:0050729,positive regulation of inflammatory response,1/24,133/18493,0.15914641589677714,0.20538597156031835,0.11801588107349381,1,bp,NAC,5320,PLA2G2A
GO:0007292,female gamete generation,1/24,134/18493,0.16024557090867675,0.20578069848371658,0.11824269328123307,1,bp,NAC,3479,IGF1
GO:0046631,alpha-beta T cell activation,1/24,134/18493,0.16024557090867675,0.20578069848371658,0.11824269328123307,1,bp,NAC,7704,ZBTB16
GO:0061041,regulation of wound healing,1/24,134/18493,0.16024557090867675,0.20578069848371658,0.11824269328123307,1,bp,NAC,2247,FGF2
GO:0071901,negative regulation of protein serine/threonine kinase activity,1/24,134/18493,0.16024557090867675,0.20578069848371658,0.11824269328123307,1,bp,NAC,10252,SPRY1
GO:0097530,granulocyte migration,1/24,134/18493,0.16024557090867675,0.20578069848371658,0.11824269328123307,1,bp,NAC,7060,THBS4
R-HSA-166520,Signaling by NTRKs,1/21,99/10554,0.17971653032835222,0.2063412014881081,0.09809089374646904,1,re,NAC,4915,NTRK2
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",1/21,99/10554,0.17971653032835222,0.2063412014881081,0.09809089374646904,1,re,NAC,2247,FGF2
GO:0001837,epithelial to mesenchymal transition,1/24,135/18493,0.16134334890846935,0.20678095210897704,0.1188174443802749,1,bp,NAC,10252,SPRY1
GO:0033135,regulation of peptidyl-serine phosphorylation,1/24,135/18493,0.16134334890846935,0.20678095210897704,0.1188174443802749,1,bp,NAC,4915,NTRK2
hsa04960,Aldosterone-regulated sodium reabsorption,1/23,37/7844,0.10318026682651771,0.20805201343707666,0.13709888775913484,1,kg,NAC,3479,IGF1
hsa05216,Thyroid cancer,1/23,37/7844,0.10318026682651771,0.20805201343707666,0.13709888775913484,1,kg,NAC,4616,GADD45B
GO:0001889,liver development,1/24,137/18493,0.1635347804706223,0.20917614425088474,0.12019373463427861,1,bp,NAC,3725,JUN
GO:0045580,regulation of T cell differentiation,1/24,137/18493,0.1635347804706223,0.20917614425088474,0.12019373463427861,1,bp,NAC,7704,ZBTB16
GO:0000790,nuclear chromatin,2/24,369/19659,0.0739591593695965,0.2098980757525351,0.16877769249107358,2,cc,NAC,9314/3725,KLF4/JUN
GO:0009897,external side of plasma membrane,2/24,359/19659,0.07051251744492418,0.2098980757525351,0.16877769249107358,2,cc,NAC,3977/3953,LIFR/LEPR
GO:0014069,postsynaptic density,2/24,316/19659,0.05635669445957235,0.2098980757525351,0.16877769249107358,2,cc,NAC,8516/4915,ITGA8/NTRK2
GO:0016529,sarcoplasmic reticulum,1/24,67/19659,0.07871177840720067,0.2098980757525351,0.16877769249107358,1,cc,NAC,7060,THBS4
GO:0031093,platelet alpha granule lumen,1/24,67/19659,0.07871177840720067,0.2098980757525351,0.16877769249107358,1,cc,NAC,3479,IGF1
GO:0032279,asymmetric synapse,2/24,320/19659,0.057625710087697124,0.2098980757525351,0.16877769249107358,2,cc,NAC,8516/4915,ITGA8/NTRK2
GO:0032589,neuron projection membrane,1/24,57/19659,0.06735289104319675,0.2098980757525351,0.16877769249107358,1,cc,NAC,8516,ITGA8
GO:0043195,terminal bouton,1/24,51/19659,0.06047326627888061,0.2098980757525351,0.16877769249107358,1,cc,NAC,4915,NTRK2
GO:0098984,neuron to neuron synapse,2/24,342/19659,0.06478354622855552,0.2098980757525351,0.16877769249107358,2,cc,NAC,8516/4915,ITGA8/NTRK2
GO:0099572,postsynaptic specialization,2/24,340/19659,0.06412066394694188,0.2098980757525351,0.16877769249107358,2,cc,NAC,8516/4915,ITGA8/NTRK2
GO:0045834,positive regulation of lipid metabolic process,1/24,138/18493,0.1646284373277106,0.21036756966900558,0.12087833407105947,1,bp,NAC,2247,FGF2
GO:0070665,positive regulation of leukocyte proliferation,1/24,139/18493,0.16572072376214964,0.21155490031447644,0.12156058062950884,1,bp,NAC,3479,IGF1
GO:0005924,cell-substrate adherens junction,2/24,405/19659,0.08680732163494792,0.21186049152801856,0.17035565839241257,2,cc,NAC,2318/8516,FLNC/ITGA8
GO:0005925,focal adhesion,2/24,402/19659,0.08571151069873091,0.21186049152801856,0.17035565839241257,2,cc,NAC,2318/8516,FLNC/ITGA8
GO:0030055,cell-substrate junction,2/24,409/19659,0.08827520480334107,0.21186049152801856,0.17035565839241257,2,cc,NAC,2318/8516,FLNC/ITGA8
GO:0009166,nucleotide catabolic process,1/24,140/18493,0.16681164141659577,0.2123206073771587,0.12200056001544322,1,bp,NAC,3479,IGF1
GO:0046330,positive regulation of JNK cascade,1/24,140/18493,0.16681164141659577,0.2123206073771587,0.12200056001544322,1,bp,NAC,4616,GADD45B
GO:0061008,hepaticobiliary system development,1/24,140/18493,0.16681164141659577,0.2123206073771587,0.12200056001544322,1,bp,NAC,3725,JUN
GO:0008643,carbohydrate transport,1/24,141/18493,0.1679011919318253,0.21266391204646232,0.12219782472011956,1,bp,NAC,3479,IGF1
GO:0009127,purine nucleoside monophosphate biosynthetic process,1/24,141/18493,0.1679011919318253,0.21266391204646232,0.12219782472011956,1,bp,NAC,3479,IGF1
GO:0009168,purine ribonucleoside monophosphate biosynthetic process,1/24,141/18493,0.1679011919318253,0.21266391204646232,0.12219782472011956,1,bp,NAC,3479,IGF1
GO:0045807,positive regulation of endocytosis,1/24,141/18493,0.1679011919318253,0.21266391204646232,0.12219782472011956,1,bp,NAC,6424,SFRP4
GO:0060041,retina development in camera-type eye,1/24,141/18493,0.1679011919318253,0.21266391204646232,0.12219782472011956,1,bp,NAC,4915,NTRK2
GO:0062013,positive regulation of small molecule metabolic process,1/24,142/18493,0.16898937694673588,0.21320935982482142,0.12251124193967744,1,bp,NAC,3479,IGF1
GO:0106106,cold-induced thermogenesis,1/24,142/18493,0.16898937694673588,0.21320935982482142,0.12251124193967744,1,bp,NAC,3953,LEPR
GO:0120161,regulation of cold-induced thermogenesis,1/24,142/18493,0.16898937694673588,0.21320935982482142,0.12251124193967744,1,bp,NAC,3953,LEPR
GO:2000241,regulation of reproductive process,1/24,142/18493,0.16898937694673588,0.21320935982482142,0.12251124193967744,1,bp,NAC,3479,IGF1
GO:0038127,ERBB signaling pathway,1/24,143/18493,0.1700761980983504,0.21416391158598103,0.1230597325024344,1,bp,NAC,10252,SPRY1
GO:2001056,positive regulation of cysteine-type endopeptidase activity,1/24,143/18493,0.1700761980983504,0.21416391158598103,0.1230597325024344,1,bp,NAC,4804,NGFR
GO:0008203,cholesterol metabolic process,1/24,144/18493,0.1711616570218183,0.21532169656381991,0.12372500196176155,1,bp,NAC,3953,LEPR
GO:0009142,nucleoside triphosphate biosynthetic process,1/24,145/18493,0.17224575535041808,0.21563971495124737,0.1239077370332209,1,bp,NAC,3479,IGF1
GO:0009408,response to heat,1/24,145/18493,0.17224575535041808,0.21563971495124737,0.1239077370332209,1,bp,NAC,3479,IGF1
GO:0019362,pyridine nucleotide metabolic process,1/24,145/18493,0.17224575535041808,0.21563971495124737,0.1239077370332209,1,bp,NAC,3479,IGF1
GO:0046496,nicotinamide nucleotide metabolic process,1/24,145/18493,0.17224575535041808,0.21563971495124737,0.1239077370332209,1,bp,NAC,3479,IGF1
GO:0048592,eye morphogenesis,1/24,145/18493,0.17224575535041808,0.21563971495124737,0.1239077370332209,1,bp,NAC,4915,NTRK2
GO:0006661,phosphatidylinositol biosynthetic process,1/24,146/18493,0.1733284947155581,0.21595298525079623,0.12408774382791359,1,bp,NAC,2247,FGF2
GO:0009267,cellular response to starvation,1/24,146/18493,0.1733284947155581,0.21595298525079623,0.12408774382791359,1,bp,NAC,3725,JUN
GO:0035107,appendage morphogenesis,1/24,146/18493,0.1733284947155581,0.21595298525079623,0.12408774382791359,1,bp,NAC,7704,ZBTB16
GO:0035108,limb morphogenesis,1/24,146/18493,0.1733284947155581,0.21595298525079623,0.12408774382791359,1,bp,NAC,7704,ZBTB16
GO:1901292,nucleoside phosphate catabolic process,1/24,146/18493,0.1733284947155581,0.21595298525079623,0.12408774382791359,1,bp,NAC,3479,IGF1
GO:0035264,multicellular organism growth,1/24,147/18493,0.17440987674677988,0.21709175637291123,0.12474208782373994,1,bp,NAC,3479,IGF1
GO:0010977,negative regulation of neuron projection development,1/24,148/18493,0.1754899030717596,0.21801762862459023,0.12527409898649505,1,bp,NAC,4804,NGFR
GO:0042133,neurotransmitter metabolic process,1/24,148/18493,0.1754899030717596,0.21801762862459023,0.12527409898649505,1,bp,NAC,9314,KLF4
R-HSA-199418,Negative regulation of the PI3K/AKT network,1/21,106/10554,0.1911839328127376,0.21816080676790917,0.10370972138372592,1,re,NAC,2247,FGF2
GO:0001764,neuron migration,1/24,149/18493,0.1765685753163102,0.21831214698308324,0.12544333081526027,1,bp,NAC,4915,NTRK2
GO:0001890,placenta development,1/24,149/18493,0.1765685753163102,0.21831214698308324,0.12544333081526027,1,bp,NAC,9021,SOCS3
GO:0051384,response to glucocorticoid,1/24,149/18493,0.1765685753163102,0.21831214698308324,0.12544333081526027,1,bp,NAC,2353,FOS
GO:0060402,calcium ion transport into cytosol,1/24,149/18493,0.1765685753163102,0.21831214698308324,0.12544333081526027,1,bp,NAC,2247,FGF2
GO:1902652,secondary alcohol metabolic process,1/24,149/18493,0.1765685753163102,0.21831214698308324,0.12544333081526027,1,bp,NAC,3953,LEPR
GO:0031214,biomineral tissue development,1/24,150/18493,0.177645895104383,0.2188098062206883,0.12572928848293413,1,bp,NAC,3479,IGF1
GO:0072524,pyridine-containing compound metabolic process,1/24,150/18493,0.177645895104383,0.2188098062206883,0.12572928848293413,1,bp,NAC,3479,IGF1
GO:1903707,negative regulation of hemopoiesis,1/24,150/18493,0.177645895104383,0.2188098062206883,0.12572928848293413,1,bp,NAC,7704,ZBTB16
GO:1990845,adaptive thermogenesis,1/24,150/18493,0.177645895104383,0.2188098062206883,0.12572928848293413,1,bp,NAC,3953,LEPR
GO:0035257,nuclear hormone receptor binding,1/23,152/17632,0.18066342654015022,0.21937701794161096,0.12451739924446445,1,mf,NAC,3164,NR4A1
GO:0008360,regulation of cell shape,1/24,151/18493,0.17872186405807067,0.21971777979461388,0.1262510149694328,1,bp,NAC,3679,ITGA7
GO:0030856,regulation of epithelial cell differentiation,1/24,151/18493,0.17872186405807067,0.21971777979461388,0.1262510149694328,1,bp,NAC,6424,SFRP4
GO:0016052,carbohydrate catabolic process,1/24,152/18493,0.1797964837976086,0.2206206617648991,0.12676981579316524,1,bp,NAC,3479,IGF1
GO:0030509,BMP signaling pathway,1/24,152/18493,0.1797964837976086,0.2206206617648991,0.12676981579316524,1,bp,NAC,6424,SFRP4
GO:0042129,regulation of T cell proliferation,1/24,153/18493,0.180869755941377,0.22172785770885253,0.12740601652223155,1,bp,NAC,3479,IGF1
R-HSA-1912422,Pre-NOTCH Expression and Processing,1/21,109/10554,0.19605165113700118,0.22235126287489157,0.10570178880300449,1,re,NAC,3725,JUN
GO:0043271,negative regulation of ion transport,1/24,154/18493,0.1819416821059031,0.22283131415614385,0.12804006851645486,1,bp,NAC,6424,SFRP4
GO:0009156,ribonucleoside monophosphate biosynthetic process,1/24,155/18493,0.1830122639058629,0.22371998707436774,0.12855070474264688,1,bp,NAC,3479,IGF1
GO:0071695,anatomical structure maturation,1/24,155/18493,0.1830122639058629,0.22371998707436774,0.12855070474264688,1,bp,NAC,3479,IGF1
GO:2001236,regulation of extrinsic apoptotic signaling pathway,1/24,156/18493,0.1840815029540832,0.2248151688620018,0.12918000207304084,1,bp,NAC,3479,IGF1
GO:0006606,protein import into nucleus,1/24,157/18493,0.1851494008615432,0.22548241588490284,0.12956340579191752,1,bp,NAC,3479,IGF1
GO:0030203,glycosaminoglycan metabolic process,1/24,157/18493,0.1851494008615432,0.22548241588490284,0.12956340579191752,1,bp,NAC,2247,FGF2
GO:0045931,positive regulation of mitotic cell cycle,1/24,157/18493,0.1851494008615432,0.22548241588490284,0.12956340579191752,1,bp,NAC,3479,IGF1
hsa04975,Fat digestion and absorption,1/23,41/7844,0.11370405819046414,0.22557417995850143,0.14864537318617552,1,kg,NAC,5320,PLA2G2A
GO:0015718,monocarboxylic acid transport,1/24,158/18493,0.186215959237379,0.22614428757573085,0.12994372081614855,1,bp,NAC,5320,PLA2G2A
GO:0046165,alcohol biosynthetic process,1/24,158/18493,0.186215959237379,0.22614428757573085,0.12994372081614855,1,bp,NAC,2247,FGF2
GO:0090316,positive regulation of intracellular protein transport,1/24,158/18493,0.186215959237379,0.22614428757573085,0.12994372081614855,1,bp,NAC,3479,IGF1
GO:0050806,positive regulation of synaptic transmission,1/24,159/18493,0.18728117968888192,0.22722515440269395,0.13056479269334684,1,bp,NAC,4915,NTRK2
hsa05169,Epstein-Barr virus infection,2/23,201/7844,0.11641857641426641,0.22729341109452011,0.149778285445255,2,kg,NAC,3725/4616,JUN/GADD45B
GO:0090288,negative regulation of cellular response to growth factor stimulus,1/24,160/18493,0.1883450638215025,0.22830238109952222,0.1311837729322418,1,bp,NAC,10252,SPRY1
GO:0007519,skeletal muscle tissue development,1/24,161/18493,0.1894076132388527,0.22894843836979675,0.1315550009055846,1,bp,NAC,2353,FOS
GO:0035821,modification of morphology or physiology of other organism,1/24,161/18493,0.1894076132388527,0.22894843836979675,0.1315550009055846,1,bp,NAC,3725,JUN
GO:0060401,cytosolic calcium ion transport,1/24,161/18493,0.1894076132388527,0.22894843836979675,0.1315550009055846,1,bp,NAC,2247,FGF2
GO:0006733,oxidoreduction coenzyme metabolic process,1/24,162/18493,0.19046882954270794,0.2293761113434468,0.13180074409054118,1,bp,NAC,3479,IGF1
GO:0016125,sterol metabolic process,1/24,162/18493,0.19046882954270794,0.2293761113434468,0.13180074409054118,1,bp,NAC,3953,LEPR
GO:0043902,positive regulation of multi-organism process,1/24,162/18493,0.19046882954270794,0.2293761113434468,0.13180074409054118,1,bp,NAC,3725,JUN
GO:0050680,negative regulation of epithelial cell proliferation,1/24,162/18493,0.19046882954270794,0.2293761113434468,0.13180074409054118,1,bp,NAC,4804,NGFR
GO:0030307,positive regulation of cell growth,1/24,163/18493,0.19152871433300678,0.23043853663256936,0.13241121936116473,1,bp,NAC,3479,IGF1
GO:0007416,synapse assembly,1/24,165/18493,0.19364449576353493,0.23212283826737967,0.13337902811614236,1,bp,NAC,4915,NTRK2
GO:0051100,negative regulation of binding,1/24,165/18493,0.19364449576353493,0.23212283826737967,0.13337902811614236,1,bp,NAC,3725,JUN
GO:0071772,response to BMP,1/24,165/18493,0.19364449576353493,0.23212283826737967,0.13337902811614236,1,bp,NAC,6424,SFRP4
GO:0071773,cellular response to BMP stimulus,1/24,165/18493,0.19364449576353493,0.23212283826737967,0.13337902811614236,1,bp,NAC,6424,SFRP4
GO:0031960,response to corticosteroid,1/24,166/18493,0.19470039559448626,0.23274323786732598,0.1337355130544713,1,bp,NAC,2353,FOS
GO:0045619,regulation of lymphocyte differentiation,1/24,166/18493,0.19470039559448626,0.23274323786732598,0.1337355130544713,1,bp,NAC,7704,ZBTB16
GO:2000045,regulation of G1/S transition of mitotic cell cycle,1/24,166/18493,0.19470039559448626,0.23274323786732598,0.1337355130544713,1,bp,NAC,9314,KLF4
hsa00565,Ether lipid metabolism,1/23,47/7844,0.12926854822037515,0.23283095934428735,0.15342733307240156,1,kg,NAC,5320,PLA2G2A
hsa04024,cAMP signaling pathway,2/23,212/7844,0.12709560784205975,0.23283095934428735,0.15342733307240156,2,kg,NAC,2353/3725,FOS/JUN
hsa04913,Ovarian steroidogenesis,1/23,49/7844,0.13439835864588945,0.23283095934428735,0.15342733307240156,1,kg,NAC,3479,IGF1
hsa04930,Type II diabetes mellitus,1/23,46/7844,0.12669275099967603,0.23283095934428735,0.15342733307240156,1,kg,NAC,9021,SOCS3
hsa05030,Cocaine addiction,1/23,49/7844,0.13439835864588945,0.23283095934428735,0.15342733307240156,1,kg,NAC,3725,JUN
hsa05144,Malaria,1/23,49/7844,0.13439835864588945,0.23283095934428735,0.15342733307240156,1,kg,NAC,7060,THBS4
hsa05166,Human T-cell leukemia virus 1 infection,2/23,219/7844,0.13401368105809974,0.23283095934428735,0.15342733307240156,2,kg,NAC,2353/3725,FOS/JUN
hsa05170,Human immunodeficiency virus 1 infection,2/23,212/7844,0.12709560784205975,0.23283095934428735,0.15342733307240156,2,kg,NAC,2353/3725,FOS/JUN
R-HSA-2262752,Cellular responses to stress,2/21,426/10554,0.20714159839138813,0.23350507455029207,0.11100411014275344,2,re,NAC,2353/3725,FOS/JUN
GO:0006022,aminoglycan metabolic process,1/24,167/18493,0.19575497029333078,0.23357331782010124,0.1342124814483883,1,bp,NAC,2247,FGF2
GO:0009124,nucleoside monophosphate biosynthetic process,1/24,167/18493,0.19575497029333078,0.23357331782010124,0.1342124814483883,1,bp,NAC,3479,IGF1
GO:0051897,positive regulation of protein kinase B signaling,1/24,168/18493,0.19680822145086452,0.23461421252001038,0.13481058512694666,1,bp,NAC,2247,FGF2
GO:0006986,response to unfolded protein,1/24,169/18493,0.19786015065605844,0.2350042265576079,0.13503468928522205,1,bp,NAC,7060,THBS4
GO:0021543,pallium development,1/24,169/18493,0.19786015065605844,0.2350042265576079,0.13503468928522205,1,bp,NAC,4915,NTRK2
GO:0030324,lung development,1/24,169/18493,0.19786015065605844,0.2350042265576079,0.13503468928522205,1,bp,NAC,10252,SPRY1
GO:0050821,protein stabilization,1/24,169/18493,0.19786015065605844,0.2350042265576079,0.13503468928522205,1,bp,NAC,3479,IGF1
GO:0022408,negative regulation of cell-cell adhesion,1/24,170/18493,0.19891075949606374,0.23582016002412676,0.13550352903224586,1,bp,NAC,9314,KLF4
GO:0060538,skeletal muscle organ development,1/24,170/18493,0.19891075949606374,0.23582016002412676,0.13550352903224586,1,bp,NAC,2353,FOS
GO:0001659,temperature homeostasis,1/24,171/18493,0.1999600495562115,0.23641584710520172,0.1358458140246584,1,bp,NAC,3953,LEPR
GO:0010950,positive regulation of endopeptidase activity,1/24,171/18493,0.1999600495562115,0.23641584710520172,0.1358458140246584,1,bp,NAC,4804,NGFR
GO:0032874,positive regulation of stress-activated MAPK cascade,1/24,171/18493,0.1999600495562115,0.23641584710520172,0.1358458140246584,1,bp,NAC,4616,GADD45B
GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,1/24,172/18493,0.20100802242001736,0.23743843814094945,0.13643340031959764,1,bp,NAC,4616,GADD45B
GO:0030323,respiratory tube development,1/24,173/18493,0.20205467966918078,0.23824083593720682,0.13689446239787556,1,bp,NAC,10252,SPRY1
GO:0048167,regulation of synaptic plasticity,1/24,173/18493,0.20205467966918078,0.23824083593720682,0.13689446239787556,1,bp,NAC,4915,NTRK2
GO:0005604,basement membrane,1/24,92/19659,0.10653191250784111,0.2396968031426425,0.19273865749773886,1,cc,NAC,7060,THBS4
GO:0031091,platelet alpha granule,1/24,91/19659,0.10543473515930402,0.2396968031426425,0.19273865749773886,1,cc,NAC,3479,IGF1
GO:0021953,central nervous system neuron differentiation,1/24,175/18493,0.2041440536413146,0.24004971674776523,0.13793385501555636,1,bp,NAC,4915,NTRK2
GO:0048736,appendage development,1/24,175/18493,0.2041440536413146,0.24004971674776523,0.13793385501555636,1,bp,NAC,7704,ZBTB16
GO:0060173,limb development,1/24,175/18493,0.2041440536413146,0.24004971674776523,0.13793385501555636,1,bp,NAC,7704,ZBTB16
GO:0010821,regulation of mitochondrion organization,1/24,176/18493,0.20518677351862724,0.2408391359761625,0.138387459539117,1,bp,NAC,3479,IGF1
GO:0035637,multicellular organismal signaling,1/24,176/18493,0.20518677351862724,0.2408391359761625,0.138387459539117,1,bp,NAC,4915,NTRK2
GO:0007088,regulation of mitotic nuclear division,1/24,177/18493,0.2062281840899841,0.24140609635804097,0.13871323801606378,1,bp,NAC,3479,IGF1
GO:0015698,inorganic anion transport,1/24,177/18493,0.2062281840899841,0.24140609635804097,0.13871323801606378,1,bp,NAC,6424,SFRP4
GO:0050792,regulation of viral process,1/24,177/18493,0.2062281840899841,0.24140609635804097,0.13871323801606378,1,bp,NAC,3725,JUN
R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,1/21,122/10554,0.2168245455104466,0.24149320637690458,0.11480152425387653,1,re,NAC,3725,JUN
R-HSA-5619507,Activation of HOX genes during differentiation,1/21,122/10554,0.2168245455104466,0.24149320637690458,0.11480152425387653,1,re,NAC,3725,JUN
GO:0042098,T cell proliferation,1/24,178/18493,0.20726828692804067,0.24196846817791967,0.13903637988066964,1,bp,NAC,3479,IGF1
GO:0051170,import into nucleus,1/24,178/18493,0.20726828692804067,0.24196846817791967,0.13903637988066964,1,bp,NAC,3479,IGF1
GO:0071346,cellular response to interferon-gamma,1/24,178/18493,0.20726828692804067,0.24196846817791967,0.13903637988066964,1,bp,NAC,9021,SOCS3
GO:0031345,negative regulation of cell projection organization,1/24,179/18493,0.20830708360364703,0.2429624886995775,0.1396075494049433,1,bp,NAC,4804,NGFR
R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),1/21,125/10554,0.22154516555915782,0.24528214758335332,0.11660271871534622,1,re,NAC,3479,IGF1
GO:0051147,regulation of muscle cell differentiation,1/24,182/18493,0.21141565233726534,0.2463666676383047,0.14156360888521666,1,bp,NAC,3479,IGF1
GO:0016605,PML body,1/24,98/19659,0.11308794411458534,0.24673733261364073,0.19839990195541285,1,cc,NAC,7704,ZBTB16
GO:0042594,response to starvation,1/24,183/18493,0.21244924003558407,0.2471270532073117,0.14200053051233752,1,bp,NAC,3725,JUN
GO:0048839,inner ear development,1/24,183/18493,0.21244924003558407,0.2471270532073117,0.14200053051233752,1,bp,NAC,8516,ITGA8
GO:0034404,nucleobase-containing small molecule biosynthetic process,1/24,184/18493,0.2134815293987269,0.24766148804127797,0.1423076196349672,1,bp,NAC,3479,IGF1
GO:0043112,receptor metabolic process,1/24,184/18493,0.2134815293987269,0.24766148804127797,0.1423076196349672,1,bp,NAC,6424,SFRP4
GO:0046328,regulation of JNK cascade,1/24,184/18493,0.2134815293987269,0.24766148804127797,0.1423076196349672,1,bp,NAC,4616,GADD45B
R-HSA-114608,Platelet degranulation ,1/21,129/10554,0.2277971854460693,0.24777939469572452,0.11778986505059909,1,re,NAC,3479,IGF1
R-HSA-1483206,Glycerophospholipid biosynthesis,1/21,129/10554,0.2277971854460693,0.24777939469572452,0.11778986505059909,1,re,NAC,5320,PLA2G2A
R-HSA-1500931,Cell-Cell communication,1/21,129/10554,0.2277971854460693,0.24777939469572452,0.11778986505059909,1,re,NAC,2318,FLNC
GO:1902806,regulation of cell cycle G1/S phase transition,1/24,185/18493,0.21451252198676696,0.24841316162217567,0.142739535306984,1,bp,NAC,9314,KLF4
GO:2000377,regulation of reactive oxygen species metabolic process,1/24,185/18493,0.21451252198676696,0.24841316162217567,0.142739535306984,1,bp,NAC,9314,KLF4
GO:0006367,transcription initiation from RNA polymerase II promoter,1/24,186/18493,0.21554221935798823,0.2493829246273958,0.14329676633218053,1,bp,NAC,3164,NR4A1
GO:0008022,protein C-terminus binding,1/23,187/17632,0.21759923701972173,0.25221729745467747,0.14315739277613274,1,mf,NAC,7704,ZBTB16
GO:0017137,Rab GTPase binding,1/23,185/17632,0.21553224761885104,0.25221729745467747,0.14315739277613274,1,mf,NAC,4804,NGFR
GO:0019887,protein kinase regulator activity,1/23,180/17632,0.2103418973962572,0.25221729745467747,0.14315739277613274,1,mf,NAC,9021,SOCS3
GO:0051427,hormone receptor binding,1/23,185/17632,0.21553224761885104,0.25221729745467747,0.14315739277613274,1,mf,NAC,3164,NR4A1
GO:0010952,positive regulation of peptidase activity,1/24,189/18493,0.21862355572676995,0.252272910834182,0.1449573679102389,1,bp,NAC,4804,NGFR
GO:0035966,response to topologically incorrect protein,1/24,189/18493,0.21862355572676995,0.252272910834182,0.1449573679102389,1,bp,NAC,7060,THBS4
GO:1901136,carbohydrate derivative catabolic process,1/24,189/18493,0.21862355572676995,0.252272910834182,0.1449573679102389,1,bp,NAC,2247,FGF2
GO:0005516,calmodulin binding,1/23,192/17632,0.22274394375404982,0.2524431362545898,0.14328557785348237,1,mf,NAC,4804,NGFR
GO:0051015,actin filament binding,1/23,190/17632,0.22068995610355524,0.2524431362545898,0.14328557785348237,1,mf,NAC,2318,FLNC
GO:0007565,female pregnancy,1/24,191/18493,0.22067133237670922,0.253958046222353,0.14592565574437036,1,bp,NAC,2353,FOS
GO:0043401,steroid hormone mediated signaling pathway,1/24,191/18493,0.22067133237670922,0.253958046222353,0.14592565574437036,1,bp,NAC,3164,NR4A1
GO:1901991,negative regulation of mitotic cell cycle phase transition,1/24,191/18493,0.22067133237670922,0.253958046222353,0.14592565574437036,1,bp,NAC,9314,KLF4
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,1/21,134/10554,0.23554497720275536,0.25471724278902613,0.12108799317644706,1,re,NAC,3479,IGF1
GO:0034764,positive regulation of transmembrane transport,1/24,192/18493,0.22169329107100266,0.2549079774105412,0.1464714913011104,1,bp,NAC,3479,IGF1
GO:0010001,glial cell differentiation,1/24,194/18493,0.2237333569272979,0.2567983751634561,0.1475577239911755,1,bp,NAC,4915,NTRK2
GO:0060541,respiratory system development,1/24,194/18493,0.2237333569272979,0.2567983751634561,0.1475577239911755,1,bp,NAC,10252,SPRY1
R-HSA-202733,Cell surface interactions at the vascular wall,1/21,137/10554,0.240158055404869,0.2582046144815355,0.1227458269182172,1,re,NAC,7102,TSPAN7
GO:0006575,cellular modified amino acid metabolic process,1/24,197/18493,0.22678385001501267,0.26006954329749904,0.14943735474952669,1,bp,NAC,5320,PLA2G2A
GO:0034341,response to interferon-gamma,1/24,198/18493,0.22779812568180513,0.26100191608595513,0.1499731011555868,1,bp,NAC,9021,SOCS3
GO:0007163,establishment or maintenance of cell polarity,1/24,199/18493,0.22881112622750832,0.26146963058773415,0.1502418524174133,1,bp,NAC,10252,SPRY1
GO:0007266,Rho protein signal transduction,1/24,199/18493,0.22881112622750832,0.26146963058773415,0.1502418524174133,1,bp,NAC,4804,NGFR
GO:0097164,ammonium ion metabolic process,1/24,199/18493,0.22881112622750832,0.26146963058773415,0.1502418524174133,1,bp,NAC,5320,PLA2G2A
R-HSA-6807070,PTEN Regulation,1/21,140/10554,0.24474461411076498,0.26162355301495566,0.12437112876772086,1,re,NAC,3725,JUN
R-HSA-73887,Death Receptor Signalling,1/21,141/10554,0.2462675988528119,0.2617472764949887,0.12442994468352603,1,re,NAC,4804,NGFR
GO:0016363,nuclear matrix,1/24,108/19659,0.12391233660728396,0.262402595168366,0.2109962388049727,1,cc,NAC,862,RUNX1T1
GO:0051783,regulation of nuclear division,1/24,201/18493,0.23083330808762548,0.263548239955678,0.15143623251115534,1,bp,NAC,3479,IGF1
GO:0043903,"regulation of symbiosis, encompassing mutualism through parasitism",1/24,203/18493,0.23285040784173383,0.2653839885507283,0.1524910635019402,1,bp,NAC,3725,JUN
GO:0046434,organophosphate catabolic process,1/24,203/18493,0.23285040784173383,0.2653839885507283,0.1524910635019402,1,bp,NAC,3479,IGF1
GO:0032869,cellular response to insulin stimulus,1/24,204/18493,0.2338570557483386,0.26629727946057524,0.15301584535818466,1,bp,NAC,9021,SOCS3
GO:0050670,regulation of lymphocyte proliferation,1/24,205/18493,0.23486243770809767,0.26720752781351115,0.15353887894490595,1,bp,NAC,3479,IGF1
GO:0032944,regulation of mononuclear cell proliferation,1/24,206/18493,0.23586655524391387,0.26811474334036484,0.15406016985349047,1,bp,NAC,3479,IGF1
hsa05213,Endometrial cancer,1/23,58/7844,0.157126920849885,0.26842515645188686,0.17688264481639102,1,kg,NAC,4616,GADD45B
GO:2000027,regulation of animal organ morphogenesis,1/24,208/18493,0.23787100312658183,0.27015647202730003,0.1552333581100746,1,bp,NAC,10252,SPRY1
hsa00590,Arachidonic acid metabolism,1/23,63/7844,0.16950606800590184,0.2715479883539647,0.17894048013055439,1,kg,NAC,5320,PLA2G2A
hsa04137,Mitophagy - animal,1/23,65/7844,0.1744088705688066,0.2715479883539647,0.17894048013055439,1,kg,NAC,3725,JUN
hsa04213,Longevity regulating pathway - multiple species,1/23,62/7844,0.16704423523932566,0.2715479883539647,0.17894048013055439,1,kg,NAC,3479,IGF1
hsa04730,Long-term depression,1/23,60/7844,0.16209961255261818,0.2715479883539647,0.17894048013055439,1,kg,NAC,3479,IGF1
hsa04927,Cortisol synthesis and secretion,1/23,65/7844,0.1744088705688066,0.2715479883539647,0.17894048013055439,1,kg,NAC,3164,NR4A1
hsa05217,Basal cell carcinoma,1/23,63/7844,0.16950606800590184,0.2715479883539647,0.17894048013055439,1,kg,NAC,4616,GADD45B
hsa05321,Inflammatory bowel disease (IBD),1/23,65/7844,0.1744088705688066,0.2715479883539647,0.17894048013055439,1,kg,NAC,3725,JUN
hsa05223,Non-small cell lung cancer,1/23,66/7844,0.17684987789325912,0.2719066872608859,0.179176849970802,1,kg,NAC,4616,GADD45B
GO:0043583,ear development,1/24,210/18493,0.23987041154461586,0.27195098231937653,0.15626449335074347,1,bp,NAC,8516,ITGA8
GO:0048762,mesenchymal cell differentiation,1/24,210/18493,0.23987041154461586,0.27195098231937653,0.15626449335074347,1,bp,NAC,10252,SPRY1
GO:0009952,anterior/posterior pattern specification,1/24,211/18493,0.24086822974310207,0.27260566664642527,0.15664067847718954,1,bp,NAC,7704,ZBTB16
GO:1901988,negative regulation of cell cycle phase transition,1/24,211/18493,0.24086822974310207,0.27260566664642527,0.15664067847718954,1,bp,NAC,9314,KLF4
GO:0030018,Z disc,1/24,126/19659,0.14307799547061373,0.27330351761259425,0.21976160041948367,1,cc,NAC,2318,FLNC
GO:0031674,I band,1/24,137/19659,0.15459183997800074,0.27330351761259425,0.21976160041948367,1,cc,NAC,2318,FLNC
GO:0034399,nuclear periphery,1/24,134/19659,0.15146648948914976,0.27330351761259425,0.21976160041948367,1,cc,NAC,862,RUNX1T1
GO:0042383,sarcolemma,1/24,133/19659,0.15042224765486267,0.27330351761259425,0.21976160041948367,1,cc,NAC,2318,FLNC
GO:0043204,perikaryon,1/24,125/19659,0.14202386281511847,0.27330351761259425,0.21976160041948367,1,cc,NAC,8516,ITGA8
GO:0043679,axon terminus,1/24,120/19659,0.13673453196863217,0.27330351761259425,0.21976160041948367,1,cc,NAC,4915,NTRK2
GO:0044306,neuron projection terminus,1/24,138/19659,0.15563116975161617,0.27330351761259425,0.21976160041948367,1,cc,NAC,4915,NTRK2
GO:0007254,JNK cascade,1/24,213/18493,0.2428601016812043,0.27462035909374194,0.15779833156545006,1,bp,NAC,4616,GADD45B
GO:0001649,osteoblast differentiation,1/24,214/18493,0.2438541584404852,0.2747861368351948,0.15789358834502126,1,bp,NAC,3479,IGF1
GO:0017038,protein import,1/24,214/18493,0.2438541584404852,0.2747861368351948,0.15789358834502126,1,bp,NAC,3479,IGF1
GO:0032388,positive regulation of intracellular transport,1/24,214/18493,0.2438541584404852,0.2747861368351948,0.15789358834502126,1,bp,NAC,3479,IGF1
GO:0050807,regulation of synapse organization,1/24,214/18493,0.2438541584404852,0.2747861368351948,0.15789358834502126,1,bp,NAC,4915,NTRK2
GO:0031901,early endosome membrane,1/24,143/19659,0.16080947783932276,0.27567339058169615,0.22166720002914164,1,cc,NAC,4915,NTRK2
hsa05120,Epithelial cell signaling in Helicobacter pylori infection,1/23,68/7844,0.18171119808689595,0.27593181931713834,0.18182926904081853,1,kg,NAC,3725,JUN
hsa05211,Renal cell carcinoma,1/23,69/7844,0.18413154819543565,0.27619732229315347,0.18200422607251018,1,kg,NAC,3725,JUN
GO:0070663,regulation of leukocyte proliferation,1/24,216/18493,0.24583852107566306,0.27678173770411024,0.1590402713099136,1,bp,NAC,3479,IGF1
GO:0009108,coenzyme biosynthetic process,1/24,217/18493,0.24682882996082922,0.2771748852460567,0.15926617599659793,1,bp,NAC,3479,IGF1
GO:0030595,leukocyte chemotaxis,1/24,217/18493,0.24682882996082922,0.2771748852460567,0.15926617599659793,1,bp,NAC,7060,THBS4
GO:0045665,negative regulation of neuron differentiation,1/24,217/18493,0.24682882996082922,0.2771748852460567,0.15926617599659793,1,bp,NAC,4804,NGFR
GO:0019722,calcium-mediated signaling,1/24,220/18493,0.24979228490596583,0.2800177990691769,0.160899729530477,1,bp,NAC,3479,IGF1
GO:0050803,regulation of synapse structure or activity,1/24,220/18493,0.24979228490596583,0.2800177990691769,0.160899729530477,1,bp,NAC,4915,NTRK2
GO:0005125,cytokine activity,1/23,219/17632,0.2499709511926108,0.28018722001809127,0.15903299381831806,1,mf,NAC,2247,FGF2
GO:0044706,multi-multicellular organism process,1/24,221/18493,0.25077761764619755,0.28087959420303815,0.16139492163758556,1,bp,NAC,2353,FOS
GO:2001234,negative regulation of apoptotic signaling pathway,1/24,222/18493,0.2517617100923718,0.2817385142276154,0.1618884616914756,1,bp,NAC,3479,IGF1
GO:0097191,extrinsic apoptotic signaling pathway,1/24,224/18493,0.2537261800745513,0.2836921168592181,0.1630110122439041,1,bp,NAC,3479,IGF1
R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,1/21,156/10554,0.2687643232242154,0.2840350234074095,0.13502513846192638,1,re,NAC,7102,TSPAN7
GO:0048588,developmental cell growth,1/24,226/18493,0.2556857067793621,0.2856368317767723,0.16412845586816116,1,bp,NAC,3479,IGF1
GO:0060560,developmental growth involved in morphogenesis,1/24,227/18493,0.2566636201224013,0.2864825432863636,0.16461440623848184,1,bp,NAC,10252,SPRY1
GO:0031669,cellular response to nutrient levels,1/24,228/18493,0.2576403021062542,0.2873254271984623,0.1650987318561144,1,bp,NAC,3725,JUN
GO:0033157,regulation of intracellular protein transport,1/24,232/18493,0.26153474608742233,0.2914180117486141,0.16745035289373755,1,bp,NAC,3479,IGF1
hsa05212,Pancreatic cancer,1/23,75/7844,0.1985104745275117,0.29415050458458697,0.1938347355841951,1,kg,NAC,4616,GADD45B
hsa05220,Chronic myeloid leukemia,1/23,76/7844,0.2008832714236204,0.29415050458458697,0.1938347355841951,1,kg,NAC,4616,GADD45B
GO:0032872,regulation of stress-activated MAPK cascade,1/24,235/18493,0.26444272230675314,0.29440533118614487,0.16916688266833632,1,bp,NAC,4616,GADD45B
GO:0048705,skeletal system morphogenesis,1/24,236/18493,0.265409606667835,0.29522835321456425,0.1696397955410555,1,bp,NAC,6424,SFRP4
GO:0070302,regulation of stress-activated protein kinase signaling cascade,1/24,237/18493,0.2663752729569281,0.2960486109898335,0.17011112005908544,1,bp,NAC,4616,GADD45B
GO:0034329,cell junction assembly,1/24,238/18493,0.2673397226419102,0.2968661132419157,0.17058086123870977,1,bp,NAC,2318,FLNC
GO:0009152,purine ribonucleotide biosynthetic process,1/24,239/18493,0.2683029571889711,0.29768086866902954,0.1710490240779718,1,bp,NAC,3479,IGF1
GO:0003714,transcription corepressor activity,1/23,238/17632,0.2685812371173558,0.2977748498475032,0.16901565264822163,1,mf,NAC,862,RUNX1T1
GO:0009755,hormone-mediated signaling pathway,1/24,240/18493,0.26926497806261307,0.2984928859377856,0.17151561355675216,1,bp,NAC,3164,NR4A1
GO:0031330,negative regulation of cellular catabolic process,1/24,245/18493,0.2740569284693043,0.30354554758726526,0.17441890004608515,1,bp,NAC,3953,LEPR
GO:0050714,positive regulation of protein secretion,1/24,246/18493,0.2750116979627686,0.3043431503905383,0.17487720689567104,1,bp,NAC,3479,IGF1
GO:0021537,telencephalon development,1/24,248/18493,0.27691762799385344,0.30619110273489164,0.17593905022627382,1,bp,NAC,4915,NTRK2
GO:0046034,ATP metabolic process,1/24,250/18493,0.2788187557492986,0.3080306015390462,0.17699603610732845,1,bp,NAC,3479,IGF1
GO:1901617,organic hydroxy compound biosynthetic process,1/24,251/18493,0.279767522391957,0.30881572471690916,0.17744717209720542,1,bp,NAC,2247,FGF2
GO:0031256,leading edge membrane,1/24,167/19659,0.18524461359952216,0.31017702742245573,0.24941135245957696,1,cc,NAC,8516,ITGA8
GO:0009260,ribonucleotide biosynthetic process,1/24,253/18493,0.2816614684291743,0.3106419426468019,0.17849652671666252,1,bp,NAC,3479,IGF1
GO:0005088,Ras guanyl-nucleotide exchange factor activity,1/23,254/17632,0.2839096844312998,0.31138481518271593,0.1767406071728522,1,mf,NAC,2247,FGF2
GO:0001818,negative regulation of cytokine production,1/24,256/18493,0.28449344098098306,0.31349871958567127,0.1801380460712212,1,bp,NAC,9314,KLF4
GO:0006164,purine nucleotide biosynthetic process,1/24,258/18493,0.2863754751201141,0.31526834327840914,0.18115488133840332,1,bp,NAC,3479,IGF1
GO:0031334,positive regulation of protein complex assembly,1/24,259/18493,0.2873147122244253,0.31526834327840914,0.18115488133840332,1,bp,NAC,3725,JUN
GO:0032868,response to insulin,1/24,259/18493,0.2873147122244253,0.31526834327840914,0.18115488133840332,1,bp,NAC,9021,SOCS3
GO:0046390,ribose phosphate biosynthetic process,1/24,259/18493,0.2873147122244253,0.31526834327840914,0.18115488133840332,1,bp,NAC,3479,IGF1
GO:0071383,cellular response to steroid hormone stimulus,1/24,259/18493,0.2873147122244253,0.31526834327840914,0.18115488133840332,1,bp,NAC,3164,NR4A1
GO:0030100,regulation of endocytosis,1/24,260/18493,0.2882527645939884,0.3160302922049053,0.18159270127912425,1,bp,NAC,6424,SFRP4
GO:0000082,G1/S transition of mitotic cell cycle,1/24,263/18493,0.2910598275810078,0.3188383415308844,0.1832062214859117,1,bp,NAC,9314,KLF4
GO:0002793,positive regulation of peptide secretion,1/24,265/18493,0.2929253053956644,0.31953248200014867,0.18360507832334147,1,bp,NAC,3479,IGF1
GO:0016054,organic acid catabolic process,1/24,265/18493,0.2929253053956644,0.31953248200014867,0.18360507832334147,1,bp,NAC,2247,FGF2
GO:0031647,regulation of protein stability,1/24,265/18493,0.2929253053956644,0.31953248200014867,0.18360507832334147,1,bp,NAC,3479,IGF1
GO:0046395,carboxylic acid catabolic process,1/24,265/18493,0.2929253053956644,0.31953248200014867,0.18360507832334147,1,bp,NAC,2247,FGF2
GO:0046651,lymphocyte proliferation,1/24,264/18493,0.2919931552901712,0.31953248200014867,0.18360507832334147,1,bp,NAC,3479,IGF1
GO:0032943,mononuclear cell proliferation,1/24,266/18493,0.29385627931877756,0.32000973490886186,0.18387931040496222,1,bp,NAC,3479,IGF1
GO:0042063,gliogenesis,1/24,266/18493,0.29385627931877756,0.32000973490886186,0.18387931040496222,1,bp,NAC,4915,NTRK2
hsa00564,Glycerophospholipid metabolism,1/23,97/7844,0.24918731079118994,0.3211248587700628,0.21160987698155614,1,kg,NAC,5320,PLA2G2A
hsa04012,ErbB signaling pathway,1/23,85/7844,0.221938210704265,0.3211248587700628,0.21160987698155614,1,kg,NAC,3725,JUN
hsa04064,NF-kappa B signaling pathway,1/23,100/7844,0.25585557853224516,0.3211248587700628,0.21160987698155614,1,kg,NAC,4616,GADD45B
hsa04066,HIF-1 signaling pathway,1/23,100/7844,0.25585557853224516,0.3211248587700628,0.21160987698155614,1,kg,NAC,3479,IGF1
hsa04211,Longevity regulating pathway,1/23,89/7844,0.23112467141804038,0.3211248587700628,0.21160987698155614,1,kg,NAC,3479,IGF1
hsa04540,Gap junction,1/23,88/7844,0.22883783156838478,0.3211248587700628,0.21160987698155614,1,kg,NAC,80310,PDGFD
hsa04713,Circadian entrainment,1/23,97/7844,0.24918731079118994,0.3211248587700628,0.21160987698155614,1,kg,NAC,2353,FOS
hsa04750,Inflammatory mediator regulation of TRP channels,1/23,100/7844,0.25585557853224516,0.3211248587700628,0.21160987698155614,1,kg,NAC,3479,IGF1
hsa04912,GnRH signaling pathway,1/23,93/7844,0.2402073314001394,0.3211248587700628,0.21160987698155614,1,kg,NAC,3725,JUN
hsa04914,Progesterone-mediated oocyte maturation,1/23,99/7844,0.2536391421564672,0.3211248587700628,0.21160987698155614,1,kg,NAC,3479,IGF1
hsa04925,Aldosterone synthesis and secretion,1/23,98/7844,0.25141639196478005,0.3211248587700628,0.21160987698155614,1,kg,NAC,3164,NR4A1
hsa04933,AGE-RAGE signaling pathway in diabetic complications,1/23,100/7844,0.25585557853224516,0.3211248587700628,0.21160987698155614,1,kg,NAC,3725,JUN
hsa04972,Pancreatic secretion,1/23,98/7844,0.25141639196478005,0.3211248587700628,0.21160987698155614,1,kg,NAC,5320,PLA2G2A
hsa05222,Small cell lung cancer,1/23,93/7844,0.2402073314001394,0.3211248587700628,0.21160987698155614,1,kg,NAC,4616,GADD45B
GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1/23,267/17632,0.2961373142386259,0.3213404899185089,0.18239140294652212,1,mf,NAC,7704,ZBTB16
GO:0006260,DNA replication,1/24,268/18493,0.29571470429483904,0.321763398884569,0.18488697513312083,1,bp,NAC,3725,JUN
GO:0060485,mesenchyme development,1/24,269/18493,0.29664215818218687,0.3225019942684798,0.1853113760029896,1,bp,NAC,10252,SPRY1
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,1/24,270/18493,0.2975684415559593,0.323238080986666,0.18573433538007508,1,bp,NAC,9314,KLF4
GO:0021700,developmental maturation,1/24,271/18493,0.29849355582927617,0.3237007875506448,0.186000209053976,1,bp,NAC,3479,IGF1
GO:0072522,purine-containing compound biosynthetic process,1/24,271/18493,0.29849355582927617,0.3237007875506448,0.186000209053976,1,bp,NAC,3479,IGF1
GO:0007162,negative regulation of cell adhesion,1/24,276/18493,0.3031016400343586,0.3281492713894516,0.18855633173212008,1,bp,NAC,9314,KLF4
GO:0072593,reactive oxygen species metabolic process,1/24,276/18493,0.3031016400343586,0.3281492713894516,0.18855633173212008,1,bp,NAC,9314,KLF4
GO:0005096,GTPase activator activity,1/23,279/17632,0.3072468917245792,0.3283997356872771,0.18639819879050817,1,mf,NAC,3725,JUN
GO:0005126,cytokine receptor binding,1/23,281/17632,0.3090821041762608,0.3283997356872771,0.18639819879050817,1,mf,NAC,3977,LIFR
hsa04625,C-type lectin receptor signaling pathway,1/23,104/7844,0.26465852764674047,0.32881817071261693,0.21667949631896877,1,kg,NAC,3725,JUN
GO:0140014,mitotic nuclear division,1/24,277/18493,0.30401976928940455,0.3288687579385802,0.18896975256301163,1,bp,NAC,3479,IGF1
GO:0050768,negative regulation of neurogenesis,1/24,279/18493,0.3058525514373093,0.3303003823598586,0.18979237163557994,1,bp,NAC,4804,NGFR
GO:0051188,cofactor biosynthetic process,1/24,279/18493,0.3058525514373093,0.3303003823598586,0.18979237163557994,1,bp,NAC,3479,IGF1
hsa04928,"Parathyroid hormone synthesis, secretion and action",1/23,106/7844,0.26902256237610245,0.330897751722606,0.21804986634694618,1,kg,NAC,2353,FOS
GO:0009205,purine ribonucleoside triphosphate metabolic process,1/24,280/18493,0.3067672071288381,0.331012535479287,0.19020157863842485,1,bp,NAC,3479,IGF1
GO:0045930,negative regulation of mitotic cell cycle,1/24,281/18493,0.3076807077618424,0.3317222593242807,0.19060938976714742,1,bp,NAC,9314,KLF4
GO:0018105,peptidyl-serine phosphorylation,1/24,282/18493,0.3085930547316269,0.33215368629619924,0.1908572900196478,1,bp,NAC,4915,NTRK2
GO:0044843,cell cycle G1/S phase transition,1/24,282/18493,0.3085930547316269,0.33215368629619924,0.1908572900196478,1,bp,NAC,9314,KLF4
GO:0070661,leukocyte proliferation,1/24,283/18493,0.3095042494318869,0.3328582185017888,0.19126211800451773,1,bp,NAC,3479,IGF1
hsa04931,Insulin resistance,1/23,108/7844,0.2733618175049969,0.332905975773412,0.21937321467310847,1,kg,NAC,9021,SOCS3
GO:0048562,embryonic organ morphogenesis,1/24,284/18493,0.3104142932547117,0.33328422048953726,0.19150690103201104,1,bp,NAC,8516,ITGA8
GO:0051403,stress-activated MAPK cascade,1/24,284/18493,0.3104142932547117,0.33328422048953726,0.19150690103201104,1,bp,NAC,4616,GADD45B
GO:0009126,purine nucleoside monophosphate metabolic process,1/24,287/18493,0.3131375333553833,0.3342710952773104,0.19207396457926046,1,bp,NAC,3479,IGF1
GO:0009144,purine nucleoside triphosphate metabolic process,1/24,287/18493,0.3131375333553833,0.3342710952773104,0.19207396457926046,1,bp,NAC,3479,IGF1
GO:0009167,purine ribonucleoside monophosphate metabolic process,1/24,286/18493,0.3122309338283813,0.3342710952773104,0.19207396457926046,1,bp,NAC,3479,IGF1
GO:0009199,ribonucleoside triphosphate metabolic process,1/24,286/18493,0.3122309338283813,0.3342710952773104,0.19207396457926046,1,bp,NAC,3479,IGF1
GO:0009895,negative regulation of catabolic process,1/24,287/18493,0.3131375333553833,0.3342710952773104,0.19207396457926046,1,bp,NAC,3953,LEPR
GO:0034330,cell junction organization,1/24,287/18493,0.3131375333553833,0.3342710952773104,0.19207396457926046,1,bp,NAC,2318,FLNC
GO:0090068,positive regulation of cell cycle process,1/24,286/18493,0.3122309338283813,0.3342710952773104,0.19207396457926046,1,bp,NAC,3479,IGF1
GO:0030522,intracellular receptor signaling pathway,1/24,288/18493,0.31404298755726545,0.3349619694586951,0.1924709445901523,1,bp,NAC,3164,NR4A1
GO:0072330,monocarboxylic acid biosynthetic process,1/24,293/18493,0.3185531270767965,0.339493349070341,0.1950746996240729,1,bp,NAC,3479,IGF1
hsa04725,Cholinergic synapse,1/23,112/7844,0.2819665256322875,0.3400184573801114,0.22406008744774136,1,kg,NAC,2353,FOS
GO:0030017,sarcomere,1/24,197/19659,0.2148306722532819,0.34230804706339746,0.2752476986620886,1,cc,NAC,2318,FLNC
GO:0032993,protein-DNA complex,1/24,201/19659,0.2186968078460595,0.34230804706339746,0.2752476986620886,1,cc,NAC,2353,FOS
GO:0070382,exocytic vesicle,1/24,197/19659,0.2148306722532819,0.34230804706339746,0.2752476986620886,1,cc,NAC,3479,IGF1
R-HSA-913531,Interferon Signaling,1/21,197/10554,0.3270387917243692,0.3436678828289982,0.16337352664196858,1,re,NAC,9021,SOCS3
GO:0051961,negative regulation of nervous system development,1/24,298/18493,0.323034840402883,0.3439870180644821,0.19765678593487265,1,bp,NAC,4804,NGFR
GO:0016323,basolateral plasma membrane,1/24,213/19659,0.23018606056134783,0.3451963695205356,0.2775701801700213,1,cc,NAC,3953,LEPR
GO:0030016,myofibril,1/24,218/19659,0.23492530703480896,0.3451963695205356,0.2775701801700213,1,cc,NAC,2318,FLNC
GO:0044449,contractile fiber part,1/24,214/19659,0.23113615490190775,0.3451963695205356,0.2775701801700213,1,cc,NAC,2318,FLNC
GO:0009161,ribonucleoside monophosphate metabolic process,1/24,300/18493,0.32481960483044414,0.3453205143156443,0.1984230200344732,1,bp,NAC,3479,IGF1
GO:0043414,macromolecule methylation,1/24,300/18493,0.32481960483044414,0.3453205143156443,0.1984230200344732,1,bp,NAC,2353,FOS
GO:0018209,peptidyl-serine modification,1/24,301/18493,0.3257102951775045,0.345983827064065,0.19880416309812768,1,bp,NAC,4915,NTRK2
GO:0070588,calcium ion transmembrane transport,1/24,302/18493,0.3265998594318881,0.346644858987855,0.19918399558771363,1,bp,NAC,2247,FGF2
GO:0010506,regulation of autophagy,1/24,303/18493,0.3274882989554784,0.3473036171261287,0.19956252154794393,1,bp,NAC,3953,LEPR
GO:0010948,negative regulation of cell cycle process,1/24,304/18493,0.32837561510858826,0.3479601084933325,0.19993974500935716,1,bp,NAC,9314,KLF4
GO:0009141,nucleoside triphosphate metabolic process,1/24,307/18493,0.33103083692460744,0.3504873432581354,0.20139190766283313,1,bp,NAC,3479,IGF1
GO:0009416,response to light stimulus,1/24,308/18493,0.33191367316753095,0.35113542748636833,0.20176430033709272,1,bp,NAC,2353,FOS
GO:0030695,GTPase regulator activity,1/23,309/17632,0.33429181619068327,0.3515233531077288,0.19952305903947457,1,mf,NAC,3725,JUN
GO:0007204,positive regulation of cytosolic calcium ion concentration,1/24,309/18493,0.3327953928180112,0.3517812750488675,0.20213540781122283,1,bp,NAC,2247,FGF2
GO:0043292,contractile fiber,1/24,229/19659,0.24525342431673802,0.35316493101610275,0.28397764920885454,1,cc,NAC,2318,FLNC
GO:0031098,stress-activated protein kinase signaling cascade,1/24,313/18493,0.33631113249039724,0.3552080935179521,0.20410447608709176,1,bp,NAC,4616,GADD45B
GO:0008202,steroid metabolic process,1/24,318/18493,0.3406808453992263,0.35923825730308656,0.20642022981827315,1,bp,NAC,3953,LEPR
GO:0051235,maintenance of location,1/24,318/18493,0.3406808453992263,0.35923825730308656,0.20642022981827315,1,bp,NAC,2247,FGF2
GO:0042742,defense response to bacterium,1/24,319/18493,0.34155147316871237,0.35986373736784727,0.2067796340189391,1,bp,NAC,5320,PLA2G2A
GO:0016042,lipid catabolic process,1/24,321/18493,0.3432894245878021,0.3614012854629702,0.2076631174027374,1,bp,NAC,5320,PLA2G2A
GO:0009123,nucleoside monophosphate metabolic process,1/24,322/18493,0.3441567509035569,0.36202052386205463,0.20801893510882166,1,bp,NAC,3479,IGF1
R-HSA-1483257,Phospholipid metabolism,1/21,212/10554,0.34723186976389475,0.36283779649485637,0.17248655860536463,1,re,NAC,5320,PLA2G2A
GO:0005085,guanyl-nucleotide exchange factor activity,1/23,327/17632,0.35003083736762897,0.36431781032140975,0.20678513485735334,1,mf,NAC,2247,FGF2
GO:0009101,glycoprotein biosynthetic process,1/24,326/18493,0.34761509124124,0.3653620529496664,0.20993899564855237,1,bp,NAC,3479,IGF1
hsa04110,Cell cycle,1/23,124/7844,0.30719976901361046,0.36576393049773853,0.24102543986586109,1,kg,NAC,4616,GADD45B
hsa04114,Oocyte meiosis,1/23,125/7844,0.3092638111525594,0.36576393049773853,0.24102543986586109,1,kg,NAC,3479,IGF1
hsa04270,Vascular smooth muscle contraction,1/23,132/7844,0.32354828266089075,0.37543810157820345,0.24740037502371984,1,kg,NAC,5320,PLA2G2A
hsa04728,Dopaminergic synapse,1/23,131/7844,0.3215250850667688,0.37543810157820345,0.24740037502371984,1,kg,NAC,2353,FOS
GO:0006909,phagocytosis,1/24,342/18493,0.3612744935218969,0.3794113506865589,0.2180117974971259,1,bp,NAC,3953,LEPR
hsa04120,Ubiquitin mediated proteolysis,1/23,137/7844,0.3335780108358104,0.3799082901185618,0.250346070510306,1,kg,NAC,9021,SOCS3
hsa04910,Insulin signaling pathway,1/23,137/7844,0.3335780108358104,0.3799082901185618,0.250346070510306,1,kg,NAC,9021,SOCS3
GO:0009165,nucleotide biosynthetic process,1/24,344/18493,0.36296252165310694,0.3808757205372813,0.21885323226911915,1,bp,NAC,3479,IGF1
R-HSA-112315,Transmission across Chemical Synapses,1/21,227/10554,0.3668470536041416,0.381193027767432,0.181212305220511,1,re,NAC,7102,TSPAN7
GO:0001505,regulation of neurotransmitter levels,1/24,346/18493,0.36464627406164296,0.38202440828590545,0.21951327441173643,1,bp,NAC,9314,KLF4
GO:0006898,receptor-mediated endocytosis,1/24,346/18493,0.36464627406164296,0.38202440828590545,0.21951327441173643,1,bp,NAC,6424,SFRP4
GO:0031331,positive regulation of cellular catabolic process,1/24,347/18493,0.3654865501085115,0.3822871415247898,0.21966424234025986,1,bp,NAC,3479,IGF1
GO:1901293,nucleoside phosphate biosynthetic process,1/24,347/18493,0.3654865501085115,0.3822871415247898,0.21966424234025986,1,bp,NAC,3479,IGF1
GO:0060589,nucleoside-triphosphatase regulator activity,1/23,353/17632,0.3721379798903697,0.383414888371896,0.21762454964349104,1,mf,NAC,3725,JUN
GO:0006959,humoral immune response,1/24,349/18493,0.36716390835154256,0.38373214273323986,0.22049454778649824,1,bp,NAC,5320,PLA2G2A
GO:0051480,regulation of cytosolic calcium ion concentration,1/24,350/18493,0.3680009931288555,0.3842973334042879,0.22081930937810804,1,bp,NAC,2247,FGF2
GO:0006732,coenzyme metabolic process,1/24,351/18493,0.3688370167283105,0.38486050739872785,0.22114291217652016,1,bp,NAC,3479,IGF1
GO:0061695,"transferase complex, transferring phosphorus-containing groups",1/24,259/19659,0.2727463531863069,0.385053675086551,0.3096191831836302,1,cc,NAC,9021,SOCS3
GO:0045862,positive regulation of proteolysis,1/24,352/18493,0.36967198043675076,0.38542167092159624,0.22146535974718187,1,bp,NAC,4804,NGFR
R-HSA-201681,TCF dependent signaling in response to WNT,1/21,233/10554,0.37453485496127203,0.3870193501266478,0.18398203401606347,1,re,NAC,27123,DKK2
R-HSA-157118,Signaling by NOTCH,1/21,235/10554,0.3770776396831782,0.38749414906669144,0.1842077448873915,1,re,NAC,3725,JUN
GO:0006913,nucleocytoplasmic transport,1/24,357/18493,0.37383094554906715,0.3894447681744097,0.22377705301098247,1,bp,NAC,3479,IGF1
GO:0032259,methylation,1/24,358/18493,0.37465957685182505,0.3899947601740105,0.2240930813644438,1,bp,NAC,2353,FOS
GO:0006869,lipid transport,1/24,359/18493,0.37548715722985415,0.3905427770065123,0.22440797477629404,1,bp,NAC,5320,PLA2G2A
GO:0051169,nuclear transport,1/24,360/18493,0.3763136879581258,0.3910888247449432,0.22472173673612778,1,bp,NAC,3479,IGF1
GO:0004857,enzyme inhibitor activity,1/23,371/17632,0.38701961404203633,0.39476000632287706,0.22406398707696842,1,mf,NAC,9021,SOCS3
GO:0045088,regulation of innate immune response,1/24,365/18493,0.3804306413738856,0.39505087418889484,0.22699835160145881,1,bp,NAC,9021,SOCS3
hsa04514,Cell adhesion molecules (CAMs),1/23,146/7844,0.3512741305605678,0.39639190879770486,0.2612081897939519,1,kg,NAC,8516,ITGA8
hsa04072,Phospholipase D signaling pathway,1/23,148/7844,0.35514510260802123,0.39711679655260557,0.26168586507959457,1,kg,NAC,80310,PDGFD
hsa04145,Phagosome,1/23,152/7844,0.362820868060565,0.39761396326040693,0.26201348028285265,1,kg,NAC,7060,THBS4
hsa04150,mTOR signaling pathway,1/23,153/7844,0.3647261098747363,0.39761396326040693,0.26201348028285265,1,kg,NAC,3479,IGF1
hsa04934,Cushing syndrome,1/23,155/7844,0.36852025863159665,0.39761396326040693,0.26201348028285265,1,kg,NAC,3164,NR4A1
hsa05160,Hepatitis C,1/23,155/7844,0.36852025863159665,0.39761396326040693,0.26201348028285265,1,kg,NAC,9021,SOCS3
GO:1903532,positive regulation of secretion by cell,1/24,373/18493,0.3869636467298394,0.4015134798468814,0.23071179948187476,1,bp,NAC,3479,IGF1
R-HSA-5673001,RAF/MAP kinase cascade,1/21,248/10554,0.393367328796867,0.4020127645946003,0.1911096334235791,1,re,NAC,2247,FGF2
GO:0030900,forebrain development,1/24,374/18493,0.38777561540966743,0.4020343510682164,0.23101109487992302,1,bp,NAC,4915,NTRK2
GO:1901990,regulation of mitotic cell cycle phase transition,1/24,375/18493,0.3885865533880418,0.40255332247946507,0.23130929863690397,1,bp,NAC,9314,KLF4
GO:0150034,distal axon,1/24,280/19659,0.2914175464565253,0.4035012181705735,0.32445273390908685,1,cc,NAC,4915,NTRK2
hsa04218,Cellular senescence,1/23,160/7844,0.37791103559688066,0.4042004989427506,0.26635377337262983,1,kg,NAC,4616,GADD45B
GO:0019898,extrinsic component of membrane,1/24,287/19659,0.2975385421970609,0.40420330260732795,0.3250172754883485,1,cc,NAC,9021,SOCS3
GO:0005769,early endosome,1/24,341/19659,0.34308372285809163,0.40495127943905895,0.3256187188471965,1,cc,NAC,4915,NTRK2
GO:0005788,endoplasmic reticulum lumen,1/24,301/19659,0.3096288637767497,0.40495127943905895,0.3256187188471965,1,cc,NAC,80310,PDGFD
GO:0031253,cell projection membrane,1/24,334/19659,0.3373435142422293,0.40495127943905895,0.3256187188471965,1,cc,NAC,8516,ITGA8
GO:0031965,nuclear membrane,1/24,302/19659,0.3104847841853332,0.40495127943905895,0.3256187188471965,1,cc,NAC,3164,NR4A1
GO:0031983,vesicle lumen,1/24,339/19659,0.34144854412350367,0.40495127943905895,0.3256187188471965,1,cc,NAC,3479,IGF1
GO:0034774,secretory granule lumen,1/24,321/19659,0.3265553526628072,0.40495127943905895,0.3256187188471965,1,cc,NAC,3479,IGF1
GO:0060205,cytoplasmic vesicle lumen,1/24,338/19659,0.34062949271960485,0.40495127943905895,0.3256187188471965,1,cc,NAC,3479,IGF1
GO:0062023,collagen-containing extracellular matrix,1/24,332/19659,0.33569464567767604,0.40495127943905895,0.3256187188471965,1,cc,NAC,7060,THBS4
R-HSA-5684996,MAPK1/MAPK3 signaling,1/21,254/10554,0.40074805459285223,0.4073176948320793,0.1936315017877457,1,re,NAC,2247,FGF2
GO:0010639,negative regulation of organelle organization,1/24,384/18493,0.3958388196543877,0.40941224010505656,0.23525046949996348,1,bp,NAC,3479,IGF1
GO:0050808,synapse organization,1/24,384/18493,0.3958388196543877,0.40941224010505656,0.23525046949996348,1,bp,NAC,4915,NTRK2
hsa05164,Influenza A,1/23,167/7844,0.39083397296714806,0.41279537076352807,0.2720174886503351,1,kg,NAC,9021,SOCS3
hsa05225,Hepatocellular carcinoma,1/23,168/7844,0.39265901121408764,0.41279537076352807,0.2720174886503351,1,kg,NAC,4616,GADD45B
hsa04530,Tight junction,1/23,170/7844,0.3962934099245746,0.4130855035654465,0.2722086758625535,1,kg,NAC,3725,JUN
GO:0045787,positive regulation of cell cycle,1/24,390/18493,0.4006277864947929,0.4140352502659334,0.23790687593903403,1,bp,NAC,3479,IGF1
GO:2001233,regulation of apoptotic signaling pathway,1/24,391/18493,0.401422402476902,0.41452615924565434,0.23818895487231526,1,bp,NAC,3479,IGF1
R-HSA-76002,"Platelet activation, signaling and aggregation",1/21,262/10554,0.4104560725908202,0.4149175516407204,0.19724433694295704,1,re,NAC,3479,IGF1
GO:0010876,lipid localization,1/24,393/18493,0.40300860680385064,0.4158330652542516,0.23893991007589185,1,bp,NAC,5320,PLA2G2A
GO:0016607,nuclear speck,1/24,382/19659,0.3757598899047402,0.4162263395867892,0.3346849221823597,1,cc,NAC,7704,ZBTB16
GO:0030133,transport vesicle,1/24,381/19659,0.3749817782062732,0.4162263395867892,0.3346849221823597,1,cc,NAC,3479,IGF1
GO:0033267,axon part,1/24,373/19659,0.3687233350556154,0.4162263395867892,0.3346849221823597,1,cc,NAC,4915,NTRK2
GO:0045177,apical part of cell,1/24,373/19659,0.3687233350556154,0.4162263395867892,0.3346849221823597,1,cc,NAC,8516,ITGA8
GO:0009100,glycoprotein metabolic process,1/24,394/18493,0.4038001976014586,0.4163186456988011,0.23921892720427804,1,bp,NAC,3479,IGF1
GO:0031252,cell leading edge,1/24,390/19659,0.3819514503216451,0.4166743094417947,0.3350451318610922,1,cc,NAC,8516,ITGA8
GO:0051222,positive regulation of protein transport,1/24,402/18493,0.4100968125217582,0.4224746352984276,0.24275619185268577,1,bp,NAC,3479,IGF1
GO:0051047,positive regulation of secretion,1/24,404/18493,0.4116609799329769,0.4237494372802151,0.24348869991023195,1,bp,NAC,3479,IGF1
GO:0043547,positive regulation of GTPase activity,1/24,405/18493,0.4124415723638246,0.424216272288565,0.243756945810416,1,bp,NAC,3725,JUN
hsa04621,NOD-like receptor signaling pathway,1/23,178/7844,0.41062405448282957,0.42442654370914323,0.2796820185331966,1,kg,NAC,3725,JUN
hsa05034,Alcoholism,1/23,180/7844,0.4141555423804665,0.4245094309399781,0.2797366382745256,1,kg,NAC,4915,NTRK2
GO:0009896,positive regulation of catabolic process,1/24,407/18493,0.413999780719552,0.42548154959846196,0.24448398094039772,1,bp,NAC,3479,IGF1
GO:0003779,actin binding,1/23,421/17632,0.42660808308536813,0.42660808308536813,0.2421408108327683,1,mf,NAC,2318,FLNC
GO:0005543,phospholipid binding,1/23,417/17632,0.4235332440563465,0.42660808308536813,0.2421408108327683,1,mf,NAC,5320,PLA2G2A
GO:0046394,carboxylic acid biosynthetic process,1/24,412/18493,0.4178779949003464,0.42878778432416875,0.24638376115043742,1,bp,NAC,3479,IGF1
GO:1901987,regulation of cell cycle phase transition,1/24,412/18493,0.4178779949003464,0.42878778432416875,0.24638376115043742,1,bp,NAC,9314,KLF4
GO:0006816,calcium ion transport,1/24,413/18493,0.41865068048866527,0.4289020004690354,0.24644939036000246,1,bp,NAC,2247,FGF2
GO:0016053,organic acid biosynthetic process,1/24,413/18493,0.41865068048866527,0.4289020004690354,0.24644939036000246,1,bp,NAC,3479,IGF1
GO:0000280,nuclear division,1/24,416/18493,0.4209628443259794,0.4305905434469995,0.24741963621350938,1,bp,NAC,3479,IGF1
GO:0001558,regulation of cell growth,1/24,416/18493,0.4209628443259794,0.4305905434469995,0.24741963621350938,1,bp,NAC,3479,IGF1
GO:0050804,modulation of chemical synaptic transmission,1/24,418/18493,0.4224993880551533,0.4318216755772528,0.2481270513400925,1,bp,NAC,4915,NTRK2
GO:0099177,regulation of trans-synaptic signaling,1/24,419/18493,0.4232661938469472,0.43226476647203976,0.2483816537452454,1,bp,NAC,4915,NTRK2
GO:0032386,regulation of intracellular transport,1/24,422/18493,0.4255607611974628,0.43426617409371304,0.24953167330142334,1,bp,NAC,3479,IGF1
GO:0031349,positive regulation of defense response,1/24,427/18493,0.4293656111359828,0.4378044006630265,0.25156475726934446,1,bp,NAC,5320,PLA2G2A
GO:0048608,reproductive structure development,1/24,428/18493,0.43012367741145807,0.4382328433642271,0.25181094274388083,1,bp,NAC,9021,SOCS3
GO:0044282,small molecule catabolic process,1/24,431/18493,0.4323920900085806,0.4398529731302973,0.2527418779988236,1,bp,NAC,2247,FGF2
GO:0061458,reproductive system development,1/24,431/18493,0.4323920900085806,0.4398529731302973,0.2527418779988236,1,bp,NAC,9021,SOCS3
GO:0048732,gland development,1/24,434/18493,0.43465184790327593,0.4418052090364803,0.2538636432234939,1,bp,NAC,3725,JUN
GO:0002683,negative regulation of immune system process,1/24,437/18493,0.436902982685509,0.4433984104406144,0.2547791052972081,1,bp,NAC,7704,ZBTB16
GO:1904951,positive regulation of establishment of protein localization,1/24,437/18493,0.436902982685509,0.4433984104406144,0.2547791052972081,1,bp,NAC,3479,IGF1
GO:0097060,synaptic membrane,1/24,431/19659,0.41277059023347396,0.4435743656240317,0.3566752939959319,1,cc,NAC,8516,ITGA8
GO:0050708,regulation of protein secretion,1/24,438/18493,0.4376514501431713,0.44381073560257484,0.25501602954723285,1,bp,NAC,3479,IGF1
GO:0019932,second-messenger-mediated signaling,1/24,439/18493,0.43839896413910384,0.4442214503815763,0.25525202846257034,1,bp,NAC,3479,IGF1
GO:0006874,cellular calcium ion homeostasis,1/24,448/18493,0.4450838755856894,0.4506430809013577,0.258941931808758,1,bp,NAC,2247,FGF2
GO:0043254,regulation of protein complex assembly,1/24,451/18493,0.44729518364129794,0.45252874663242076,0.26002544545368167,1,bp,NAC,3725,JUN
GO:0005635,nuclear envelope,1/24,461/19659,0.43438226071070396,0.45400628508587615,0.36506353332928637,1,cc,NAC,3164,NR4A1
GO:0010008,endosome membrane,1/24,462/19659,0.4350893565406313,0.45400628508587615,0.36506353332928637,1,cc,NAC,4915,NTRK2
GO:0031012,extracellular matrix,1/24,490/19659,0.4545476096867195,0.4545476096867195,0.36549880895861947,1,cc,NAC,7060,THBS4
GO:0043025,neuronal cell body,1/24,483/19659,0.449744159197189,0.4545476096867195,0.36549880895861947,1,cc,NAC,8516,ITGA8
GO:0098793,presynapse,1/24,482/19659,0.4490546515388967,0.4545476096867195,0.36549880895861947,1,cc,NAC,4915,NTRK2
GO:0048285,organelle fission,1/24,458/18493,0.45242210954396,0.45735890575098687,0.26280088079511316,1,bp,NAC,3479,IGF1
hsa05203,Viral carcinogenesis,1/23,201/7844,0.45003479017095105,0.4574733817440246,0.3014587111192973,1,kg,NAC,3725,JUN
GO:0070838,divalent metal ion transport,1/24,459/18493,0.4531507965065854,0.45773877186062406,0.2630191538995429,1,bp,NAC,2247,FGF2
GO:0055074,calcium ion homeostasis,1/24,461/18493,0.4546053835318853,0.45885072563490675,0.2636580885034403,1,bp,NAC,2247,FGF2
GO:0072511,divalent inorganic cation transport,1/24,462/18493,0.4553312858608136,0.459226032473931,0.2638737418265172,1,bp,NAC,2247,FGF2
GO:0002791,regulation of peptide secretion,1/24,465/18493,0.45750344168253543,0.46105824697921405,0.26492654211036276,1,bp,NAC,3479,IGF1
GO:0006914,autophagy,1/24,466/18493,0.4582256469964703,0.46106956101972224,0.2649330432187342,1,bp,NAC,3953,LEPR
GO:0061919,process utilizing autophagic mechanism,1/24,466/18493,0.4582256469964703,0.46106956101972224,0.2649330432187342,1,bp,NAC,3953,LEPR
GO:0048871,multicellular organismal homeostasis,1/24,471/18493,0.4618228745017855,0.46432889009985717,0.266805871193198,1,bp,NAC,3953,LEPR
GO:0031667,response to nutrient levels,1/24,481/18493,0.46894878179951727,0.4711282494143872,0.2707128195312146,1,bp,NAC,3725,JUN
GO:0072503,cellular divalent inorganic cation homeostasis,1/24,483/18493,0.4703630713203447,0.47218336184403026,0.27131909279355065,1,bp,NAC,2247,FGF2
GO:0016049,cell growth,1/24,485/18493,0.47177375085918516,0.47323322108612775,0.27192234754614164,1,bp,NAC,3479,IGF1
GO:0009150,purine ribonucleotide metabolic process,1/24,488/18493,0.4738830207280793,0.47498166760766525,0.27292701429714483,1,bp,NAC,3479,IGF1
GO:0051656,establishment of organelle localization,1/24,491/18493,0.47598421762956467,0.4767193283903825,0.27392548350476065,1,bp,NAC,10252,SPRY1
GO:0051051,negative regulation of transport,1/24,495/18493,0.47877330662501993,0.4791427304727244,0.275317983341873,1,bp,NAC,6424,SFRP4
GO:0060627,regulation of vesicle-mediated transport,1/24,498/18493,0.48085578137875273,0.48085578137875273,0.2763023115823211,1,bp,NAC,6424,SFRP4
R-HSA-195721,Signaling by WNT,1/21,330/10554,0.487139226643285,0.4897724116521676,0.23282899025909498,1,re,NAC,27123,DKK2
R-HSA-112316,Neuronal System,1/21,368/10554,0.5257518871504332,0.5257518871504332,0.24993298540258282,1,re,NAC,7102,TSPAN7
hsa04080,Neuroactive ligand-receptor interaction,1/23,338/7844,0.6374228637605923,0.6426476413324004,0.4234819716097119,1,kg,NAC,3953,LEPR
hsa05168,Herpes simplex virus 1 infection,1/23,492/7844,0.7750827592618204,0.7750827592618204,0.5107520108100998,1,kg,NAC,9021,SOCS3
